Compounds > beta-lactams
Page last updated: 2024-09-04

beta-lactams and ertapenem

beta-lactams has been researched along with ertapenem in 608 studies

Compound Research Comparison

Studies
(beta-lactams)		Trials
(beta-lactams)		Recent Studies (post-2010)
(beta-lactams)		Studies
(ertapenem)		Trials
(ertapenem)		Recent Studies (post-2010) (ertapenem)
7,5791793,39585089485

Research

Studies (608)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's233 (38.32)29.6817
2010's364 (59.87)24.3611
2020's11 (1.81)2.80

Authors

AuthorsStudies
Odenholt, I1
Citron, DM; Fernandez, H; Goldstein, EJ; Merriam, CV; Tyrrell, KL; Warren, YA1
Caballero-Lopez, J; Carides, A; Friedland, IR; Ortiz-Ruiz, G; Woods, GL1
Friedland, I; Jiang, Q; Legua, P; Lema, J; Moll, J; Woods, G1
Ceesay, TP; Gesser, R; Graham, DR; Holtom, P; Lucasti, C; Malafaia, O; McAdams, A; Nichols, RL; Perez, NQ; Woods, GL1
Friedland, IR; Isaacs, R; Mixson, LA; Motyl, M; Woods, GL1
Bartizal, K; Gesser, RM; Motyl, M; Pelak, BA; Woods, GL1
Ashwood, MS; Brands, KM; Cameron, M; Conrad, KM; Cottrell, IF; Davies, AJ; Dolling, UH; Houghton, PG; Jobson, RB; Kennedy, DJ; Pipik, B; Reamer, RA; Reider, PJ; Williams, JM1
Cajigas, J; Gesser, RM; Imbeault, D; Jasovich, A; Jiang, Q; Jimenez-Cruz, F; Woods, GL1
Ho, DH; LeBlanc, BM; Rolston, KV; Streeter, H1
Bartizal, K; Friedland, I; Motyl, M; Pelak, BA; Teppler, H; Woods, GL1
Goldstein, EJ2
Citron, DM; Gesser, RM; Goldstein, EJ; Merriam, CV; Tyrrell, KL; Warren, Y1
Burdmann, EA; Gesser, RM; Jiang, Q; Reyna, OG; Tomera, KM; Wimmer, WM; Woods, GL1
Banevicius, M; Capitano, B; Kim, MK; Nicolau, D; Nightingale, C; Xuan, D1
Armstrong, SH; Hilliard, NJ; Johnson, CN; Quarles, S; Waites, KB1
Birk, KL; Hsieh, JY; Kitchen, CJ; Musson, DG1
Birk, KL; Blum, RA; Deutsch, P; Greenberg, H; Haesen, R; Hesney, M; Holland, S; Kitchen, CJ; Li, SX; Lins, RL; Majumdar, AK; McCrea, J; Mistry, G; Musson, DG; Rogers, JD; Waldman, S; Xi, L1
Adeyi, B; Fernandez, A; Geib, J; Hassett, JM; Teppler, H; Woods, GL; Yellin, AE1
Citron, DM; Goldstein, EJ; Motyl, M; Pelak, BA; Teppler, H; Woods, GL1
Bartizal, KF; Hicks, PS; Motyl, M; Pelak, B; Woods, GL1
Birk, KL; Fang, W; Hsieh, JY; Kitchen, CJ; Majumdar, AK; Musson, DG; Rogers, JD; Zhang, J1
Aldridge, KE1
Friedland, I; Majumdar, A; Mixson, LA; Motyl, M; Woods, GL1
Cambronero-Hernandez, E; Carides, A; Isaacs, R; Oliveria, T; Rohlf, J; Simon, S; Vetter, N1
Cunha, BA1
Carides, A; Choe, KA; Christou, NV; Dellinger, EP; Fernandez, A; Malafaia, O; Rotstein, OD; Satishchandran, V; Solomkin, JS; Tellado, JM; Teppler, H; Yellin, AE1
Hussar, DA1
De Lepeleire, I; Deutsch, P; Guillaume, M; Laethem, T; Li, S; Majumdar, A; McCrea, J; Musson, D; Parneix-Spake, A; Rogers, D; Zhang, J1
Gesser, R; McCarroll, K; Tellado, J; Teppler, H; Woods, GL1
Gesser, RM; McCarroll, K; Teppler, H; Woods, GL2
Birk, K; Deutsch, P; Fisher, A; Greenberg, H; Holland, S; Li, SX; Majumdar, A; Mistry, G; Musson, DG; Rogers, JD; Waldman, S; Wickersham, P1
Gunderson, B; Hermsen, ED; Hovde, LB; Ibrahim, KH; Rotschafer, JC; Rotschafer, SE1
Zaĭtsev, AA1
Acosta, F; Cottagnoud, M; Cottagnoud, P; Pfister, M; Täuber, MG1
Adeyi, B; Angel-Muller, E; Hague, C; Higareda, I; Ismail, M; Roy, S; Teppler, H; Woods, GL1
Livermore, DM; Scott, GM; Sefton, AM1
Curran, M; Perry, C; Simpson, D1
Isaacs, RD; Shah, PM1
Karpov, OI; Strekachev, AIu; Zaĭtsev, AA1
Andrews, JM; Ashby, JP; Jevons, G; Wise, R1
Almaraz, F; Baquero, F; Cantón, R; Loza, E; Morosini, MI; Reig, M1
Lauwers, S; Piérard, D; Roebben, E; Rosseel, P; Vandoorslaer, K; Wybo, I1
Fisher, AL; Kitchen, CJ; Musson, DG1
Gesser, RM; McCarroll, KA; Woods, GL2
Friedland, IR; Isaacs, RD; McCarroll, KA; Woods, GL1
Forsyth, RJ; Kanike, JD; McQuade, MS; Schariter, J; Van Nostrand, V1
Birk, K; Deutsch, P; Holland, S; Majumdar, A; Mistry, G; Muckow, J; Musson, DG; Rogers, JD; Sciberras, D; Xi, L1
Meibohm, AR; Teppler, H; Woods, GL1
Bethel, CR; Bonomo, RA; Helfand, MS; Hujer, AM1
Alhambra, A; Alós, JI; Cacho, J; Cuadros, JA; Gómez-Garcés, JL1
Hammond, ML1
Wexler, HM1
DiNubile, MJ; Majumdar, AK; Nix, DE1
Goldstein, EJ; Snydman, DR1
DiNubile, MJ; Lipsky, BA1
Gesser, RM; Graham, DR; Meibohm, AR; Roy, S; Solomkin, J; Teppler, H; Woods, GL1
Carides, A; Friedland, I; Isaacs, R; Ortiz-Ruiz, G; Vetter, N; Woods, GL1
Gesser, RM; Jiang, Q; Wells, WG; Woods, GL1
Friedland, IR; Gesser, RM; Herman, G; Isaacs, R; Meibohm, A; Mistry, G; Teppler, H; Woods, GL1
Tice, AD1
Alexander, S; Fenton, K; James, D; Livermore, DM; Marsden, B; Rudd, E; Warner, M1
DiNubile, MJ; Friedland, IR; McCarroll, KA; Woods, GL1
Holland, S; Lin, JH; Majumdar, A; Mistry, G; Musson, D; Sahly, Y; Singh, R; Waldman, S; Wong, BK; Xu, X; Yu, S1
Chow, N; Jacoby, GA; Mills, DM1
Kaye, KM; Martin, SI1
Ferguson, EC; Matthias, KR; Nix, DE1
Bulitta, J; Burkhardt, O; De Roux, A; Kruse, G; Kurowski, M; Lode, H; Nord, CE; Pletz, MW; Rau, M1
Blain, H; Durant, R; Jeandel, C; Raschilas, F; Tigoulet, F1
Debbia, EA; Gualco, L; Marchese, A; Schito, AM; Schito, GC1
Brink, AJ; Feldman, C; Grolman, DC; Muckart, D; Pretorius, J; Richards, GA; Senekal, M; Sieling, W1
Babalola, C; Banevicius, MA; Maglio, D; Nicolau, DP; Nightingale, CH; Sutherland, C1
Burgess, DS; Frei, CR; Moczygemba, LR1
Guest, SS; Seto, AH; Song, JC1
Baysallar, M; Doğanci, L; Kiliç, A; Küçükkaraaslan, A; Senses, Z1
Allouch, P; Decousser, JW; Methlouthi, I; Pina, P1
Livermore, DM; Mushtaq, S; Warner, M1
Alhambra, A; Alós, JI; Gómez-Garcés, JL; Hernáiz, C1
Embil, JM; Gin, A; Hoban, DJ; Johanson, C; Noreddin, A; Vercaigne, L; Zhanel, GG1
Chryssouli, Z; Galani, I; Giamarellou, H; Orlandou, K; Souli, M1
Lemaire, S; Mingeot-Leclercq, MP; Tulkens, PM; Van Bambeke, F1
Borner, K; Burkhardt, O; Derendorf, H; Drewelow, B; Majcher-Peszynska, J; Mundkowski, R; Welte, T1
Chan, CY; Dinubile, MJ; Friedland, I; Giezek, H; Motyl, MR; Quinn, JP; Shivaprakash, M; Weinstein, RA1
Antia, FD; Capodanno, V; Helmy, R; Sajonz, P; Sudah, O; Vailaya, A1
Abramson, MA; Chow, JW; DiNubile, MJ; Motyl, MR; Polis, A; Satishchandran, V; Teppler, H1
Deters, M; Kaever, V; Koal, T; Resch, K1
Brands, KM; Conrad, KM; DiMichele, LM; Dolling, UH; Houghton, PG; Jobson, RB; Marchesini, G; Novak, TJ; Pipik, B; Savary, KA; Sidler, DR; Skerlj, RT; Tsay, FR; Williams, JM1
Avlamis, A; Katsandri, A; Legakis, NJ; Pantazatou, A; Papaparaskevas, J1
Jenkinson, P; Livermore, DM; Natarajan, M; Rizkalla, E; Samuel, JR; Warner, M1
Engel, AE; Glass, D; Li, C; Wexler, HM1
Keating, GM; Perry, CM1
Bishai, WR; Helke, K; Nuermberger, E1
Allaouchiche, B; Boselli, E; Breilh, D; Fleureau, C; Gordien, JB; Janvier, G; Lalaude, O; Saux, MC1
Abramson, MA; Armstrong, DG; Citron, DM; Lipsky, BA; Morgenstern, DE; Tice, AD1
Cheng, NC; Hsueh, PR; Huang, WK; Liu, CY; Liu, YC; Shyr, JM; Teng, LJ1
Chuang, YM; Ho, YC; Hsueh, PR; Teng, LJ; Tseng, SP1
Henne-Bruns, D; Isenmann, R; Kaever, V; Koal, T; Wagner, E; Wittau, M1
Lovering, AM; MacGowan, AP; Soltani, M1
Cazorla, E; Ferreres, L; Rizo, C; Román, J; Urgal, A1
Burkhardt, O; Drewelow, B; Majcher-Peszynska, J; Mundkowski, RG; Welte, T1
Bertino, JS; Chen, M; Drusano, GL; Ma, L; Nafziger, AN1
Detora, D; McGachy, NT; Natishan, TK; Sajonz, P; Wu, Y1
Asperger, W; Chan, CY; Dela Pena, AS; DiNubile, MJ; Giezek, H; Kafka, R; Köckerling, F; Raz, R; Shivaprakash, M; Vrijens, F; Warren, B1
Brink, AJ; Elliott, E; Els, Z; Livermore, DM; Turton, J; van Greune, J; Warner, M; Woodford, N1
Falagas, ME; Galanakis, E; Kateifidis, A; Leventakos, K; Mantadakis, E; Maraki, S; Samonis, G; Spanaki, AM; Tselentis, Y1
Antia, FD; Capodanno, V; Helmy, R; McPherson, L; Natishan, TK; Sajonz, P; Sudah, O; Vailaya, A1
Behra-Miellet, J; Calvet, L; Dubreuil, L1
Betriu, C; Culebras, E; Gómez, M; Picazo, JJ; Rodríguez-Avial, I; Salso, S; Sánchez, A1
Borer, A; Riesenberg, K; Saidel-Odes, L; Schlaeffer, F; Smolyakov, R1
Batard, E; Bugnon, D; Caillon, J; Grossi, O; Jacqueline, C; Le Mabecque, V; Miegeville, AF; Potel, G1
Brunner, M; Burkhardt, O; Derendorf, H; Grant, M; Schmidt, S; Tang, Y1
Bethel, CR; Bonomo, RA; Deeley, K; Doi, Y; Hujer, AM; Hujer, KM; Marsh, JW; Paterson, DL; Silveira, F; Szabó, D1
Cirioni, O; Della Vittoria, A; Ghiselli, R; Giacometti, A; Licci, A; Mocchegiani, F; Orlando, F; Saba, V; Scalise, G; Silvestri, C1
Cielecka-Piontek, J; Jelińska, A; Zajac, M2
Eagye, KJ; Kiffer, CR; Kuti, JL; Mendes, C; Nicolau, DP1
Baek, JY; Heo, ST; Ko, KS; Kwon, KT; Lee, JY; Lee, MY; Lee, NY; Oh, WS; Park, S; Peck, KR; Ryu, SY; Song, JH1
Satti, F; Shames, R; Smith, MA; Vellozzi, EM1
Deutsch, PJ; Fisher, A; Hesney, M; Majumdar, AK; Mistry, GC; Sica, D; Swan, S; Wagner, JA; Xi, L; Xu, Y1
Hernández, JR; Martínez-Martínez, L; Pascual, A; Romero, L; Velasco, C1
Bernander, S; Ericson, E; Fraenkel, CJ; Larsson, P; Melhus, A; Rydberg, J; Törnqvist, E; Ullberg, M1
Adeyi, B; DiNubile, MJ; Friedland, IR; Ginanni, JA; McCarroll, KA; Stratchounski, LS; Wood, CA; Woods, GL; Yakovlev, SV1
Allaouchiche, B; Boselli, E; Breilh, D; Gordien, JB; Saux, MC1
Donskey, CJ; Pultz, NJ; Stiefel, U1
Borbone, S; Cascone, C; Mezzatesta, ML; Santagati, M; Stefani, S1
Derkatch, S; Hoban, DJ; Laing, N; Noreddin, AM; Zhanel, GG1
Armstrong, DG; Bevilacqua, NJ; Rogers, LC1
Abramson, MA; Awad, SS; Finn, TS; Itani, KM; Jensen, EH; Wilson, SE2
Sexton, DJ1
Burkhardt, O; Derendorf, H; Drewelow, B; Katterwe, D; Kumar, V; Majcher-Peszynska, J; Welte, T1
DeRyke, CA; Nicolau, DP1
Burkhardt, O; Derendorf, H; Welte, T1
Banevicius, MA; DeRyke, CA; Fan, HW; Nicolau, DP1
Dallow, JW; Hill, RL; Livermore, DM; Palepou, MF; Pike, R; Ward, ME; Warner, M; Woodford, N1
Broide, E; Raveh, D; Rudensky, B; Yinnon, AM1
Abramson, MA; Jensen, EH; Namias, N; Solomkin, JS; Tomassini, JE1
Abramson, MA; Armstrong, DG; Lipsky, BA; Polis, AB; Sheehan, P; Tice, AD1
Lartigue, MF; Nordmann, P; Poirel, L; Poyart, C; Réglier-Poupet, H1
Dilay, L; Hoban, DJ; Karlowsky, JA; Noreddin, AM; Rubinstein, E; Thomson, K; Wiebe, R; Zhanel, GG1
Abramson, MA; Hoey, CT; Lipsky, BA; Tice, AD; Turpin, RS; Wu, J1
Chan, CY; Chow, JW; DiNubile, MJ; Friedland, IR; Giezek, H; McCarroll, K; Motyl, MR; Quinn, JP; Shivaprakash, M; Weinstein, RA1
Apolônio, ACM; Coutinho, SC; Diniz, CG; Farias, LM; Geralda de Sousa-Gaia, L; Nicoli, JR; Roque de Carvalho, MA; Valéria Dos Santos, K1
Bassetti, M; Di Biagio, A; Fasce, R; Molinari, MP; Mussap, M; Pallavicini, FB; Righi, E; Rosso, R; Viscoli, C1
Carrero, HA; Erwin, DP; Ewell, AJ; Mody, RM; Moran, KA; Selby, EB; Summers, AM1
Chen, YS; Chiu, CJ; Chu, C; Lee, CH; Liu, JW; Su, LH1
Chan, J; Chen, HH; Lye, DC; Teng, CP1
Fung, CP; Huang, SS; Lee, CW; Lee, N; Lee, SC; Shieh, WB; Siu, LK1
Brink, AJ; Feldman, C; Richards, GA1
Lunde, JL; Nelson, RE; Storandt, HF1
Arrieta, AC; Congeni, BL; Fernsler, D; Gesser, R; Higareda, I; Johnson, J; West, J; Yellin, AE1
Allaouchiche, B; Bel, JC; Boselli, E; Breilh, D; Djabarouti, S; Saux, MC1
Abidi, MH; Chandrasekar, PH; Cronin, SM; Ibrahim, RB; Shearer, CJ1
Basoli, A; Chirletti, P; Cirino, E; D'Ovidio, NG; Doglietto, GB; Ecari, M; Giglio, D; Giulini, SM; Malizia, A; Petrovic, J; Taffurelli, M1
Bast, DJ; De Azavedo, JC; Dresser, L; Duncan, CL; Low, DE; Walker, SE1
Lister, PD1
Apolônio, ACM; Carvalho, MAR; Coutinho, SC; Diniz, CG; Farias, LM; Martins, WA; Nicoli, JR; Santos, KVD1
Chua, AC; Fei, YS; Ong, C; Tambyah, PA1
Estrada, JL; Lluis-Casajuana, F; Martínez-Granados, F; Martínez-Lazcano, MT; Navarro, JN; Ordovás-Baines, JP1
Bachelet, M; Couet, W; Lefeuvre, S; Marchand, S; Venisse, N1
Nicolau, DP1
Acuña, C; Gobernado, M1
Alos, JI; Cacho, J; Cuadros, J; Gomez-Garces, JL; Orden, B; Tamayo, J1
Shah, PM1
Koh, TH; Koh, TY; Wang, G1
Bouziges, N; Jourdan, N; Lavigne, JP; Lemaire, X; Richard, JL; Sotto, A1
Baietto, L; Bonora, S; D'Avolio, A; De Rosa, FG; Di Perri, G; Garazzino, S; Sciandra, M; Siccardi, M1
Berg, ML; Crank, CW; Hayden, MK; Philbrick, AH1
Baudry, P; Hoban, DJ; Laing, N; Noreddin, AM; Vashisht, V; Zhanel, GG1
Falagas, ME; Karageorgopoulos, DE; Makris, GC; Matthaiou, DK; Peppas, G1
Joseph, J; Rodvold, KA1
Abramson, MA; Finn, TS; Itani, KM; Jensen, EH; Tomassini, JE1
May, T1
Boulamery, A; Bruguerolle, B; Guilhaumou, R; Marouani, H; Rocher, E; Simon, N1
Epstein, NE; Hollingsworth, R; Silvergleid, RS1
Aybey, AD; Dinleyici, EC; Durmaz, G; Erben, N; Kiremitci, A; Usluer, G; Yargic, ZA1
Fernández, L; Gómez-Rice, A; Lillo, M; Maseda, E; Ramasco, F; Villagrán, MJ1
Gobernado, M; González-Esteban, J; Redondo, E; Sanz-Rodríguez, C; Torroba, L; Villanueva, R1
Abramson, MA; Itani, KM; Jensen, EH; Kumar, RN; Pellissier, JM; Turpin, RS; Wilson, SE1
Abrahamian, FM; Deblieux, PM; Emerman, CL; Kollef, MH; Kupersmith, E; Leeper, KV; Paterson, DL; Shorr, AF1
Lima, AL; Oliveira, PR; Paula, AP; Zumiotti, AV1
Goff, DA; Mangino, JE1
Girlich, D; Nordmann, P; Poirel, L2
Levin, AS; Oliveira, MS1
Burkhardt, O; Fliser, D; Hafer, C; Haller, H; Kaever, V; Kielstein, JT; Kumar, V; Langhoff, A; Welte, T1
Abusada, NJ; Fica, AE1
Brunner, M; Burkhardt, O; Derendorf, H; Lobmeyer, MT; Röck, K; Sahre, M; Schmidt, S1
Michalska, K; Pajchel, G; Tyski, S1
Abramson, MA; Itani, K; Jensen, E; Suding, P; Wilson, SE1
Blanchet, B; Chhun, S; Jullien, V; Lanternier, F; Legrand, T; Pons, G; Rey, E; Zahar, JR1
Carey, PR; Kalp, M1
Arguedas, A; Blumer, J; Botet, FA; Cespedes, J; Gesser, R; Snyder, T; Wang, J; West, J; Wimmer, W; Yogev, R1
Dunne, WM; Fraser, VJ; Frye, JG; Marschall, J; Tibbetts, RJ; Warren, DK1
Chan, J; Leo, YS; Lye, DC; Teng, CP; Wijaya, L1
Dibirov, MD; Fesenko, TA; Karsot'ian, GS; Khachatrian, NN; Poliakov, IA1
Brink, AJ; Kiem, S; Richards, GA; Schentag, J; Schillack, V1
Arrigucci, S; Canonico, G; Cassetta, MI; Fallani, S; Garcea, A; Mazzei, T; Novelli, A; Tonelli, F1
Churchwell, MD; Depestel, DD; Jakob, V; Kinzig, M; Mueller, BA; Patel, JH; Sörgel, F; Stevenson, JM; Vilay, AM1
Herrera, ML; Jorgensen, JH; Lewis, JS; Prakash, V; Wickes, BL1
Andreacchio, K; Edelstein, PH; McGettigan, SE1
Abdel-Moety, EM; Elragehy, NA; Hassan, NY; Rezk, MR2
Elias, N; Odeh, M; Sabetay, S; Sheikh-Ahmad, M; Slobodin, G; Weller, B; Zaygraikin, N1
Carmeli, Y; Chmelnitsky, I; Colodner, R; Leavitt, A; Navon-Venezia, S; Ofek, I1
Ansaloni, L; Catena, F; Gazzotti, F; Nanetti, A; Nardo, B; Pezzilli, R; Pinna, AD; Santini, D1
Abramson, MA; Citron, DM; Goldstein, EJ; Merriam, CV1
Cuadrado Pastor, JM; Jover Díaz, F; Martín González, C; Mayol Belda, MJ1
Doumith, M; Ellington, MJ; Livermore, DM; Woodford, N1
Marco, JA; Naranjo, OR; Rodríguez de Castro, F; Violán, JS1
Chang, KT; Ledesma, KR; Quinn, JP; Tam, VH; Wang, TY1
Matull, WR; Morgan, MY; O'Beirne, J; O'Neill, S; Smith, R; Wright, G; Zambreanu, L1
Cilli, F; Eraç, B; Ermertcan, S; Limoncu, MH; Taşli, H1
Dal-Paz, K; Lima, AL; Oliveira, PR; Paula, AP; Rossi, F; Zumiotti, AV1
Ashcroft, M; Weinbren, M1
Cai, JC; Chen, GX; Chen, LR; Zhang, R; Zhou, HW1
Badal, RE; Bouchillon, SK; Hawser, SP; Hoban, DJ; Hsueh, PR; Paterson, DL1
Aguilar, L; Barberán, J; González-Comeche, J; González-Moreno, J; González-Pina, B; Granizo, JJ; Irurzun, J; López-Dupla, M; Marín, A; Murcia, JM1
Behera, B; Das, A; Kapil, A; Mathur, P1
Ermertcan, S; Hosgor-Limoncu, M; Tasli, H; Yurtman, AN1
Conejo, Mdel C; Hernández, JR; Pascual, A1
García, E; García, FJ; García, JE; García, MB; García, MI; González, B; Lozano, FS1
Awunor-Renner, C; Beckert, L; Kong, V1
Badal, RE; Bouchillon, SK; Hawser, SP; Hoban, DJ4
Bonomo, RA; Casiano-Colón, AE; Depasquale, JM; Endimiani, A; Fiorella, PD; Forero, S; Hujer, AM; Kitchel, B; Perez, F; Pickens, N; Roberts-Pollack, D; Tenover, FC1
Citron, DM; Elgourt, T; Goldstein, EJ; Lu, S; Meibohm, AR; Peraino, V1
Lee, CH; Lin, WC; Liu, JW; Su, LH; Tang, YF1
Gómez del Valle, C; Matía, M; Pérez-Calvo, JI; Torralba, MÁ1
Burkhardt, O; Derendorf, H; Kielstein, JT; Kumar, V; Schmidt, S; Welte, T1
Carmeli, Y; Jansen, JP; Kumar, R1
Couet, W; Dahyot-Fizelier, C; Frasca, D; Marchand, S; Mimoz, O; Petitpas, F1
An, MM; Chen, ML; Jiang, YY; Liu, P; Shen, H; Wang, R; Zhang, JD; Zou, Z1
Cattoir, V; Daurel, C1
Edmonds, M1
Calvert, K; Clark, J; Hayden, MK; Lolans, K; Won, S1
Geers, P; Hügel, O; Köckerling, F; Lippert, H; Schug-Pass, C1
Congeni, BL1
Bennett, JW; Herrera, ML; Jorgensen, JH; Lewis, JS; Mende, K; Murray, CK; Wickes, BL; Yu, X1
Pilla, V; Qi, C; Reed, K; Yu, JH1
Appelbaum, PC; Credito, K; Kosowska-Shick, K1
Eagye, KJ; Nicolau, DP2
Blanchard, JS; Fan, F; Tremblay, LW1
Badal, RE; Bouchillon, SK; DiPersio, J; Hawser, SP; Hoban, DJ; Labombardi, VJ1
Bazaz, R; Chapman, AL; Winstanley, TG1
Carmeli, Y; Chmelnitsky, I; Goren, MG; Navon-Venezia, S; Schechner, V; Schwaber, MJ1
Amyes, SG; Evans, BA; Hamouda, A; Towner, KJ1
dos Santos, RP; Goldani, LZ; Jacoby, T1
Abdel-Rahman, SM; Blumer, JL; Groff, M; Herman, G; Jacobs, RF; Kearns, GL; Kitchen, CJ; Majumdar, A; Mistry, GC; Topelberg, S; Wagner, JA; Xu, Y1
Giske, CG; Haldorsen, B; Samuelsen, Ø; Sundsfjord, AS; Vading, M1
Chen, CY; Huang, YB; Liao, FF1
Carattoli, A; García-Fernández, A; Giordano, A; Mancini, C; Miriagou, V; Papagiannitsis, CC; Venditti, M1
Bialek, S; Chevalier, J; Davin, A; Lavigne, JP; Leflon-Guibout, V; Marcon, E; Moreau, R; Nicolas-Chanoine, MH; Pagès, JM1
Amancio Martins, W; Bahia, JL; Cara, DC; Coutinho, SC; DE Macedo Farias, L; Galuppo Diniz, C; Lopes DE Andrade, JP; Morais Apolonio, AC; Nicoli, JR; Roque DE Carvalho, MA; Valéria Dos Santos, K1
Ko, WC; Lee, CC; Wu, JJ; Yan, JJ; Yang, FC1
Chapman, AL; Lessing, MP; Sanderson, F; Seaton, RA; Török, ME1
Chong, Y; Docquier, JD; Jeong, SH; Kim, CK; Lee, K; Seo, YH; Yong, D; Yum, JH1
Chang, CM; Chen, PL; Ko, NY; Ko, WC; Lee, CC; Lee, HC; Lee, NY; Shih, HI; Wang, LR; Wu, CJ; Yan, JJ1
Salman, S; Van Sickels, JE; Young, M1
Ferraro, MJ; Hooper, DC; Hyle, EP; Lee, H; Silver, M1
Borgianni, L; Docquier, JD; Hanson, ND; Prandi, S; Rossolini, GM; Salden, L; Santella, G1
Chumjan, W; Hajjar, E; Mahendran, KR; Schulte, A; Suginta, W; Weingart, H; Winterhalter, M1
Bolognesi, MP; Henderson, RA; Kaufman, AM; Watters, TS; Wellman, SS1
Duquaine, S; Kitchell, E; Tannen, RC; Tate, T; Wickremasinghe, IM1
Boutbaoucht, M; Laghla, B; Nejmi, H; Samkaoui, MA1
Cai, J; Liu, J; Wu, D1
Hsu, MS; Hsueh, PR; Huang, YT; Liao, CH; Liu, CY; Yang, CJ1
Bayraktar, B; Dalgic, N; Dincer, E; Pelit, S; Sancar, M1
Ahmed-Bentley, J; Peirano, G; Pitout, JD; Woodford, N1
Abdul-Baki, H; Aoun, E; Chaar, HF; El Hajj, II; Hashash, JG; Kanj, SS; Kyriacos, SB; Mansour, NM; Mroueh, M; Sharara, AI1
Chung, JK; Dong, F; Graber, CJ; Hutchings, C; Lee, W; Tran, T1
Agın, H; Devrim, I; Dizdarer, C; Gulfidan, G; Gunay, I; Güven, B; Yılmazer, MM1
Chiang, T; Colon-Urban, R; Eng, RH; Gomez, E; Huang, DB; Mariano, N; Urban, C1
Ersoy, Y; Görgeç, S; Kuzucu, C; Yetkin, F1
Hsueh, PR; Huang, WH; Ko, WC; Lee, NY; Tsui, KC1
Raghunathan, A; Samuel, L; Tibbetts, RJ1
Bencardino, A; Carattoli, A; Falcone, M; García-Fernández, A; Gianfreda, R; Giordano, A; Orsi, GB; Venditti, C; Venditti, M1
Hawser, SP2
Engler, C; Harris, P; Norton, R1
Ansaloni, L; Catena, F; Coccolini, F; Di Saverio, S; Ercolani, G; Gazzotti, F; Lazzareschi, D; Pinna, AD1
Dihmess, A; Evans, A; Fiorenza, M; Graffunder, E; Harrington, S; Lodise, TP; Martis, P; Masoud, R; McNutt, LA; Patel, N; Woo, B1
Naschitz, JE1
Gastal, SL; Goldani, LZ; Gorniak Lovatto, C; Jacoby, T; Konkewicz, L; Kuplich, NM; Lisboa, T; Nagel, FM; Pires dos Santos, R; Pires Machado, D; Pires, MR1
Boulamery, A; Boyadjiev, I; Bruguerolle, B; Leone, M; Martin, C; Simon, N1
Boselli, E; Breilh, D; Fleureau, C; Gordien, JB; Janvier, G; Joanes-Boyau, O; Rapaport, S; Saux, MC; Texier-Maugein, J1
Corona, A; Singer, M1
Cady, A; Le Touvet, B; Mallédant, Y; Seguin, P; Tribut, O; Verdier, MC1
Badal, RE; Bouchillon, SK; Cantón, R; Hackel, M; Hawser, SP; Hoban, DJ; Lascols, C1
Badal, RE; Bouchillon, SK; Hackel, M; Hawser, SP; Hoban, DJ; Lascols, C; Livermore, DM; Woodford, N1
Chen, CP; Chen, TL; Fung, CP; Lee, YT; Siu, LK1
Andrade, HM; Andrade, JP; Apolonio, AC; Bahia, JL; Carvalho, MA; Coutinho, SC; Diniz, CG; Farias, LM; Martins, WA; Nicoli, JR; Santos, KV; Veloso, LC1
Amyes, SG; Dancer, SJ; Findlay, J; Hamouda, A1
Guillon, H; Mammeri, H; Tande, D1
Aronoff, DM; Edwards, SP; Harms, PW; Lebar, B; Newton, DW; Smith, MH1
Iakovlev, AA; Kolbin, AS; Musatov, VB; Sidorenko, SV; Zagorodnikova, KA1
Beović, B; Cizman, M; Kreft, S; Seme, K1
Apuzzio, JJ; Brown, KR; Williams, SF1
Bonomo, RA; Endimiani, A; Papp-Wallace, KM; Taracila, MA1
Beloborodov, VB1
Cook, PP; Gooch, M; Rizzo, S1
Green, J; Kurtz, W; McNabb, PC; Trabue, CH; Verma, K1
Bereznitskiĭ, IaS; Bezdetko, NV1
Carmeli, Y; Crank, CW; Goff, DA; Goldstein, EJ; Graber, CJ; Lima, AL; Nicolau, DP1
Chang, SC; Chen, WC; Chen, YC; Hu, FC; Wang, JL; Wu, UI; Yang, CS1
Cardone, KE; Daoui, R; Drusano, GL; Grabe, DW; Kulawy, RW; Lodise, TP; Meola, S; Roglieri, J1
Hung, KH; Wu, JJ; Yan, JJ; Yang, FC1
Chang, HJ; Chia, JH; Kuo, AJ; Lee, MH; Liu, SW; Wu, TL1
Brockschmidt, C; Bulitta, JB; Burhenne, H; Henne-Bruns, D; Isenmann, R; Kaever, V; Mayer, B; Scheele, J; Wittau, M1
Chau, F; Fantin, B; Le, P; Lefort, A; Lepeule, R; Massias, L; Nucci, A; Ruppé, E1
Hille, DA; Namias, N; Zakrison, TL1
De Gaudio, M; De Martino, M; Filippi, L; Funghini, S; Galli, L; Giocaliere, E; la Marca, G; Malvagia, S; Ombrone, D; Villanelli, F1
Abreu-Lanfranco, O; Bhargava, P; Bheemreddy, S; Blunden, C; Carmeli, Y; Chopra, T; Chugh, N; Collins, VL; Eiseler, S; Hayakawa, K; Kaye, KS; Lephart, PR; Marchaim, D; Memon, BI; Moshos, J; Munoz-Price, LS; Pogue, JM; Shallal, A; Sunkara, B1
Chiu, CH; Su, LH; Wu, TL1
Couet, W; Grégoire, N; Marliat, M; Mimoz, O; Nordmann, P; Poirel, L1
Fong, JJ; Radigan, EA; Rosé, L1
Hsueh, PR; Huang, WH; Ko, WC; Lee, CC; Lee, NY; Tsui, KC1
Barie, PS; Hernandez-Soria, A; Kapoor, NS1
Antunes, NT; Frase, H; Toth, M; Vakulenko, SB; Vakulenko, V1
Cai, Y; Kwa, AL; Lee, W; Tan, TT; Tan, TY; Tang, S; Teo, J1
Chen, CC; Cheng, KC; Chiang, SR; Chiu, YH; Chuang, YC; Ko, WC; Ku, YH; Tang, HJ; Zhang, CC1
Badal, RE; Bouchillon, SK; Hackel, MA; Hawser, SP; Hoban, DJ; Lascols, CA; Rossi, F; Villegas, MV1
Golparian, D; Lahra, MM; Limnios, A; Ohnishi, M; Tapsall, JW; Unemo, M; Whiley, D1
Chung, MH; Kim, HY; Kim, JY; Kim, MJ; Lee, JS; Lee, MS; Park, DW; Park, YS; Peck, KR; Yeom, JS1
Chau, T; Lin, SH; Sung, CC; Wen, MJ1
Boyle, F; Boyle, L; Brisse, S; Burns, K; Condon, I; Cormican, M; Delannoy-Vieillard, AS; Finnegan, C; Humphreys, H; Khan, A; Monahan, R; Morris, C; Morris, D; Morris-Downes, M; O'Connell, N; O'Gorman, A; Powell, J; Power, L; Turton, J; Woodford, N1
Hsueh, PR1
Chen, YH; Chen, YS; Chuang, YC; Ho, CM; Ho, MW; Hsueh, PR; Huang, CC; Ko, WC; Lee, YL; Liu, CE; Liu, YC; Liu, YM; Lu, PL; Tang, HJ; Toh, HS; Wang, JH; Yu, KW1
Chen, YH; Chen, YS; Chuang, YC; Ho, CM; Hsueh, PR; Huang, CC; Ko, WC; Lee, YL; Liu, CE; Liu, YC; Liu, YM; Lu, PL; Ni, Y; Tang, HJ; Toh, HS; Wang, JH; Xu, Y; Yu, KW2
Chanawong, A; Charoensri, N; Chetchotisakd, P; Kerdsin, A; Lulitanond, A; Phumsrikaew, W; Rimrang, B; Sribenjalux, P; Wilailuckana, C; Wonglakorn, L1
Adler, A; Aronov, R; Carmeli, Y; Edgar, R; Glick, J; Paikin, S; Schwaber, MJ; Sterlin, Y1
Autenrieth, IB; Gröbner, S; Marschal, M; Pfeifer, Y; Weissgerber, P; Wienke, M1
Azana, R; Boos, A; Conley, ME; Crawford, RI; Deans, GD; Hoang, L; Janz, L; Junker, A; Leo, SH; Morton, TL; Prendiville, J; Senger, C; Tilley, P; Turvey, SE1
Casas, CO; Fernández, FM; Guilera, ED; Guillen, VV; Salido, AJ; Tarragó, AC1
Boisseau, D; Ferry-Blanco, C; Forestier, E; Gros, S; Labe, A; Lecomte, C; Levast, M; Peynaud, D; Rogeaux, O1
McDougall, DA; Morton, AP; Playford, EG1
Burian, A; Erdogan, Z; Jandrisits, C; Zeitlinger, M1
Brown, S; Pickering, M1
Dalhoff, A; Schubert, S1
Hsueh, PR; Lai, CC; Lee, CM; Lee, MC; Wang, YY1
Berbari, E; Huddleston, P; Ramos, A1
Alder, J; Arvis, P; De Waele, JJ; Hampel, B; Jensen, M; Reimnitz, P; Tellado, JM1
Aguilar, L; Granizo, JJ; Llinares, P; Lobo, E; Martin-Antona, E; Martin-Perez, E; Torres, A; Turegano, F1
Colakoğlu, S; Durmaz, S; Ekincioğlu, P; Perçin, D1
Aliosmanoglu, I; Bora, F; Dinckan, A; Gunseren, F; Kocak, H; Suleymanlar, G; Uslu, HB1
Koh, TH; Krishnan, PU; Lim, TP; Lye, D; Marimuthu, K; Ng, TM; Tan, TY; Teng, C1
Roux, B; Ziervogel, BK1
Burian, A; Burian, B; Höferl, M; Jäger, W; Riedl, M; Sauermann, R; Stella, A; Theurer, S; Zeitlinger, M1
Crandon, JL; Hagihara, M; Nicolau, DP; Urban, CM1
Andreazzi, D; Caiaffa-Junior, HH; Cury, AP; Maffucci, M; Rossi, F1
Badal, RE; Biedenbach, DJ; Bouchillon, SK; Cantón, R; Hawser, SP; Hoban, DJ; Paterson, DL1
Hodsdon, ME; Jarvis, M; Kulkarni, MV; Murray, TS; Peaper, DR; Tichy, AN1
Aarnio, M; Dean, K; Grönroos, JM; Hurme, S; Jartti, A; Mecklin, JP; Nordström, P; Paajanen, H; Rantanen, T; Rautio, T; Salminen, P; Sand, J1
Housman, ST; Kuti, JL; Nicolau, DP; Quintiliani, R; Wiskirchen, DE1
Falagas, ME; Kapaskelis, A; Tansarli, GS; Vardakas, KZ1
Baziaka, F; Galani, L; Giamarellou, H; Karaiskos, I1
Debets-Ossenkopp, Y; Murk, JL; Vainio, S; van Doorn-Schepens, M; Vandenbroucke-Grauls, C; Wilhelm, A1
Crandon, JL; Hagihara, M; Nicolau, DP; Urban, C1
Adler, M; Cars, O; Löwdin, E; Sandegren, L; Tängdén, T1
Kim, DH; Yoon, H1
Catania, MR; Cerbone, D; de Werra, C; Di Micco, R; Forestieri, P; Formato, A; Lambiase, A; Montella, E; Pilone, V1
Bou, G; Castelo-Corral, L; Gutiérrez-Urbón, JM; Llinares, P; López-Calviño, B; Molina, F; Sousa, D1
Caio, C; Ceccarelli, G; Falcone, M; Giordano, A; Mezzatesta, ML; Stefani, S; Venditti, M1
Arthur, M; Bougault, C; Dubée, V; Hugonnet, JE; Lecoq, L; Simorre, JP; Triboulet, S2
Arnould, JF; Bouquié, R; Dailly, E; Deslandes, G; Fraissinet, F; Jolliet, P; Le Floch, R; Letard de la Bouralière, MA; Naux, E1
Fernandez-Diaz, E; Iñurrieta Romero, A; Matesanz-David, M; Poza-Montoro, A; Rodríguez-Cerrillo, M1
Amaduzzi, A; Ansaloni, L; Baiocchi, GL; Catena, F; Coccolini, F; Cucchi, M; Di Saverio, S; Lazzareschi, D; Pasqualini, E; Pinna, AD; Sartelli, M; Schiavina, R; Vallicelli, C1
Boulamery, A; Bruguerolle, B; Marsot, A; Simon, N1
Borges, JV; Fonseca, ME; Jaskulski, MR; Machado, DC; Marinowic, DR; Medeiros, BC; Nodari, P; Rocha, MP; Zalewsky, R1
Ham, M; Moss, A1
Chung, C; Desjardins, M; Ellis, C; Melano, RG; Patel, SN; Tijet, N; Toye, B1
Carvalho, VC; Lima, AL; Oliveira, PR; Peixoto de Miranda, EJ1
Crandon, JL; Nicolau, DP; Nordmann, P; Wiskirchen, DE3
Badal, RE; Cao, B; Chen, M; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Y; Hu, Z; Huang, W; Kong, H; Liao, K; Lu, J; Ni, Y; Shao, H; Shen, D; Su, J; Sun, Z; Wang, H; Wang, Y; Wu, A; Xu, Y; Yang, Q; Ye, H; Yu, Y; Zhang, H; Zhang, S1
Casini, B; Ferranti, S; Flammini, S; Giani, T; Leonildi, A; Lewis, R; Menichetti, F; Rossolini, GM; Tagliaferri, E; Tascini, C1
Patel, N; Ramakrishnan, R; Siegel, G1
Cheng, KC; Chu, LW; Hon, FK; Mok, MY; Shea, YF1
Chatzipantazi, V; Koumaki, V; Markou, F; Poulou, A; Tsakris, A; Voulgari, E; Vrioni, G; Xidopoulos, G1
Fernando, SL1
Bandettini, R; Buffa, P; Castagnola, E; Caviglia, I; Ciucci, A; Ginocchio, F; Guida, E; Haupt, R; Loy, A; Masa, DL; Mattioli, G; Perotti, M; Pini Prato, A1
Suchánková, H; Urbánek, K1
Chang, CL; Chang, KK; Huang, YC; Lu, CM; Su, LH; Tai, FT1
Bayraktar, B; Celebi, S; Dalgic, N; Dokucu, AI; Kafadar, I; Kara, O; Karadag, CA; Pelit, S; Sancar, M1
Couet, W; de Castro, WV; Lamarche, I; Marchand, S1
Badal, RE; Biedenbach, DJ; Bouchillon, SK; Goff, DA; Hackel, MA; Hawser, SP; Hoban, DJ1
Arthur, M; Cordillot, M; Dubée, V; Dubost, L; Hugonnet, JE; Mainardi, JL; Marie, A; Triboulet, S1
Block, CS; Cohen, MJ; Moses, AE; Nir-Paz, R1
Aloia, TA; Ariza-Heredia, EJ; Chemaly, RF; Feig, BW; Graviss, LS; Mahajan, SN; Rolston, KV1
Cunha, BA; Hage, J; Jose, A1
Cassisa, V; Chesnay, A; Eveillard, M; Joly-Guillou, ML; Kempf, M; Lamoureux, C; Lebreton, C; Lemarié, C; Mahaza, C; Pailhoriès, H1
Chlebicki, MP; Kwa, AL; Lee, AL; Lee, W; Liew, LT; Lim, CL; Nah, SC; Wan, CN1
Chen, Z; Kang, M; Li, D; Tao, C; Wang, T; Xie, Y1
Cabrera-Alvargonzalez, JJ; Hoyos-Mallecot, Y; Liebana-Martos, C; Miranda-Casas, C; Navarro-Marí, JM; Rojo-Martín, MD1
DePestel, DD; Eyler, RF; Heung, M; Kinzig, M; Mueller, BA; Nader, AM; Pleva, M; Sörgel, F; Sowinski, KM; Vilay, AM1
Cesnauskas, G; Horn, PT; Novikovs, N; Ramesh, MK; Solomkin, JS; Stefanova, P; Sutcliffe, JA; Walpole, SM1
Burnham, CA; Frobel, RA; Herrera, ML; Wickes, BL1
Castaing, N; Cooper, A; Dartois, N; Dukart, G; Embil, JM; Lauf, L; Maroko, R; Mitha, I; Ozsvár, Z; Regöly-Mérei, J; Sabol, MB; Yan, J1
Beovic, B; Maticic, M; Soštaric, N1
Accetta, G; Adembri, C; Berti, J; Biggeri, A; Borracci, T; Cappellini, I; De Gaudio, AR; Lucchese, M; Novelli, A1
Lin, A; Russell, M; Xu, M; Yoo, J1
Johansson, A; Nagy, E; Sóki, J2
Cole, MJ; Ison, CA; Quaye, N1
Chan, KW; Huang, YC; Kao, CC; Lin, CF; Liu, JW; Liu, PY; Shi, ZY; Shyu, CL; Tung, KC; Wu, ZY1
Bai, N; Cai, Y; Liang, B; Liu, Y; Sun, C; Wang, J; Wang, R; Zhang, L1
Attallah, M; Gomaa, N; Kamel, N; Metwally, L1
Hidalgo, G; Hidalgo, M; Jugo, MB; Maccallini, GC; Villar, HE; Visser, M1
Farrell, R; Kopacz, J; Mariano, N; Piracha, N; Prasad, N; Segal-Maurer, S; Shakil, J; Tarasuk, A; Urban, C; Wang, G1
Esteban Fernández, J; Padilla Peinado, R; Rodríguez Álvarez, S; Villa Albuguer, T1
Doi, Y; Qureshi, ZA; Syed, A1
Ekelöf, J; Giske, CG; Johansson, A; Sundqvist, M1
Alffenaar, JW; Greijdanus, B; Touw, DJ; van Rijn, SP; Wessels, AM1
Cannon, JP; Clark, NM; Grim, SA; Lee, TA; Setlak, P1
Fisher, DA; Hee, KH; Lee, LS; Llorin, RM; Lye, DC; Sulaiman, Z; Tam, VH; Zhou, J1
Boyer, MW; Goulston, C; Hanson, KE; Kim, JH; Tricot, G; Zangari, M1
Barth, AL; da Silva, RC; Dalarosa, MG; Falci, DR; Luz, DI; Magagnin, CM; Ribeiro, VB; Rozales, FP; Sampaio, JM; Vieira, FJ; Zavascki, AP1
Adam, HJ; Denisuik, A; Hoban, DJ; Vashisht, S; Yachison, C; Zhanel, GG1
Kees, F; Kees, MG; Kratzer, A; Liebchen, U; Schleibinger, M1
Blackmore, T; Losco, G; Studd, R1
Kim, HJ; Kim, MJ; Lee, SE; Sohn, JW; Yang, KS; Yoon, YK1
Badal, RE; Biedenbach, DJ; Bouchillon, SK; Hackel, M; Hoban, DJ; Nga, TT; Phuong, DM; Phuong, NT; Phuong, TT1
Fernández, J; Fleites, A; Montero, I; Rodicio, MR1
Kees, F; Kees, MG; Kloft, C; Kratzer, A; Liebchen, U; Wicha, SG1
Ahn, C; Doi, Y; Hu, F; O'Hara, JA; Rivera, JI; Syed, A1
Munckhof, WJ; Oo, Y; Packham, D; Yau, W1
Brown, SD; Pickering, MK1
Aktas, B; Altınbas, A; Ekiz, F; Kaya, B; Yilmaz, B1
Jain, JG; Kuti, JL; Nicolau, DP; Sutherland, C1
Caldwell, N; Cao, YK; Dai, WM; Leng, XS; Paschke, A; Qiu, HZ; Shen, JF; Wang, J; Zhao, YJ; Zhu, WH1
Chen, CH; Chen, JB; Chiu, CH; Chuang, FR; Lee, CT; Liu, HT; Wu, CH; Yang, CC1
Bassetti, M; Righi, E1
Blanchette, LM; Kuti, JL; Nailor, MD; Nicolau, DP1
Danishuddin, M; Faheem, M; Khan, A; Khan, AU1
Bradley, P; Ji, C; Meinke, PT; Nicoll-Griffith, DA; Olsen, DB; Rindgen, D; Singh, SB; Soll, RM; Suzuki, T; Wang, L; Wang, N; Wu, H; Yu, H; Zhang, B1
Bowler, IC; Buchanan, R; Crook, D; Stoesser, N1
Cao, Y; Ding, Z; Gong, Y; Jiang, H; Liu, X; Song, X; Wang, F; Wang, T; Wang, W; Zhang, N; Zhang, W; Zhang, Z1
Bajaj, H; Benz, R; Mahendran, KR; Singh, PR; Winterhalter, M1
Araujo-Melendez, J; Criollo, E; Macias-Hernandez, AE; Ponce-de-Leon, A; Ponce-de-Leon, S; Rodriguez-Osorio, CA; Sanchez-Martinez, CO; Sifuentes-Osornio, J1
Black, DJ; Frase, H; Smith, CA; Stewart, NK; Vakulenko, SB1
Chou, YC; Lee, KH; Ng, YY; Ueng, YF; Wu, CW; Yang, WC1
Altay, MA; Baur, DA; Flores-Hidalgo, A; Ort, Y; Quereshy, FA1
Bai, KJ; Chang, FY; Chen, RJ; Chen, YH; Chen, YS; Hsu, CW; Hsueh, PR; Jean, SS; Ko, WC; Lee, WS; Liao, CH; Liu, CY; Liu, JW; Lu, MC; Wu, JJ; Yu, KW1
Abbey, A; Farrar, H; Nair, R; Patel, V1
Chowers, M; Krashin, E; Lishner, M; Reisfeld, S1
Daitch, V; Farbman, L; Lador, A; Leibovici, L; Paul, M; Tredler, Z; Zusman, O1
Chang, FY; Chiu, CH; Lin, DY; Lin, HA; Lin, HC; Lin, JC; Wang, JX; Yang, YS; Yeh, KM1
Barber, KE; Raut, A; Rybak, MJ; Smith, JR1
Cavanillas, R; Grau, S; Lozano, V; Nocea, G; Valladares, A; Xie, Y1
Chung, HS; Lee, M1
Badal, RE; Biedenbach, DJ; Bouchillon, SK; Hackel, MA; Kazmierczak, KM; Lob, SH; Sahm, DF1
George, LV; Molnar, GP; Stephens, KJ; Stewart, JT1
Chemaly, RF; Mahajan, SN; Nesher, L; Rolston, KV; Tverdek, FP1
Carvalho, M; Charlton, CL; Hindler, JA; Humphries, R; Kelesidis, T; Miller, SA; Nizet, V; Nonejuie, P; Pogliano, J; Sakoulas, G; Wong-Beringer, A1
Amicosante, G; Bottoni, C; Celenza, G; Colapietro, M; Compagnoni, C; Marcoccia, F; Maturo, MG; Perilli, M; Sabatini, A; Segatore, B1
Avdic, E; Carroll, KC; Cosgrove, SE; Smith, JM; Tamma, PD; Zhang, L1
Aarnio, M; Grönroos, JM; Hurme, S; Jartti, A; Mecklin, JP; Nordström, P; Paajanen, H; Rantanen, T; Rautio, T; Rinta-Kiikka, I; Salminen, P; Sand, J; Tuominen, R; Virtanen, J1
Arthur, M; Bougault, CM; Hugonnet, JE; Laguri, C; Simorre, JP; Triboulet, S1
Graves, B; Hajkowicz, K; Paterson, DL; Stewart, A; Ta, K1
Gentry, CA; Williams, RJ1
Garritson, S; Lee, S; Lin, M; Liu, C; Nichols, A; Prasad, P1
Anupurba, S; Banerjee, T; Filgona, J1
Buffet Croix Blanche, S; Canard, I; Charrier, JP; Chatellier, S; Mirande, C; van Belkum, A; Welker, M1
Córdoba, J; Coronado-Álvarez, NM; Parra, D; Parra-Ruiz, J1
Cipolla, A; D'Abramo, A; D'Agostino, C; Gizzi, F; Iannetta, M; Mascellino, MT; Mastroianni, CM; Oliva, A; Russo, G; Tierno, F; Trinchieri, V; Vullo, V1
Chidiac, C; Ferry, T; Laurent, F; Ragois, P1
Cattoir, V; Derdouri, S; Dupont, H; Emond, JP; Gaillard, N; Gaillot, O; Girard de Courtilles, M; Goetgheluck, AS; Lecuru, M; Lemaire, B; Mammeri, H; Plassart, C1
Badal, RE; Cao, B; Chen, S; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Z; Huang, W; Kong, H; Liao, K; Luo, Y; Ni, Y; Shao, H; Su, J; Sun, Z; Wang, Y; Wu, A; Xu, Y; Yang, Q; Yu, Y; Zhang, H; Zhang, S1
Chongtrakool, P; Diraphat, P; Malathum, K; Pornsinchai, P; Siripanichgon, K1
Cprek, JB; Gallagher, JC1
Ayaz, T; Kara, E; Sahin, OZ; Sahutoglu, T; Tufekci, A; Yildirim, S1
Coignard-Biehler, H; Delage, M; Duchatelet, S; Guet-Revillet, H; Hovnanian, A; Jais, JP; Join-Lambert, O; Jullien, V; Lortholary, O; Nassif, A; Nassif, X; Poirée, S1
Alffenaar, JW; Centis, R; D'Ambrosio, L; De Lorenzo, S; Migliori, GB; Sotgiu, G; Tiberi, S; Viggiani, P1
Bettoli, V; Join-Lambert, O; Nassif, A1
Arora, R; Chakotiya, AS; Chawla, R; Goel, R; Narula, A; Sharma, RK; Tanwar, A; Thakur, P1
Andrews, T; Campbell, F; Heath, RM; Madirrala, V; Neal, TJ; Rooney, P; Subramanian, S1
Aracil, B; Barba, MJ; Bou, G; Campos, J; Fernández, B; Ortega, A; Oteo, J; Oviaño, M1
Hung, YP; Ko, WC; Lee, JC; Li, CW; Li, MC; Lin, HJ; Liu, HC; Wu, YH1
Cachero, A; Castellote, J; Dueñas, E; Girbau, A; Grau, I1
Child, J; Crombleholme, T; Hurst, AL; Olson, D; Parker, SK; Pyle, L; Ranade, D; Somme, S; Stamatoiu, A1
Ersoy, F; Uslu, H; Yılmaz, F1
Fattouh, R; McGeer, A; Melano, RG; Patel, SN; Poutanen, SM; Tijet, N1
Albornoz, E; Bahr, G; Corso, A; Gonzalez, LJ; Pasteran, F; Vila, AJ1
Akkerman, OW; Alffenaar, JW; de Lange, WC; Kosterink, JG; van Altena, R; van der Laan, T; van der Werf, TS; van Rijn, SP; van Soolingen, D1
Ji, S; Li, C; Li, S; Liang, X; Zhang, F; Zhu, Y1
Forbes, W; Joyner, ML; Maiden, M; Manning, CC; Nikas, AN1
Raut, A; Rybak, MJ; Smith, JR; Yim, J1
Artero, A; Atienza, A; Correa, S; Faus, A; López, I; Madrazo, M; Puchades, F1
Pedroso, TM; Salgado, HR1
Jeon, YL; Kang, SY; Kim, MH; Lee, MY; Lee, WI1
Cunha, BA; Gerson, S; Giuga, J1
Cipolla, A; D'Abramo, A; De Angelis, M; Favaro, M; Ferretti, G; Gizzi, F; Iannetta, M; Mascellino, MT; Mastroianni, CM; Oliva, A; Russo, G; Vullo, V1
Gan, WJ; Mu, SM; Ran, XW; Shen, JF; Wang, J; Xian, Y; Xu, ZR; Yan, XD; Yuan, GY; Zhang, BS1
Akova, M; Almela, M; Almirante, B; Bermejo, J; Bonomo, RA; Bou, G; Calbo, E; Carmeli, Y; Cisneros, JM; García-Vázquez, E; Gasch, O; Giamarellou, H; Gracia-Ahulfinger, I; Gutiérrez-Gutiérrez, B; Hamprecht, A; Hsueh, PR; Lowman, W; Martínez-Martínez, L; Mora-Rillo, M; Oliver, A; Origüen, J; Pascual, A; Paterson, DL; Peña, C; Pérez, F; Pintado, V; Pitout, J; Prim, N; Rodríguez-Baño, J; Schwaber, MJ; Tacconelli, E; Tumbarello, M; Venditti, M; Viale, P1
Caio, C; Gona, F; Mezzatesta, ML; Salerno, I; Stefani, S; Zingali, T1
Dunyach-Remy, C; Lavigne, JP; Mesureur, J; Ngba Essebe, C; Nicolas-Chanoine, MH; Pagès, JM; Pantel, A; Sotto, A1
Alffenaar, JW; Gumbo, T; Srivastava, S; van Rijn, SP; Wessels, AM1
Centis, R; D'Ambrosio, L; Dore, S; Esposito, S; Migliori, GB; Sotgiu, G; Spanevello, A; Tiberi, S1
Kazanji, N; Klein, RE; Le, J; Lohani, S; Mertens, AN1
Bridge, L; Brown-Elliott, BA; Killingley, J; Vasireddy, S; Wallace, RJ1
Van Epps, P; Veillette, JJ1
Aktaş, Z; Akyön, Y; Aşçı Toraman, Z; Ay, S; Ayaş, R; Aydemir, Ş; Aydın, F; Bakıcı, Z; Bayramoğlu, G; Baysallar, M; Büyüktaş, A; Çağatay, M; Çakar, A; Çelik, C; Çöplü, N; Dündar, D; Erçal, BD; Güdücüoğlu, H; Gülay, Z; Günaydın, M; Gür, D; Hasdemir, U; Karatuna, O; Kayacan, Ç; Kılıç, A; Kılıç, H; Öğünç, D; Özhak Baysan, B; Parlak, M; Tünger, A; Yanık, K; Zer, Y1
Basuino, L; Chambers, HF; Choo, EJ; Hamilton, SM; Moise, P1
Chung, HS; Lee, M; Yong, D1
Aracil, B; Bautista, V; Campos, J; Fernández-Romero, S; Lara, N; Ortega, A; Oteo, J; Pérez-Vázquez, M; Sáez, D1
Hu, Q; Hu, Y; Lin, X; Lv, H; Xu, X; Zhang, R1
Aruanno, A; Buonomo, A; Centrone, M; Di Rienzo, A; Mezzacappa, S; Nucera, E; Pascolini, L; Pecora, V; Ricci, AG; Rizzi, A; Schiavino, D1
Banerjee, R; Boyce, TG; Cunningham, SA; Hasassri, ME; Jeraldo, PR; Kaye, KS; Norgan, AP; Patel, R; Pogue, JM; Weissman, SJ1
Davis, SL; Grunwald, JL; Kenney, RM; Veve, MP; Wagner, JL1
Archuleta, S; Chan, M; Fisher, DA; Llorin, RM; Lye, DC; Sulaiman, Z; Tam, VH; Tan, SY; Trad, MA; Zhong, LH1
Burgers, PC; Dekker, LJ; Goessens, WH; Kostzrewa, M; Luider, TM; Monteferrante, CG; Peer, M; Sparbier, K; Sultan, S; Ten Kate, MT1
Manzano-García, M; Márquez-Saavedra, E1
Hsiao, FY; Pai, TY; Shen, LJ; Wu, CC; Wu, FL1
Amin, A; Bourget, P; Dariane, C; De Toma, C; Lalli, A; Le Guilchet, T; Lortholary, O; Méjean, A; Michel, C; Nguyen-Khoa, T; Timsit, MO; Treluyer, JM; Urien, S1
Arai, K; Kashiwa, M; Nagano, N; Saito, R; Yamada, K1
Nielsen, EI; Sandegren, L; Tängdén, T; Ungphakorn, W1
Ariano, RE; Calic, D; Lawson, C; Lipman, J; Roberts, JA; Zelenitsky, SA; Zhanel, GG1
Dixon, N; Fowler, RC; Geyer, CN; Hanson, ND; Harrison, L; Horiyama, T; Ishii, Y; Moland, ES; Thomson, K; Yoshizumi, A1
Angwafo Iii, FF; Mbarga, JA; Mbarga, NF; Nfor, EK; Oben, CE; Sama, CB1
Kumaraswamy, M; Nizet, V; Olson, J; Pogliano, J; Quach, DT; Rybak, MJ; Sakoulas, G; Singh, NB; Yim, J1
Medeiros, ACD; Pedroso, TM; Salgado, HRN1
Bravo-Ferrer, JM; Gutiérrez-Urbón, JM; Llinares, P; Pita, S; Ramos-Merino, L; Seoane-Pillado, T; Sousa, D; Vázquez-Rodríguez, P1
Álvarez, C; Ardila, N; Ariza, B; Caro, MA; Gil, F; González, PF; Valderrama, SL1
Chelaghma, W; Kassah-Laouar, A; Loucif, L; Messala, A; Rolain, JM; Saidi, M1
Cheng, MP; Lee, TC; Paquette, K; Parkes, LO; Yansouni, CP1
Baker, MA; Cooper, MA; Li, J; Schneider, EK; Velkov, T; X Huang, J1
Carroll, K; Romagnoli, M; Simner, PJ; Wang, F; Workneh, M1
Hsueh, PR; Jean, SS1
Perovic, O; Singh-Moodley, A1
Bitterman, R; Geffen, Y; Paul, M; Polak, D1
Pai, P; Rathod, N1
Di Maggio, T; Docquier, JD; Landini, G; Pallecchi, L; Rossolini, GM; Sergio, F1
Bulitta, JB; Hemper, E; Henne-Bruns, D; Kornmann, M; Kurlbaum, M; Ly, NS; Paschke, S; Scheele, J; Wittau, M1
Battikh, H; Dekhili, A; Fendri, C; Harchay, C; Kechrid, F; Khazar, K; Masmoudi, A; Zribi, M1
Evans, D; Horn, P; Lee, P; Marsh, A; Slepavicius, A; Solomkin, J; Sutcliffe, JA; Tsai, L1
Amii, R; DeUgarte, DA; Jude, CM; Krishnadasan, A; Moran, GJ; Morim, A; Mower, WR; Pathmarajah, K; Saltzman, DJ; Talan, DA; Wu, JX1
Hackel, MA; Hoban, DJ; Karlowsky, JA; Lob, SH; Sahm, DF1
Dizbay, M; Karaşahin, EF; Karaşahin, Ö; Özger, HS1
Lavigne, JP; Meiller, E; Merens, A; Nicolas-Chanoine, MH; Pantel, A; Robert, J1
Alp, E; Badal, R; Gulay, Z; Koksal, I; Korten, V; Lob, S; Mete, B; Mulazimoglu, L; Oguz, VA; Tabak, F; Unal, S; Yilmaz, G; Zarakolu, P1
Bhattacharjee, A; Chakravarty, A; Choudhury, NA; Dhar, D; Ingti, B; Maurya, AP; Paul, D1
Ajao, AO; Albrecht, JS; Furuno, JP; Harris, AD; Johnson, JK; Pineles, LL; Robinson, GL; Thom, KA; Zhao, L1
Jitmuang, A; Kiratisin, P; Rattanaumpawan, P; Thamlikitkul, V; Werarak, P1
Kim, JH; Kim, MJ; Sohn, JW; Yang, KS; Yoon, YK1
Angeletti, S; Ciotti, M; Dolfa, C; Favalli, C; Sakarikou, C1
Fisher, S; Galanis, C; Gupta, C; Kaushik, A; Lamichhane, G; Parrish, N; Story-Roller, E1
D'Arcy, S; Doumith, M; Findlay, J; Hopkins, KL; Howe, R; Mather, B; Meunier, D; Mustafa, N; Pike, R; Woodford, N; Wootton, M1
Görür, K; İsmi, O; Özcan, C; Vayisoğlu, Y; Yeşilova, M1
Abderrahim, A; Bentakouk, MC; Dekhil, M; Djahmi, N; Kirane-Gacemi, D; Lavigne, JP; Nedjai, S; Pantel, A; Pujol, C; Sotto, A1
Bader, M; Seitz, M; Stief, C; Tilki, D; Waidelich, R1
Fakhar, Z; Govender, T; Honarparvar, B; Kruger, HG; Lamichhane, G; Maguire, GEM; Walker, RC1
Baroncelli, S; Bartoloni, A; Farese, A; Luise, F; Mancini, A; Nozzoli, C; Pieralli, F; Rossolini, GM; Sammicheli, L1
Gao, X; Liu, G; Shen, B; Song, J; Yu, Y; Zhu, C1
Fredborg, M; Sondergaard, TE; Wang, M1
Kiertiburanakul, S; Malaisri, C; Phuphuakrat, A; Santanirand, P; Wibulpolprasert, A1
Kim, HS; Kim, HY; Kim, YK; Lee, J; Lee, JA; Lee, SS; Seo, YB; Song, W; Uh, Y1
Allerberger, F; Jesumirhewe, C; Lepuschitz, S; Ruppitsch, W; Springer, B1
Ha, DT; Ho-Le, TP; Hoang, HQ; Nguyen, DA; Nguyen, TA; Nguyen, TSM; Nguyen, TV; Pham, TTN; Tran, GM; Tran, NV; Tran-Nguyen, CH1
Aarnio, M; Grönroos, J; Hurme, S; Nordström, P; Paajanen, H; Rantanen, T; Rautio, T; Salminen, P; Sippola, S; Tuominen, R1
Antonelli, M; Arcadipane, A; Capitanio, G; Cutuli, SL; De Pascale, G; Di Carlo, D; Di Gravio, V; Di Stefano, R; Martucci, G; Montini, L; Panarello, G; Polidori, P; Spanu, T; Vallecoccia, MS1
Cheng, A; Chuang, YC; Sheng, WH; Wang, JT; Yang, JJ1
Alffenaar, JC; Gumbo, T; Srivastava, S; van Rijn, SP; van Soolingen, D; Wessels, MA1
Elzanfaly, ES; Fayed, AS; Hendawy, HAM; Salama, NN; Salem, MY; Youssif, RM1
Almirante, B; Campany, D; Fàbrega, A; Fox, ML; González-López, JJ; Larrosa, N; Miguel, L; Mir, A; Piedra-Carrasco, N; Ruiz-Camps, I; Viñado, B1
Niramitranon, J; Pongprayoon, P; Somboon, K1
Cho, HL; Hsiao, CY; Huang, YJ; Hung, MC; Hung, SC; Lai, LF; Lee, YC; Tong, SH; Wang, JT1
Monogue, ML; Nicolau, DP1
Darling, LA; Evans, AM; Montero, CI; Nattanmai, SM; Stellrecht, KA1
Ambretti, S; Campoli, C; Gaibani, P; Giannella, M; Landini, MP; Lewis, RE; Re, MC; Viale, P; Volpe, SL1
Logan, J; Mellor, TE; Mitchell, N1
Aydın, A; Barış Aykan, M; Sağlam, K; Veillette, JJ1
Kim, JH; Kim, MJ; Kim, SB; Sohn, JW; Suh, JW; Yang, KS; Yoon, YK1
Achard, MES; Anderson, GJ; Djoko, KY; Hancock, SJ; Harris, PN; Lo, AW; McEwan, AG; Miraula, M; Mitić, N; Paterson, DL; Peters, KM; Phan, MD; Prombhul, S; Schembri, MA; Schenk, G; Shafer, WM; Sidjabat, HE; Walsh, TR1
Badal, R; Cao, B; Chen, S; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Z; Huang, W; Kong, H; Liao, K; Luo, Y; Ni, Y; Shao, H; Su, J; Sun, Z; Wang, Y; Wu, A; Xu, Y; Yang, Q; Yu, Y; Zhang, H; Zhang, S1
González, D; Naik, D; Pérez-Etayo, L; Vitas, AI1
Eumkeb, G; Evans, K; Hobbs, G; Nakouti, I; Teethaisong, Y1
Horvath, E; Kazmierczak, KM; Sahm, DF; Wise, MG; Young, K1
Aznar, J; Barrón-Adúriz, R; Calvo, J; Cantón, R; Castillo, FJ; Cercenado, E; Cisterna, R; González-Romo, F; López-Hontangas, JL; López-Mendoza, D; Loza, E; Molloy, B; Suárez-Barrenechea, AI; Tubau, F1
Hackel, MA; Hoban, DJ; Lob, SH; Motyl, MR; Sahm, DF; Young, K1
Li, Y; Liu, J; Liu, Y; Shen, L; Yu, J; Zhu, W1
Caetano, T; Covas, C; Mendo, S; Santos, T; Viana, AT1
Aarnio, M; Grönroos, JM; Hurme, S; Jartti, A; Mecklin, JP; Nordström, P; Paajanen, H; Rantanen, T; Rautio, T; Salminen, P; Sand, J; Tuominen, R; Virtanen, J1
Badal, R; Duan, Q; Gui, B; Huang, W; Jiang, X; Kong, H; Li, H; Liao, K; Ni, Y; Shan, B; Sun, Z; Wang, W; Wang, Y; Wu, A; Xu, Y; Yang, C; Yang, Q; Yu, Y; Zhang, H; Zhang, S1
Bobola, V; Forbes, W; Frazier, W; Joyner, ML; Manning, CC1
Caroline, C; Chien-Boon Lye, D; Choon-Kiat Tan, N; Ding, YY; Hsien-Xiong Lee, R; Lim, JP; Neo, HY; Pei-Ying Ho, E; Tan, KT; Wei-Han Ng, D1
Choi, J; Dantas, G; Das, S; Gandra, S; Green, SJ; Harazin, M; McElvania, E; Singh, KS; Thomson, RB1
Arias, CA; Dinh, AQ; Kebriaei, R; Khan, A; Murray, BE; Rice, SA; Rybak, MJ; Singh, KV; Stamper, KC; Tran, TT1
Drobniewski, F; Gonzalo, X; McHugh, TD; Ortiz Canseco, J; Satta, G1
Gasparetto, J; Telles, JP; Tuon, FF; Zequinão, T1
Aguilera Sancho-Tello, MV; Conde, I; García Eliz, M; Ladrón Abia, P; Martínez Delgado, S; Mínguez Sabater, A1
DeZotell, L; Elledge, S; Guy, J; Holmes, AK; Klindworth, K1
Chen, DQ; Chen, EZ; Ling, JH; Liu, WT; Peng, C; Wang, LJ; Yang, L; Yuan, PB; Zhong, YX; Zhu, JH1
Arimuthu, DA; Mazlan, SA; Shahar, S1
Ambrose, PG; Bhavnani, SM; Conde, H; Cotroneo, N; Friedrich, LV; Jones, S; VanScoy, BD1
Chang, YH; Hsu, CK; Huang, PY; Lai, CC; Liu, TH; Tang, HJ; Tsai, YW; Wu, JY1

Reviews

53 review(s) available for beta-lactams and ertapenem

ArticleYear
Ertapenem: a new carbapenem.
    Expert opinion on investigational drugs, 2001, Volume: 10, Issue:6

    Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Clinical Trials, Phase II as Topic; Drug Evaluation; Ertapenem; Gram-Negative Aerobic Bacteria; Gram-Positive Bacteria; Humans; Lactams; Microbial Sensitivity Tests

2001
Ertapenem. A review of its microbiologic, pharmacokinetic and clinical aspects.
    Drugs of today (Barcelona, Spain : 1998), 2002, Volume: 38, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Child; Drug Interactions; Ertapenem; Humans; Infusions, Intravenous; Lactams

2002
New drugs 2003, part I.
    Nursing, 2003, Volume: 33, Issue:2

    Topics: Adult; Anti-Bacterial Agents; Antihypertensive Agents; beta-Lactams; Carbazoles; Drug Therapy; Ertapenem; Humans; Imidazoles; Lactams; Migraine Disorders; Olmesartan Medoxomil; Pharmaceutical Preparations; Tetrazoles; Tryptamines

2003
Properties and potential of ertapenem.
    The Journal of antimicrobial chemotherapy, 2003, Volume: 52, Issue:3

    Topics: Bacteria; Bacterial Infections; beta-Lactams; Carbapenems; Clinical Trials as Topic; Drug Resistance, Bacterial; Ertapenem; Half-Life; Humans; Lactams

2003
Ertapenem: a review of its use in the management of bacterial infections.
    Drugs, 2003, Volume: 63, Issue:17

    Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Ertapenem; Humans; Lactams

2003
Ertapenem, the first of a new group of carbapenems.
    The Journal of antimicrobial chemotherapy, 2003, Volume: 52, Issue:4

    Topics: Animals; beta-Lactams; Carbapenems; Clinical Trials as Topic; Cross Infection; Ertapenem; Humans; Lactams

2003
[New approaches to antibacterial therapy of infections in the surgical practice].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2003, Volume: 48, Issue:5

    Topics: Abdominal Abscess; Aza Compounds; Bacterial Infections; beta-Lactams; Community-Acquired Infections; Cross Infection; Ertapenem; Fluoroquinolones; Humans; Lactams; Moxifloxacin; Quinolines; Randomized Controlled Trials as Topic; Surgical Wound Infection

2003
Ertapenem: a Group 1 carbapenem with distinct antibacterial and pharmacological properties.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 53 Suppl 2

    Topics: Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Carbapenems; Community-Acquired Infections; Ertapenem; Humans; Lactams

2004
In vitro activity of ertapenem: review of recent studies.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 53 Suppl 2

    Topics: Animals; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Community-Acquired Infections; Drug Resistance, Bacterial; Ertapenem; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Lactams; Microbial Sensitivity Tests

2004
Pharmacokinetics and pharmacodynamics of ertapenem: an overview for clinicians.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 53 Suppl 2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Clinical Trials as Topic; Community-Acquired Infections; Ertapenem; Female; Humans; Lactams; Male; Middle Aged; Renal Insufficiency

2004
Complicated infections of skin and skin structures: when the infection is more than skin deep.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 53 Suppl 2

    Topics: Adult; Anti-Bacterial Agents; Bacteria, Anaerobic; beta-Lactams; Ertapenem; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Lactams; Skin Diseases, Bacterial; Soft Tissue Infections

2004
Safety and tolerability of ertapenem.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 53 Suppl 2

    Topics: Adult; Aged; Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Ceftriaxone; Clinical Trials as Topic; Community-Acquired Infections; Ertapenem; Female; Humans; Lactams; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Randomized Controlled Trials as Topic

2004
Beta-lactam antibiotics: newer formulations and newer agents.
    Infectious disease clinics of North America, 2004, Volume: 18, Issue:3

    Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactams; Cefepime; Cephalosporins; Ertapenem; Humans; Lactams; United States

2004
Appropriate use of the carbapenems.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2004, Volume: 94, Issue:10 Pt 2

    Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Cilastatin; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Drug Utilization; Ertapenem; Humans; Imipenem; Lactams; Meropenem; Patient Selection; Pneumonia, Bacterial; Practice Patterns, Physicians'; Protease Inhibitors; South Africa; Surgical Wound Infection; Thienamycins; Urinary Tract Infections

2004
Ertapenem: review of a new carbapenem.
    Expert review of anti-infective therapy, 2005, Volume: 3, Issue:1

    Topics: Animals; beta-Lactams; Carbapenems; Drugs, Investigational; Ertapenem; Humans; Lactams

2005
Ertapenem: a review of its use in the treatment of bacterial infections.
    Drugs, 2005, Volume: 65, Issue:15

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Child; Child, Preschool; Drug Resistance, Bacterial; Ertapenem; Humans; Infant

2005
[Ertapenem and other antibacterials].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2006, Volume: 51, Issue:2

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Clinical Trials as Topic; Drug Evaluation, Preclinical; Ertapenem; Female; Genital Diseases, Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Pregnancy; Skin Diseases, Infectious; Urinary Tract Infections

2006
Ertapenem for diabetic foot infections.
    Drugs of today (Barcelona, Spain : 1998), 2006, Volume: 42, Issue:11

    Topics: Anti-Bacterial Agents; beta-Lactams; Diabetic Foot; Ertapenem; Humans

2006
Ertapenem: the new carbapenem 5 years after first FDA licensing for clinical practice.
    Expert opinion on pharmacotherapy, 2007, Volume: 8, Issue:2

    Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Clinical Trials as Topic; Community-Acquired Infections; Critical Illness; Drug Interactions; Drug Resistance, Bacterial; Endometritis; Ertapenem; Female; Humans; Peritonitis; Protein Binding; Renal Insufficiency; Surgical Wound Infection; Urinary Tract Infections

2007
Comparative review of the carbapenems.
    Drugs, 2007, Volume: 67, Issue:7

    Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Doripenem; Ertapenem; Humans; Imipenem; Meropenem; Thienamycins

2007
Carbapenems in the USA: focus on doripenem.
    Expert review of anti-infective therapy, 2007, Volume: 5, Issue:5

    Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Clinical Trials as Topic; Doripenem; Drug Resistance, Multiple, Bacterial; Ertapenem; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Structure-Activity Relationship; Thienamycins; United States

2007
Carbapenems: a potent class of antibiotics.
    Expert opinion on pharmacotherapy, 2008, Volume: 9, Issue:1

    Topics: Anti-Bacterial Agents; Bacteria; beta-Lactams; Carbapenems; Clinical Trials as Topic; Doripenem; Ertapenem; Humans; Imipenem; Meropenem; Molecular Structure; Structure-Activity Relationship; Thienamycins

2008
[Ertapenem].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2007, Volume: 20, Issue:3

    Topics: Adolescent; Adult; Age Factors; Aged; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactam Resistance; beta-Lactams; Cell Wall; Child; Diabetes Complications; Double-Blind Method; Drug Costs; Drug Synergism; Ertapenem; Female; Humans; Male; Obesity; Pregnancy; Randomized Controlled Trials as Topic; Tissue Distribution

2007
Parenteral carbapenems.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2008, Volume: 14 Suppl 1

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Ertapenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Humans; Imipenem; Infusions, Parenteral; Meropenem; Thienamycins

2008
Meta-analysis: ertapenem for complicated intra-abdominal infections.
    Alimentary pharmacology & therapeutics, 2008, Volume: 27, Issue:10

    Topics: Abdomen; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Ertapenem; Humans; Randomized Controlled Trials as Topic; Treatment Outcome

2008
The role of carbapenems in the treatment of severe nosocomial respiratory tract infections.
    Expert opinion on pharmacotherapy, 2008, Volume: 9, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cross Infection; Doripenem; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Ertapenem; Humans; Imipenem; Meropenem; Patient Selection; Pneumonia, Bacterial; Respiratory Tract Infections; Severity of Illness Index; Thienamycins; Treatment Outcome

2008
Health care-associated pneumonia: identification and initial management in the ED.
    The American journal of emergency medicine, 2008, Volume: 26, Issue:6 Suppl

    Topics: Acetamides; Age Distribution; Aged; Aged, 80 and over; Anti-Infective Agents; beta-Lactams; Cephalosporins; Cross Infection; Emergency Treatment; Ertapenem; Female; Humans; Length of Stay; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Oxazolidinones; Patient Care Team; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Practice Guidelines as Topic; Respiration, Artificial; Risk Factors; Severity of Illness Index; Tigecycline

2008
The challenge of multidrug resistance: the treatment of gram-negative rod infections.
    Shock (Augusta, Ga.), 2008, Volume: 30 Suppl 1

    Topics: Acinetobacter; Bacterial Infections; beta-Lactamases; beta-Lactams; Clinical Trials as Topic; Drug Resistance, Multiple; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Ertapenem; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Minocycline; Polymyxins; Pseudomonas aeruginosa; Sulbactam; Tigecycline

2008
New antimicrobial molecules and new antibiotic strategies.
    Seminars in respiratory and critical care medicine, 2009, Volume: 30, Issue:2

    Topics: Acetamides; Anti-Infective Agents; beta-Lactams; Cephalosporins; Community-Acquired Infections; Drug Design; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Ertapenem; Fluoroquinolones; Humans; Ketolides; Linezolid; Lipopeptides; Oxazolidinones; Pneumonia, Bacterial; Practice Guidelines as Topic

2009
Ertapenem versus piperacillin/tazobactam for the treatment of complicated infections: a meta-analysis of randomized controlled trials.
    BMC infectious diseases, 2009, Dec-02, Volume: 9

    Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Ertapenem; Humans; Penicillanic Acid; Piperacillin; Randomized Controlled Trials as Topic; Tazobactam; Treatment Outcome

2009
[Update on antimicrobial chemotherapy].
    Medecine et maladies infectieuses, 2010, Volume: 40, Issue:3

    Topics: Acetamides; Aminoglycosides; Anti-Infective Agents; beta-Lactams; Carbapenems; Cephalosporins; Daptomycin; Doripenem; Drug Resistance, Bacterial; Ertapenem; Fluoroquinolones; France; Humans; Linezolid; Lipoglycopeptides; Minocycline; Oxazolidinones; Penicillins; Pyrimidines; Teicoplanin; Tigecycline

2010
The treatment of diabetic foot infections: focus on ertapenem.
    Vascular health and risk management, 2009, Volume: 5

    Topics: Administration, Oral; Anti-Bacterial Agents; beta-Lactams; Combined Modality Therapy; Debridement; Diabetic Foot; Drug Administration Schedule; Ertapenem; Humans; Infusions, Intravenous; Osteomyelitis; Severity of Illness Index; Treatment Outcome; Vascular Surgical Procedures

2009
Ertapenem.
    Expert opinion on pharmacotherapy, 2010, Volume: 11, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Ertapenem; Half-Life; Humans; Outpatients

2010
Outpatient parenteral antimicrobial therapy: Recent developments and future prospects.
    Current opinion in investigational drugs (London, England : 2000), 2010, Volume: 11, Issue:8

    Topics: Ambulatory Care; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Daptomycin; Dosage Forms; Ertapenem; Humans; Infusions, Parenteral; Lipoglycopeptides; Teicoplanin

2010
Carbapenems: past, present, and future.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:11

    Topics: Anti-Bacterial Agents; beta-Alanine; beta-Lactams; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Doripenem; Drug Combinations; Ertapenem; Humans; Imipenem; Thienamycins

2011
Carbapenem stewardship: does ertapenem affect Pseudomonas susceptibility to other carbapenems? A review of the evidence.
    International journal of antimicrobial agents, 2012, Volume: 39, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Clinical Trials as Topic; Drug Interactions; Drug Resistance, Bacterial; Ertapenem; Humans; Microbial Sensitivity Tests; Pseudomonas; Pseudomonas aeruginosa; Pseudomonas Infections

2012
Successful approach to treatment of Helicobacter bilis infection in X-linked agammaglobulinemia.
    Journal of clinical immunology, 2012, Volume: 32, Issue:6

    Topics: Adolescent; Adult; Agammaglobulinemia; Anti-Bacterial Agents; Azithromycin; beta-Lactams; Chronic Disease; Ertapenem; Genetic Diseases, X-Linked; Helicobacter; Helicobacter Infections; Humans; Male; Ofloxacin; Phylogeny; Treatment Outcome

2012
Diagnosis and treatment of Fusobacterium nucleatum discitis and vertebral osteomyelitis: case report and review of the literature.
    Spine, 2013, Jan-15, Volume: 38, Issue:2

    Topics: Adult; Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Braces; Clavulanic Acid; Combined Modality Therapy; Discitis; Drug Therapy, Combination; Ertapenem; Female; Fusobacterium Infections; Fusobacterium nucleatum; Humans; Intervertebral Disc; Lumbar Vertebrae; Magnetic Resonance Imaging; Microbial Sensitivity Tests; Middle Aged; Osteomyelitis; Treatment Outcome

2013
Ertapenem use and antimicrobial resistance to group 2 carbapenems in Gram-negative infections: a systematic review.
    Expert review of anti-infective therapy, 2013, Volume: 11, Issue:1

    Topics: Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Carbapenems; Ertapenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Pseudomonas aeruginosa

2013
[Microbiology of diabetic foot infections: role of ertapenem].
    Drugs of today (Barcelona, Spain : 1998), 2013, Volume: 49 Suppl A

    Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Diabetic Foot; Drug Resistance, Bacterial; Ertapenem; Humans; Microbial Sensitivity Tests

2013
[Pharmacological characteristics of ertapenem].
    Klinicka mikrobiologie a infekcni lekarstvi, 2013, Volume: 19, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactams; Ertapenem; Humans

2013
Ertapenem versus ceftriaxone for the treatment of complicated infections: a meta-analysis of randomized controlled trials.
    Chinese medical journal, 2014, Volume: 127, Issue:6

    Topics: Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Ertapenem; Humans; Intraabdominal Infections; Pneumonia; Randomized Controlled Trials as Topic; Urinary Tract Infections

2014
The risk of seizures among the carbapenems: a meta-analysis.
    The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:8

    Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Child; Cilastatin; Cilastatin, Imipenem Drug Combination; Doripenem; Drug Combinations; Ertapenem; Humans; Imipenem; Meropenem; Risk; Seizures; Thienamycins

2014
Ertapenem-associated psychosis and encephalopathy.
    Internal medicine journal, 2014, Volume: 44, Issue:8

    Topics: Anti-Bacterial Agents; beta-Lactams; Diabetic Foot; Ertapenem; Humans; Male; Middle Aged; Neurotoxicity Syndromes; Psychoses, Substance-Induced; Severity of Illness Index; Wound Infection

2014
Assays for determination of ertapenem for applications in therapeutic drug monitoring, pharmacokinetics and sample stability.
    Biomedical chromatography : BMC, 2014, Volume: 28, Issue:11

    Topics: beta-Lactams; Chromatography, High Pressure Liquid; Drug Monitoring; Ertapenem; Humans

2014
Eravacycline for the treatment of intra-abdominal infections.
    Expert opinion on investigational drugs, 2014, Volume: 23, Issue:11

    Topics: Administration, Oral; Animals; Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Multiple, Bacterial; Ertapenem; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Intraabdominal Infections; Microbial Sensitivity Tests; Tetracyclines

2014
Antibiotic Treatment of Hidradenitis Suppurativa.
    Dermatologic clinics, 2016, Volume: 34, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Clindamycin; Drug Therapy, Combination; Ertapenem; Fluoroquinolones; Hidradenitis Suppurativa; Humans; Imipenem; Maintenance Chemotherapy; Metronidazole; Moxifloxacin; Remission Induction; Rifampin

2016
A Critical Review of Analytical Methods for Determination of Ertapenem Sodium.
    Critical reviews in analytical chemistry, 2016, Volume: 46, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactams; Chromatography, High Pressure Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Thin Layer; Disk Diffusion Antimicrobial Tests; Ertapenem; Humans

2016
Carbapenems to Treat Multidrug and Extensively Drug-Resistant Tuberculosis: A Systematic Review.
    International journal of molecular sciences, 2016, Mar-12, Volume: 17, Issue:3

    Topics: Antitubercular Agents; beta-Lactams; Carbapenems; Clinical Studies as Topic; Ertapenem; Extensively Drug-Resistant Tuberculosis; Humans; Imipenem; Meropenem; Thienamycins; Treatment Outcome; Tuberculosis, Multidrug-Resistant

2016
Ertapenem-Induced Hallucinations and Delirium in an Elderly Patient.
    The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists, 2016, Volume: 31, Issue:4

    Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Delirium; Ertapenem; Hallucinations; Humans; Male; Neurotoxicity Syndromes; Obesity, Morbid

2016
Lemierre's syndrome variant of the gut.
    BMJ case reports, 2017, Oct-20, Volume: 2017

    Topics: Abdominal Pain; Anti-Bacterial Agents; Anticoagulants; beta-Lactams; Endoscopy, Gastrointestinal; Ertapenem; Fever; Fusobacterium Infections; Fusobacterium necrophorum; Heparin; Humans; Lemierre Syndrome; Male; Penicillanic Acid; Phlebitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Portal Vein; Treatment Outcome

2017
Carbapenem stewardship with ertapenem and antimicrobial resistance-a scoping review.
    Revista da Sociedade Brasileira de Medicina Tropical, 2020, Volume: 53

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Drug Resistance, Bacterial; Ertapenem; Microbial Sensitivity Tests

2020
Clinical efficacy of ertapenem vs. other carbapenems for the treatment of extended-spectrum-β-lactamase-producing Enterobacterales infection: A systematic review and meta-analysis.
    Journal of global antimicrobial resistance, 2023, Volume: 33

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Ertapenem; Gammaproteobacteria; Humans; Treatment Outcome

2023

Trials

77 trial(s) available for beta-lactams and ertapenem

ArticleYear
A study evaluating the efficacy, safety, and tolerability of ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002, Apr-15, Volume: 34, Issue:8

    Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Double-Blind Method; Drug Tolerance; Ertapenem; Female; Humans; Lactams; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Treatment Outcome

2002
Safety and local tolerability of intramuscularly administered ertapenem diluted in lidocaine: a prospective, randomized, double-blind study versus intramuscular ceftriaxone.
    Clinical therapeutics, 2002, Volume: 24, Issue:3

    Topics: Aged; Anesthetics, Local; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Cephalosporins; Double-Blind Method; Ertapenem; Female; Humans; Injections, Intramuscular; Lactams; Lidocaine; Male; Middle Aged; Prospective Studies; Respiratory Tract Infections; Skin Diseases, Infectious

2002
Ertapenem once daily versus piperacillin-tazobactam 4 times per day for treatment of complicated skin and skin-structure infections in adults: results of a prospective, randomized, double-blind multicenter study.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002, Jun-01, Volume: 34, Issue:11

    Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Double-Blind Method; Drug Therapy, Combination; Enzyme Inhibitors; Ertapenem; Female; Humans; Lactams; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Penicillins; Piperacillin; Prospective Studies; Pseudomonas aeruginosa; Skin Diseases; Staphylococcus aureus; Tazobactam; Treatment Outcome

2002
A prospective, multicenter, randomized, double-blind study comparing ertapenem and ceftriaxone followed by appropriate oral therapy for complicated urinary tract infections in adults.
    Urology, 2002, Volume: 60, Issue:1

    Topics: Administration, Oral; Adult; Age Factors; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Cephalosporins; Double-Blind Method; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Infusions, Intravenous; Lactams; Prospective Studies; Treatment Outcome; Urinary Tract Infections

2002
General microbiology and in vitro susceptibility of anaerobes isolated from complicated skin and skin-structure infections in patients enrolled in a comparative trial of ertapenem versus piperacillin-tazobactam.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002, Sep-01, Volume: 35, Issue:Suppl 1

    Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; beta-Lactams; Double-Blind Method; Enzyme Inhibitors; Ertapenem; Humans; Lactams; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Skin Diseases, Bacterial; Tazobactam

2002
Ertapenem versus ceftriaxone followed by appropriate oral therapy for treatment of complicated urinary tract infections in adults: results of a prospective, randomized, double-blind multicenter study.
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:9

    Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; beta-Lactams; Ceftriaxone; Cephalosporins; Double-Blind Method; Ertapenem; Female; Humans; Lactams; Male; Prospective Studies; Urinary Tract Infections

2002
Pharmacokinetics of ertapenem in healthy young volunteers.
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:11

    Topics: Adult; Anti-Bacterial Agents; Area Under Curve; beta-Lactams; Blood Proteins; Dose-Response Relationship, Drug; Double-Blind Method; Ertapenem; Female; Half-Life; Humans; Injections, Intravenous; Lactams; Male; Protein Binding; Sex Characteristics; Spectrophotometry, Ultraviolet

2002
Ertapenem monotherapy versus combination therapy with ceftriaxone plus metronidazole for treatment of complicated intra-abdominal infections in adults.
    International journal of antimicrobial agents, 2002, Volume: 20, Issue:3

    Topics: Abdomen; Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; beta-Lactams; Ceftriaxone; Double-Blind Method; Drug Therapy, Combination; Ertapenem; Female; Humans; Injections, Intravenous; Lactams; Male; Metronidazole; Middle Aged

2002
A prospective, randomized, double-blind multicenter comparison of parenteral ertapenem and ceftriaxone for the treatment of hospitalized adults with community-acquired pneumonia.
    Clinical therapeutics, 2002, Volume: 24, Issue:11

    Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Community-Acquired Infections; Double-Blind Method; Ertapenem; Europe; Female; Hospitalization; Humans; Injections, Intramuscular; Injections, Intravenous; Lactams; Latin America; Male; Middle Aged; Pneumonia, Pneumococcal; Prospective Studies; Severity of Illness Index; Streptococcus pneumoniae; Treatment Outcome; United States

2002
Ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections: results of a double-blind, randomized comparative phase III trial.
    Annals of surgery, 2003, Volume: 237, Issue:2

    Topics: Abdominal Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Digestive System Surgical Procedures; Double-Blind Method; Drug Therapy, Combination; Ertapenem; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hospitalization; Humans; Lactams; Male; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Research Design; Treatment Outcome

2003
Ertapenem versus piperacillin-tazobactam for treatment of mixed anaerobic complicated intra-abdominal, complicated skin and skin structure, and acute pelvic infections.
    Surgical infections, 2002,Winter, Volume: 3, Issue:4

    Topics: Abdomen; Adult; Aged; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Ertapenem; Female; Humans; Lactams; Male; Middle Aged; Pelvic Infection; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Skin Diseases, Bacterial; Surgical Wound Infection

2002
Surgical infections with enterococcus: outcome in patients treated with ertapenem versus piperacillin-tazobactam.
    Surgical infections, 2002,Winter, Volume: 3, Issue:4

    Topics: Abdomen; Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Enterococcus; Ertapenem; Female; Gram-Positive Bacterial Infections; Humans; Lactams; Male; Middle Aged; Pelvic Infection; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Skin Diseases, Bacterial; Surgical Wound Infection; Treatment Outcome

2002
Efficacy of ertapenem in the treatment of serious infections caused by Enterobacteriaceae: analysis of pooled clinical trial data.
    The Journal of antimicrobial chemotherapy, 2003, Volume: 51, Issue:5

    Topics: Adult; Aged; beta-Lactams; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Double-Blind Method; Drug Therapy, Combination; Enterobacteriaceae Infections; Ertapenem; Escherichia coli Infections; Humans; Lactams; Middle Aged; Multicenter Studies as Topic; Penicillanic Acid; Piperacillin; Tazobactam; Treatment Outcome; Urinary Tract Infections

2003
Pharmacokinetics of intramuscularly administered ertapenem.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:5

    Topics: Anti-Bacterial Agents; Area Under Curve; beta-Lactams; Cross-Over Studies; Ertapenem; Female; Humans; Injections, Intramuscular; Injections, Intravenous; Lactams; Male; Metabolic Clearance Rate

2003
[Carbapenem antibiotic ertapenem in the treatment of extrahospital intraabdominal infections].
    Khirurgiia, 2003, Issue:4

    Topics: Abdominal Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Double-Blind Method; Ertapenem; Female; Humans; Lactams; Male; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Prospective Studies; Tazobactam; Treatment Outcome

2003
Ertapenem once a day versus piperacillin-tazobactam every 6 hours for treatment of acute pelvic infections: a prospective, multicenter, randomized, double-blind study.
    Infectious diseases in obstetrics and gynecology, 2003, Volume: 11, Issue:1

    Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Confidence Intervals; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Ertapenem; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Lactams; Middle Aged; Pelvic Infection; Penicillanic Acid; Piperacillin; Probability; Prospective Studies; Risk Assessment; Severity of Illness Index; Tazobactam; Treatment Outcome

2003
Evaluation of outpatient treatment with ertapenem in a double blind controlled clinical trial of complicated skin/skin structure infections.
    The Journal of infection, 2004, Volume: 48, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Chi-Square Distribution; Double-Blind Method; Drug Therapy, Combination; Enzyme Inhibitors; Ertapenem; Female; Humans; Infusions, Intravenous; Lactams; Logistic Models; Male; Middle Aged; Penicillanic Acid; Piperacillin; Prospective Studies; Skin Diseases; Statistics, Nonparametric; Tazobactam; Treatment Outcome

2004
Ertapenem therapy for community-acquired pneumonia in the elderly.
    Journal of the American Geriatrics Society, 2003, Volume: 51, Issue:11

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Community-Acquired Infections; Double-Blind Method; Ertapenem; Female; Humans; Lactams; Logistic Models; Male; Odds Ratio; Pneumonia, Pneumococcal; Retrospective Studies; Statistics, Nonparametric; Streptococcus pneumoniae; Treatment Outcome

2003
Management of complicated appendicitis and comparison of outcome with other primary sites of intra-abdominal infection: results of a trial comparing ertapenem and piperacillin-tazobactam.
    Journal of chemotherapy (Florence, Italy), 2004, Volume: 16, Issue:1

    Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Appendicitis; Bacterial Infections; beta-Lactams; Colonic Diseases; Demography; Double-Blind Method; Ertapenem; Female; Humans; Lactams; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Risk Factors; Severity of Illness Index

2004
Treatment of polymicrobial infections: post hoc analysis of three trials comparing ertapenem and piperacillin-tazobactam.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 53 Suppl 2

    Topics: Abdomen; Adolescent; Adult; Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Double-Blind Method; Ertapenem; Female; Humans; Lactams; Male; Pelvic Infection; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Skin Diseases, Bacterial; Treatment Outcome

2004
Ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults: combined analysis of two multicentre randomized, double-blind studies.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 53 Suppl 2

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Child; Child, Preschool; Community-Acquired Infections; Double-Blind Method; Ertapenem; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Lactams; Male; Middle Aged; Pneumonia, Bacterial; Treatment Outcome

2004
Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 53 Suppl 2

    Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Double-Blind Method; Drug Administration Schedule; Ertapenem; Female; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Lactams; Male; Middle Aged; Multicenter Studies as Topic; Pyelonephritis; Randomized Controlled Trials as Topic; Treatment Outcome; Urinary Tract Infections

2004
Efficacy of ertapenem against methicillin-susceptible Staphylococcus aureus in complicated skin/skin structure infections: results of a double-blind clinical trial versus piperacillin-tazobactam.
    International journal of antimicrobial agents, 2004, Volume: 23, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Double-Blind Method; Ertapenem; Female; Humans; Lactams; Male; Methicillin Resistance; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Skin Diseases, Bacterial; Staphylococcal Infections; Staphylococcus aureus

2004
Comparative disposition of [14C]ertapenem, a novel carbapenem antibiotic, in rat, monkey and man.
    Xenobiotica; the fate of foreign compounds in biological systems, 2004, Volume: 34, Issue:4

    Topics: Adult; Animals; beta-Lactams; Carbapenems; Carbon Radioisotopes; Ertapenem; Feces; Female; Humans; Lactams; Macaca mulatta; Male; Metabolic Clearance Rate; Middle Aged; Organ Specificity; Radioisotope Dilution Technique; Radiopharmaceuticals; Rats; Species Specificity; Tissue Distribution

2004
Ertapenem pharmacokinetics and impact on intestinal microflora, in comparison to those of ceftriaxone, after multiple dosing in male and female volunteers.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:10

    Topics: Adult; beta-Lactams; Ceftriaxone; Cephalosporins; Cross-Over Studies; Double-Blind Method; Ertapenem; Feces; Female; Humans; Intestines; Lactams; Male; Mass Spectrometry; Sex Characteristics

2004
[Efficacy of invanz proven in the treatment of intra-abdominal infections in one of the largest studies yet conducted on surgical patients].
    Khirurgiia, 2003, Volume: 59, Issue:1-2

    Topics: beta-Lactams; Ertapenem; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Lactams; Peritonitis; Postoperative Complications; Treatment Outcome

2003
Penetration of ertapenem into different pulmonary compartments of patients undergoing lung surgery.
    Journal of clinical pharmacology, 2005, Volume: 45, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; beta-Lactams; Bronchoalveolar Lavage Fluid; Community-Acquired Infections; Drug Administration Schedule; Ertapenem; Female; Half-Life; Humans; Injections, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Pulmonary Alveoli; Respiratory Mucosa; Thoracotomy

2005
Bowel colonization with resistant gram-negative bacilli after antimicrobial therapy of intra-abdominal infections: observations from two randomized comparative clinical trials of ertapenem therapy.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2005, Volume: 24, Issue:7

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Carrier State; Ceftriaxone; Digestive System Surgical Procedures; Drug Resistance, Bacterial; Drug Therapy, Combination; Ertapenem; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intestines; Lactams; Male; Metronidazole; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination

2005
Acquisition of resistant bowel flora during a double-blind randomized clinical trial of ertapenem versus piperacillin-tazobactam therapy for intraabdominal infections.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:8

    Topics: Abdominal Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Double-Blind Method; Drug Resistance, Bacterial; Drug Therapy, Combination; Enterobacteriaceae; Ertapenem; Female; Humans; Lactams; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Rectum; Treatment Outcome

2005
Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trial.
    Lancet (London, England), 2005, Nov-12, Volume: 366, Issue:9498

    Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Diabetic Foot; Double-Blind Method; Drug Administration Schedule; Ertapenem; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Severity of Illness Index; Treatment Outcome

2005
Intraabdominal tissue concentration of ertapenem.
    The Journal of antimicrobial chemotherapy, 2006, Volume: 57, Issue:2

    Topics: Abdomen; Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; beta-Lactams; Chromatography, High Pressure Liquid; Ertapenem; Female; Humans; Male; Mass Spectrometry; Middle Aged; Prospective Studies

2006
Efficacy and safety of ertapenem versus piperacillin-tazobactam for the treatment of intra-abdominal infections requiring surgical intervention.
    Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2006, Volume: 10, Issue:4

    Topics: Abdomen; Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Alanine Transaminase; Anti-Bacterial Agents; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; beta-Lactams; Diarrhea; Ertapenem; Escherichia coli Infections; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Treatment Outcome

2006
Penetration of ertapenem into skeletal muscle and subcutaneous adipose tissue in healthy volunteers measured by in vivo microdialysis.
    The Journal of antimicrobial chemotherapy, 2006, Volume: 58, Issue:3

    Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Ertapenem; Female; Half-Life; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Microdialysis; Muscle, Skeletal; Prospective Studies; Skin Diseases, Bacterial; Subcutaneous Fat; Tissue Distribution

2006
Pharmacokinetics of ertapenem in patients with varying degrees of renal insufficiency and in patients on hemodialysis.
    Journal of clinical pharmacology, 2006, Volume: 46, Issue:10

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Alanine Transaminase; Anti-Bacterial Agents; Area Under Curve; Aspartate Aminotransferases; beta-Lactams; Drug Administration Schedule; Ertapenem; Female; Half-Life; Humans; Infusions, Intravenous; Kidney; Kidney Failure, Chronic; Male; Metabolic Clearance Rate; Middle Aged; Renal Dialysis; Renal Insufficiency; Time Factors

2006
Ertapenem versus cefepime for initial empirical treatment of pneumonia acquired in skilled-care facilities or in hospitals outside the intensive care unit.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2006, Volume: 25, Issue:10

    Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Cefepime; Cephalosporins; Cross Infection; Double-Blind Method; Drug Administration Schedule; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Humans; Intensive Care Units; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Skilled Nursing Facilities

2006
Pharmacokinetics and lung concentrations of ertapenem in patients with ventilator-associated pneumonia.
    Intensive care medicine, 2006, Volume: 32, Issue:12

    Topics: Aged; Anti-Bacterial Agents; Area Under Curve; beta-Lactams; Ertapenem; Female; Half-Life; Humans; Infusions, Intravenous; Intensive Care Units; Lung; Male; Middle Aged; Pneumonia, Ventilator-Associated

2006
Ertapenem versus cefotetan prophylaxis in elective colorectal surgery.
    The New England journal of medicine, 2006, Dec-21, Volume: 355, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Cefotetan; Clostridioides difficile; Clostridium Infections; Colorectal Surgery; Double-Blind Method; Elective Surgical Procedures; Ertapenem; Female; Humans; Infusions, Intravenous; Logistic Models; Male; Middle Aged; Prospective Studies; Risk Factors; Surgical Wound Infection; Treatment Failure

2006
Polyethylene glycol versus sodium phosphate mechanical bowel preparation in elective colorectal surgery.
    American journal of surgery, 2007, Volume: 193, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Cathartics; Cefotetan; Colectomy; Colon; Ertapenem; Female; Humans; Male; Middle Aged; Phosphates; Polyethylene Glycols; Preoperative Care; Randomized Controlled Trials as Topic; Rectum; Surgical Wound Infection

2007
Randomized, multicenter, double-blind study of efficacy, safety, and tolerability of intravenous ertapenem versus piperacillin/tazobactam in treatment of complicated intra-abdominal infections in hospitalized adults.
    Surgical infections, 2007, Volume: 8, Issue:1

    Topics: Abdominal Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; APACHE; Bacterial Infections; Bacteroides; beta-Lactams; Double-Blind Method; Ertapenem; Escherichia coli; Female; Humans; Male; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination

2007
Bowel colonization with vancomycin-resistant enterococci after antimicrobial therapy for intra-abdominal infections: observations from 2 randomized comparative clinical trials of ertapenem therapy.
    Diagnostic microbiology and infectious disease, 2007, Volume: 58, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Enterococcus; Ertapenem; Female; Gram-Positive Bacterial Infections; Humans; Intestines; Male; Middle Aged; Vancomycin Resistance

2007
Efficacy of ertapenem in the treatment of early ventilator-associated pneumonia caused by extended-spectrum beta-lactamase-producing organisms in an intensive care unit.
    The Journal of antimicrobial chemotherapy, 2007, Volume: 60, Issue:2

    Topics: Aged; Anti-Bacterial Agents; APACHE; Bacteria; beta-Lactamases; beta-Lactams; Ertapenem; Female; Humans; Intensive Care Units; Liver; Male; Microbial Sensitivity Tests; Pilot Projects; Pneumonia, Ventilator-Associated; Prospective Studies

2007
Ertapenem or ticarcillin/clavulanate for the treatment of intra-abdominal infections or acute pelvic infections in pediatric patients.
    American journal of surgery, 2007, Volume: 194, Issue:3

    Topics: Abdominal Cavity; Acute Disease; Adolescent; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Child; Child, Preschool; Clavulanic Acids; Ertapenem; Female; Humans; Male; Pelvis; Prospective Studies; Ticarcillin

2007
A prospective, double-blind, multicenter, randomized trial comparing ertapenem 3 vs >or=5 days in community-acquired intraabdominal infection.
    Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2008, Volume: 12, Issue:3

    Topics: Anti-Bacterial Agents; APACHE; Appendicitis; beta-Lactams; Community-Acquired Infections; Double-Blind Method; Ertapenem; Humans; Peritonitis; Prospective Studies; Surgical Wound Infection

2008
Effect of body mass index and ertapenem versus cefotetan prophylaxis on surgical site infection in elective colorectal surgery.
    Surgical infections, 2008, Volume: 9, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; beta-Lactams; Body Mass Index; Cefotetan; Colon; Digestive System Surgical Procedures; Ertapenem; Female; Humans; Male; Middle Aged; Obesity; Rectum; Retrospective Studies; Surgical Wound Infection

2008
[Septic shock due to community-acquired complicated intra-abdominal infection treated with ertapenem: outcome in 25 cases].
    Revista espanola de anestesiologia y reanimacion, 2008, Volume: 55, Issue:4

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Cohort Studies; Community-Acquired Infections; Critical Care; Emergencies; Ertapenem; Female; Hospital Mortality; Humans; Intestinal Perforation; Length of Stay; Male; Middle Aged; Peritonitis; Prospective Studies; Shock, Septic; Survival Analysis; Treatment Outcome

2008
Comparative costs of ertapenem and cefotetan as prophylaxis for elective colorectal surgery.
    Surgical infections, 2008, Volume: 9, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Cefotetan; Colorectal Surgery; Cost-Benefit Analysis; Elective Surgical Procedures; Ertapenem; Female; Hospital Costs; Humans; Length of Stay; Male; Middle Aged; Surgical Wound Infection; Treatment Failure; Treatment Outcome

2008
Definitive risk factors for anastomotic leaks in elective open colorectal resection.
    Archives of surgery (Chicago, Ill. : 1960), 2008, Volume: 143, Issue:9

    Topics: Aged; Anastomosis, Surgical; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Cefotetan; Colectomy; Elective Surgical Procedures; Ertapenem; Female; Humans; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Risk Factors; Serum Albumin

2008
Safety and tolerability of ertapenem versus ceftriaxone in a double-blind study performed in children with complicated urinary tract infection, community-acquired pneumonia or skin and soft-tissue infection.
    International journal of antimicrobial agents, 2009, Volume: 33, Issue:2

    Topics: Adolescent; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Child; Child, Preschool; Community-Acquired Infections; Double-Blind Method; Ertapenem; Female; Humans; Infant; Male; Molecular Sequence Data; Pneumonia, Bacterial; Skin Diseases, Bacterial; Soft Tissue Infections; Urinary Tract Infections

2009
Infection after elective colorectal surgery: bacteriological analysis of failures in a randomized trial of cefotetan vs. ertapenem prophylaxis.
    Surgical infections, 2009, Volume: 10, Issue:2

    Topics: Antibiotic Prophylaxis; Bacteria; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Cefotetan; Colon; Elective Surgical Procedures; Ertapenem; Humans; Microbial Sensitivity Tests; Rectum; Surgical Wound Infection; Treatment Failure

2009
Pharmacokinetics of ertapenem following intravenous and subcutaneous infusions in patients.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Ertapenem; Humans; Infusions, Intravenous; Infusions, Subcutaneous; Male; Microbial Sensitivity Tests; Middle Aged; Young Adult

2010
Prospective randomized trial comparing short-term antibiotic therapy versus standard therapy for acute uncomplicated sigmoid diverticulitis.
    International journal of colorectal disease, 2010, Volume: 25, Issue:6

    Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Colon, Sigmoid; Demography; Diverticulitis, Colonic; Ertapenem; Female; Follow-Up Studies; Humans; Length of Stay; Male; Middle Aged; Parenteral Nutrition; Patient Dropouts; Time Factors; Treatment Outcome

2010
Prophylaxis with ertapenem in patients with obstructive jaundice undergoing endoscopic retrograde cholangiopancreatography: safety, efficacy, and biliary penetration.
    Southern medical journal, 2011, Volume: 104, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Biliary Tract; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis; Ertapenem; Female; Humans; Jaundice, Obstructive; Male; Middle Aged; Sepsis; Young Adult

2011
A prospective, multi centre, randomized clinical study to compare the efficacy and safety of Ertapenem 3 days versus Ampicillin-Sulbactam 3 days in the treatment of localized community acquired intra-abdominal infection. (T.E.A. Study: Three days Ertapene
    BMC gastroenterology, 2011, Apr-18, Volume: 11

    Topics: Abdomen; Adult; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Clinical Protocols; Community-Acquired Infections; Drug Therapy, Combination; Ertapenem; Humans; Peritonitis; Sulbactam

2011
Penetration of ertapenem into muscle measured by in vivo microdialysis in mechanically ventilated patients.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:7

    Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Ertapenem; Female; Humans; Male; Microdialysis; Middle Aged; Muscle, Skeletal; Respiration, Artificial

2011
Comparison of ertapenem and ceftriaxone therapy for acute pyelonephritis and other complicated urinary tract infections in Korean adults: a randomized, double-blind, multicenter trial.
    Journal of Korean medical science, 2012, Volume: 27, Issue:5

    Topics: Acute Disease; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Double-Blind Method; Ertapenem; Humans; Odds Ratio; Pyelonephritis; Republic of Korea; Risk Factors; Urinary Tract Infections

2012
Randomised clinical trial of moxifloxacin versus ertapenem in complicated intra-abdominal infections: results of the PROMISE study.
    International journal of antimicrobial agents, 2013, Volume: 41, Issue:1

    Topics: Administration, Intravenous; Adult; Aged; Anti-Bacterial Agents; Aza Compounds; beta-Lactams; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Ertapenem; Female; Fluoroquinolones; Humans; Incidence; Intraabdominal Infections; Male; Middle Aged; Moxifloxacin; Prospective Studies; Quinolines; Treatment Outcome

2013
A prospective randomized controlled multicenter trial comparing antibiotic therapy with appendectomy in the treatment of uncomplicated acute appendicitis (APPAC trial).
    BMC surgery, 2013, Feb-08, Volume: 13

    Topics: Acute Disease; Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Appendectomy; Appendicitis; beta-Lactams; Ertapenem; Follow-Up Studies; Humans; Middle Aged; Prospective Studies; Treatment Outcome; Young Adult

2013
Comparative pharmacokinetics, pharmacodynamics, and tolerability of ertapenem 1 gram/day administered as a rapid 5-minute infusion versus the standard 30-minute infusion in healthy adult volunteers.
    Pharmacotherapy, 2013, Volume: 33, Issue:3

    Topics: Adult; Anti-Bacterial Agents; Area Under Curve; beta-Lactams; Cross-Over Studies; Drug Administration Schedule; Ertapenem; Female; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Monte Carlo Method; Prospective Studies; Therapeutic Equivalency; Time Factors

2013
Treatment of elderly patients with uncomplicated diverticulitis, even with comorbidity, at home.
    European journal of internal medicine, 2013, Volume: 24, Issue:5

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Comorbidity; Diverticulitis, Colonic; Ertapenem; Female; Hospitalization; Humans; Infusions, Intravenous; Male; Nurses, Community Health; Outpatients; Prospective Studies; Treatment Outcome

2013
T.E.A. Study: three-day ertapenem versus three-day Ampicillin-Sulbactam.
    BMC gastroenterology, 2013, Apr-30, Volume: 13

    Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactams; Chi-Square Distribution; Drug Administration Schedule; Ertapenem; Female; Humans; Male; Middle Aged; Peritonitis; Sulbactam; Surgical Wound Infection; Treatment Outcome

2013
Ertapenem versus standard triple antibiotic therapy for the treatment of perforated appendicitis in pediatric patients: a prospective randomized trial.
    European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie, 2014, Volume: 24, Issue:5

    Topics: Adolescent; Ampicillin; Anti-Bacterial Agents; Appendectomy; Appendicitis; beta-Lactams; Child; Child, Preschool; Clindamycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Ertapenem; Female; Gentamicins; Humans; Infant; Intestines; Male; Prospective Studies; Surgical Wound Infection

2014
Pharmacokinetics of ertapenem in critically ill patients receiving continuous venovenous hemodialysis or hemodiafiltration.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:3

    Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Critical Illness; Ertapenem; Female; Gram-Negative Bacterial Infections; Hemofiltration; Humans; Male; Middle Aged; Renal Dialysis

2014
Phase 2, randomized, double-blind study of the efficacy and safety of two dose regimens of eravacycline versus ertapenem for adult community-acquired complicated intra-abdominal infections.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:4

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Double-Blind Method; Ertapenem; Female; Humans; Intraabdominal Infections; Male; Middle Aged; Young Adult

2014
Phase 3 study comparing tigecycline and ertapenem in patients with diabetic foot infections with and without osteomyelitis.
    Diagnostic microbiology and infectious disease, 2014, Volume: 78, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Diabetic Foot; Drug-Related Side Effects and Adverse Reactions; Ertapenem; Female; Humans; Male; Middle Aged; Minocycline; Nausea; Osteomyelitis; Tigecycline; Treatment Outcome; Vancomycin; Vomiting; Young Adult

2014
Ertapenem prophylaxis of surgical site infections in elective colorectal surgery in China: a multicentre, randomized, double-blind, active-controlled study.
    The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:12

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Ceftriaxone; China; Colorectal Surgery; Double-Blind Method; Ertapenem; Female; Humans; Infusions, Intravenous; Laparotomy; Male; Metronidazole; Middle Aged; Placebos; Surgical Wound Infection; Treatment Outcome; Young Adult

2014
Antibiotic Therapy vs Appendectomy for Treatment of Uncomplicated Acute Appendicitis: The APPAC Randomized Clinical Trial.
    JAMA, 2015, Jun-16, Volume: 313, Issue:23

    Topics: Acute Disease; Administration, Intravenous; Adolescent; Adult; Anti-Bacterial Agents; Appendectomy; Appendicitis; Appendix; beta-Lactams; Drug Therapy, Combination; Emergency Treatment; Ertapenem; Female; Follow-Up Studies; Humans; Intention to Treat Analysis; Laparoscopy; Length of Stay; Levofloxacin; Male; Metronidazole; Postoperative Complications; Treatment Failure; Young Adult

2015
Ertapenem versus piperacillin/tazobactam for diabetic foot infections in China: a Phase 3, multicentre, randomized, double-blind, active-controlled, non-inferiority trial.
    The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactams; China; Diabetic Foot; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Ertapenem; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Treatment Outcome; Young Adult

2016
Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: a multinational pre-registered cohort study.
    The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:6

    Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Humans; Male; Middle Aged; Retrospective Studies; Sepsis; Survival Analysis; Treatment Outcome

2016
Cross-reactivity and Tolerability of Ertapenem in Patients With IgE-Mediated Hypersensitivity to β-Lactams.
    Journal of investigational allergology & clinical immunology, 2016, Volume: 26, Issue:2

    Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Cross Reactions; Drug Hypersensitivity; Ertapenem; Female; Humans; Imipenem; Immunoglobulin E; Male; Meropenem; Middle Aged; Skin Tests; Thienamycins

2016
Assessing the Efficacy and Safety of Eravacycline vs Ertapenem in Complicated Intra-abdominal Infections in the Investigating Gram-Negative Infections Treated With Eravacycline (IGNITE 1) Trial: A Randomized Clinical Trial.
    JAMA surgery, 2017, 03-01, Volume: 152, Issue:3

    Topics: Abdominal Abscess; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Appendicitis; Bacterial Infections; beta-Lactams; Double-Blind Method; Ertapenem; Female; Gram-Negative Bacteria; Humans; Intention to Treat Analysis; Male; Middle Aged; Peritonitis; Tetracyclines; Treatment Outcome; Young Adult

2017
Antibiotics-First Versus Surgery for Appendicitis: A US Pilot Randomized Controlled Trial Allowing Outpatient Antibiotic Management.
    Annals of emergency medicine, 2017, Volume: 70, Issue:1

    Topics: Administration, Intravenous; Adolescent; Adult; Aged; Anti-Bacterial Agents; Appendectomy; Appendicitis; beta-Lactams; Cefdinir; Cephalosporins; Child; Cost-Benefit Analysis; Drug Therapy, Combination; Ertapenem; Feasibility Studies; Female; Follow-Up Studies; Humans; Male; Metronidazole; Middle Aged; Outpatients; Pain; Pilot Projects; Quality of Life; Severity of Illness Index; Treatment Outcome; United States; Young Adult

2017
Efficacy and safety of de-escalation therapy to ertapenem for treatment of infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae: an open-label randomized controlled trial.
    BMC infectious diseases, 2017, 03-01, Volume: 17, Issue:1

    Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Humans; Male; Middle Aged; Treatment Outcome; Urinary Tract Infections

2017
A randomized controlled trial of sitafloxacin vs. ertapenem as a switch therapy after treatment for acute pyelonephritis caused by extended-spectrum β-lactamase-producing Escherichia coli: A pilot study.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2017, Volume: 23, Issue:8

    Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Male; Middle Aged; Pilot Projects; Pyelonephritis

2017
Randomized controlled trial of piperacillin-tazobactam, cefepime and ertapenem for the treatment of urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli.
    BMC infectious diseases, 2017, 06-07, Volume: 17, Issue:1

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Cross Infection; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Genotype; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Republic of Korea; Tazobactam; Urinary Tract Infections

2017
Economic evaluation of antibiotic therapy versus appendicectomy for the treatment of uncomplicated acute appendicitis from the APPAC randomized clinical trial.
    The British journal of surgery, 2017, Volume: 104, Issue:10

    Topics: Acute Disease; Adolescent; Adult; Anti-Bacterial Agents; Appendectomy; Appendicitis; beta-Lactams; Cost-Benefit Analysis; Ertapenem; Finland; Humans; Length of Stay; Levofloxacin; Metronidazole; Middle Aged; Recurrence; Sick Leave; Treatment Outcome; Young Adult

2017
Double carbapenem as a rescue strategy for the treatment of severe carbapenemase-producing Klebsiella pneumoniae infections: a two-center, matched case-control study.
    Critical care (London, England), 2017, 07-05, Volume: 21, Issue:1

    Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Case-Control Studies; Drug Resistance, Multiple; Ertapenem; Female; Humans; Italy; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Statistics, Nonparametric

2017
Five-Year Follow-up of Antibiotic Therapy for Uncomplicated Acute Appendicitis in the APPAC Randomized Clinical Trial.
    JAMA, 2018, 09-25, Volume: 320, Issue:12

    Topics: Acute Disease; Adolescent; Adult; Anti-Bacterial Agents; Appendectomy; Appendicitis; beta-Lactams; Drug Therapy, Combination; Ertapenem; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Levofloxacin; Male; Metronidazole; Middle Aged; Postoperative Complications; Recurrence; Reoperation; Young Adult

2018

Other Studies

478 other study(ies) available for beta-lactams and ertapenem

ArticleYear
Comparative in vitro activities of ertapenem (MK-0826) against 469 less frequently identified anaerobes isolated from human infections.
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:4

    Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Ertapenem; Humans; Lactams; Microbial Sensitivity Tests

2002
Ertapenem (Invanz)--a new parenteral carbapenem.
    The Medical letter on drugs and therapeutics, 2002, Mar-18, Volume: 44, Issue:1126

    Topics: Anti-Bacterial Agents; beta-Lactams; Clinical Trials as Topic; Community-Acquired Infections; Dose-Response Relationship, Drug; Ertapenem; Gram-Negative Bacterial Infections; Humans; Infusions, Parenteral; Injections, Intramuscular; Injections, Intravenous; Lactams; Pneumonia; Urinary Tract Infections

2002
Use of surrogate antimicrobial agents to predict susceptibility to ertapenem.
    Diagnostic microbiology and infectious disease, 2002, Volume: 43, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Bacterial; Ertapenem; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Lactams; Microbial Sensitivity Tests; Oxacillin; Penicillins; Sensitivity and Specificity; Thienamycins

2002
Comparative in vitro activities of ertapenem against aerobic and facultative bacterial pathogens from patients with complicated skin and skin structure infections.
    Diagnostic microbiology and infectious disease, 2002, Volume: 43, Issue:2

    Topics: Aerobiosis; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Ertapenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Lactams; Microbial Sensitivity Tests; Skin Diseases, Bacterial

2002
Efficient one-pot synthesis of the 2-aminocarbonylpyrrolidin-4-ylthio-containing side chain of the new broad-spectrum carbapenem antibiotic ertapenem.
    The Journal of organic chemistry, 2002, Jul-12, Volume: 67, Issue:14

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Carbapenems; Chromatography, High Pressure Liquid; Combinatorial Chemistry Techniques; Ertapenem; Lactams; Molecular Structure; Pyrrolidines; Stereoisomerism

2002
In vitro activity of ertapenem against bacterial isolates from cancer patients.
    Diagnostic microbiology and infectious disease, 2002, Volume: 43, Issue:3

    Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Ertapenem; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Lactams; Microbial Sensitivity Tests; Neoplasms; Staphylococcus; Streptococcus

2002
Comparative in-vitro activities of ertapenem against aerobic bacterial pathogens isolated from patients with complicated intra-abdominal infections.
    Journal of chemotherapy (Florence, Italy), 2002, Volume: 14, Issue:3

    Topics: Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Lactams; Microbial Sensitivity Tests

2002
Intra-abdominal anaerobic infections: bacteriology and therapeutic potential of newer antimicrobial carbapenem, fluoroquinolone, and desfluoroquinolone therapeutic agents.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002, Sep-01, Volume: 35, Issue:Suppl 1

    Topics: Abdominal Abscess; Anti-Bacterial Agents; Aza Compounds; Bacteremia; Bacteria, Anaerobic; Bacteroides fragilis; Bacteroides Infections; beta-Lactams; Carbapenems; Clinical Trials as Topic; Ertapenem; Fluoroquinolones; Gemifloxacin; Humans; Indoles; Lactams; Moxifloxacin; Naphthyridines; Quinolines; Quinolones

2002
Pharmacodynamic assessment of ertapenem (MK-0826) against Streptococcus pneumoniae in a murine neutropenic thigh infection model.
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:9

    Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Ertapenem; Female; Lactams; Mice; Mice, Inbred ICR; Muscular Diseases; Neutropenia; Protein Binding; Streptococcus pneumoniae; Survival Analysis

2002
In vitro activity of ertapenem (MK-0826) against multi-drug resistant Streptococcus pneumoniae compared with 13 other antimicrobials.
    International journal of antimicrobial agents, 2002, Volume: 20, Issue:2

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Drug Resistance, Multiple, Bacterial; Ertapenem; Humans; Lactams; Microbial Sensitivity Tests; Streptococcus pneumoniae

2002
Modified high-performance liquid chromatographic method for the determination of ertapenem in human urine: enhanced selectivity and automation.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2002, Nov-05, Volume: 779, Issue:2

    Topics: Anti-Bacterial Agents; Automation; beta-Lactams; Calibration; Chromatography, High Pressure Liquid; Ertapenem; Humans; Lactams; Linear Models; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet

2002
Comparative in vitro activities of ertapenem against bacterial pathogens from patients with acute pelvic infection.
    The Journal of antimicrobial chemotherapy, 2002, Volume: 50, Issue:5

    Topics: Acute Disease; Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Ertapenem; Humans; Lactams; Microbial Sensitivity Tests; Pelvic Infection

2002
Comparative in vitro activity of ertapenem against bacterial pathogens isolated from patients with lower respiratory tract infections.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2002, Volume: 8, Issue:11

    Topics: Anti-Bacterial Agents; beta-Lactams; Bronchitis, Chronic; Community-Acquired Infections; Ertapenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Lactams; Microbial Sensitivity Tests; Pneumonia, Bacterial

2002
Assay methodology for the quantitation of unbound ertapenem, a new carbapenem antibiotic, in human plasma.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2003, Jan-05, Volume: 783, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactams; Chromatography, High Pressure Liquid; Ertapenem; Humans; Lactams; Reference Standards; Reproducibility of Results; Spectrophotometry, Ultraviolet; Ultrafiltration

2003
Ertapenem (MK-0826), a new carbapenem: comparative in vitro activity against clinically significant anaerobes.
    Diagnostic microbiology and infectious disease, 2002, Volume: 44, Issue:2

    Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; beta-Lactams; Drug Resistance, Microbial; Ertapenem; Humans; Lactams; Microbial Sensitivity Tests; Sampling Studies; Sensitivity and Specificity

2002
In vitro activity of ertapenem against common clinical isolates in relation to human pharmacokinetics.
    Journal of chemotherapy (Florence, Italy), 2002, Volume: 14, Issue:5

    Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Ceftriaxone; Community-Acquired Infections; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae; Ertapenem; Haemophilus influenzae; Humans; Lactams; Microbial Sensitivity Tests; Moraxella catarrhalis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Staphylococcus aureus; Streptococcus agalactiae; Streptococcus pyogenes

2002
Tissue penetration by ertapenem, a parenteral carbapenem administered once daily, in suction-induced skin blister fluid in healthy young volunteers.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:4

    Topics: Adult; Anti-Bacterial Agents; Area Under Curve; beta-Lactams; Blister; Drug Administration Schedule; Ertapenem; Female; Humans; Lactams; Male; Middle Aged; Protein Binding

2003
Mutation prevention concentration of ceftriaxone, meropenem, imipenem, and ertapenem against three strains of Streptococcus pneumoniae.
    Diagnostic microbiology and infectious disease, 2003, Volume: 45, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Drug Resistance, Microbial; Ertapenem; Humans; Imipenem; Lactams; Meropenem; Microbial Sensitivity Tests; Mutation; Pharmacogenetics; Probability; Sensitivity and Specificity; Streptococcus pneumoniae; Thienamycins

2003
Activities of ertapenem, a new long-acting carbapenem, against penicillin-sensitive or -resistant pneumococci in experimental meningitis.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:6

    Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Disease Models, Animal; Ertapenem; Lactams; Meningitis, Pneumococcal; Penicillin Resistance; Rabbits; Streptococcus pneumoniae; Vancomycin

2003
In vitro susceptibility of ertapenem by BSAC standardized methodology.
    The Journal of antimicrobial chemotherapy, 2003, Volume: 52, Issue:4

    Topics: beta-Lactam Resistance; beta-Lactams; Ertapenem; Lactams; Microbial Sensitivity Tests; United Kingdom

2003
[Comparative in vitro activity of ertapenem against aerobic and anaerobic bacteria].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2003, Volume: 16, Issue:2

    Topics: Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; beta-Lactams; Drug Resistance; Ertapenem; Lactams; Microbial Sensitivity Tests; Species Specificity

2003
In vitro activity of ertapenem against anaerobes isolated from the respiratory tract.
    Pathologie-biologie, 2003, Volume: 51, Issue:8-9

    Topics: Bacteria, Anaerobic; beta-Lactams; Drug Resistance, Bacterial; Ertapenem; Humans; Lactams; Microbial Sensitivity Tests; Respiratory System; Species Specificity

2003
Column-switching technique for the sensitive determination of ertapenem in human cerebrospinal fluid using liquid chromatography and ultraviolet absorbance detection.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2004, Jan-05, Volume: 799, Issue:1

    Topics: beta-Lactams; Chromatography, High Pressure Liquid; Ertapenem; Humans; Lactams; Sensitivity and Specificity; Spectrophotometry, Ultraviolet

2004
Stability and compatibility of reconstituted ertapenem with commonly used i.v. infusion and coinfusion solutions.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2004, Jan-01, Volume: 61, Issue:1

    Topics: beta-Lactams; Chromatography, High Pressure Liquid; Drug Interactions; Drug Stability; Ertapenem; Health Services Research; Infusions, Intravenous; Lactams; United States

2004
Pharmacokinetics of total and unbound ertapenem in healthy elderly subjects.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:2

    Topics: Adult; Aged; Area Under Curve; beta-Lactams; Carbapenems; Creatinine; Ertapenem; Female; Half-Life; Humans; Injections, Intravenous; Lactams; Male; Spectrophotometry, Ultraviolet

2004
Exploring the effectiveness of tazobactam against ceftazidime resistant Escherichia coli: insights from the comparison between susceptibility testing and beta-lactamase inhibition.
    FEMS microbiology letters, 2004, May-01, Volume: 234, Issue:1

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Ertapenem; Escherichia coli; Escherichia coli Infections; Lactams; Microbial Sensitivity Tests; Penicillanic Acid; Tazobactam

2004
In vitro susceptibility of recent antibiotic-resistant urinary pathogens to ertapenem and 12 other antibiotics.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 53, Issue:6

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Genes, Bacterial; Humans; Lactams; Microbial Sensitivity Tests; Urinary Tract Infections

2004
Intra-abdominal infections: review of the bacteriology, antimicrobial susceptibility and the role of ertapenem in their therapy.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 53 Suppl 2

    Topics: Abdomen; Abdominal Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Clinical Trials as Topic; Community-Acquired Infections; Ertapenem; Female; Humans; Lactams; Male; Microbial Sensitivity Tests; Middle Aged; Rats

2004
Ertapenem: a new opportunity for outpatient parenteral antimicrobial therapy.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 53 Suppl 2

    Topics: Ambulatory Care; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Ertapenem; Humans; Infusions, Intravenous; Lactams; Outpatients; Self Administration

2004
Activity of ertapenem against Neisseria gonorrhoeae.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 54, Issue:1

    Topics: beta-Lactams; Drug Resistance, Bacterial; Ertapenem; Gonorrhea; Humans; Lactams; Microbial Sensitivity Tests; Neisseria gonorrhoeae

2004
Ertapenem as initial antimicrobial monotherapy for patients with chronic obstructive pulmonary disease hospitalized with typical community-acquired pneumonia.
    Pulmonary pharmacology & therapeutics, 2004, Volume: 17, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Community-Acquired Infections; Drug Therapy, Combination; Enterobacteriaceae; Ertapenem; Female; Haemophilus influenzae; Hospitalization; Humans; Injections, Intravenous; Lactams; Male; Middle Aged; Pneumonia, Bacterial; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Streptococcus pneumoniae; Treatment Outcome

2004
Treatment of complicated community-acquired infections with ertapenem, the first Group 1 carbapenem. Introduction.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 53 Suppl 2

    Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Carbapenems; Community-Acquired Infections; Drug Resistance, Bacterial; Ertapenem; Humans; Lactams

2004
Role of beta-lactamases and porins in resistance to ertapenem and other beta-lactams in Klebsiella pneumoniae.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:8

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Electrophoresis, Polyacrylamide Gel; Ertapenem; Klebsiella pneumoniae; Lactams; Microbial Sensitivity Tests; Plasmids; Porins

2004
Effect of ertapenem protein binding on killing of bacteria.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:9

    Topics: Bacteria; beta-Lactams; Chromatography, High Pressure Liquid; Enterobacter cloacae; Enterobacteriaceae Infections; Ertapenem; Humans; Indicators and Reagents; Kinetics; Lactams; Microbial Sensitivity Tests; Protein Binding; Regression Analysis; Spectrophotometry, Ultraviolet; Staphylococcal Infections; Staphylococcus aureus

2004
Ertapanem therapy for community-acquired pneumonia in the elderly.
    Journal of the American Geriatrics Society, 2004, Volume: 52, Issue:10

    Topics: Aged; beta-Lactams; Community-Acquired Infections; Ertapenem; Humans; Lactams; Pneumonia

2004
In vitro activity of ertapenem against selected respiratory pathogens.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 54, Issue:5

    Topics: Bacteria; beta-Lactams; Ertapenem; Humans; Lactams; Microbial Sensitivity Tests; Moraxella catarrhalis; Respiratory Tract Infections; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes

2004
Pharmacodynamic profile of ertapenem against Klebsiella pneumoniae and Escherichia coli in a murine thigh model.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:1

    Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Colony Count, Microbial; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Lactams; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Thigh

2005
Pharmacodynamic modeling of carbapenems and fluoroquinolones against bacteria that produce extended-spectrum beta-lactamases.
    Clinical therapeutics, 2004, Volume: 26, Issue:11

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Ciprofloxacin; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Fluoroquinolones; Gatifloxacin; Humans; Imipenem; Klebsiella pneumoniae; Lactams; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Models, Biological; Monte Carlo Method; Ofloxacin; Thienamycins

2004
Ertapenem-associated seizures in a peritoneal dialysis patient.
    The Annals of pharmacotherapy, 2005, Volume: 39, Issue:2

    Topics: beta-Lactams; Ertapenem; Humans; Lactams; Male; Middle Aged; Peritoneal Dialysis; Seizures

2005
[Investigation of the in-vitro effectiveness of ertapenem against Pseudomonas aeruginosa strains isolated from intensive care unit patients].
    Mikrobiyoloji bulteni, 2004, Volume: 38, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Multiple, Bacterial; Ertapenem; Humans; Imipenem; Intensive Care Units; Lactams; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins

2004
In vitro activity of ertapenem against bacteraemic pneumococci: report of a French multicentre study including 339 strains.
    The Journal of antimicrobial chemotherapy, 2005, Volume: 55, Issue:3

    Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Drug Resistance, Bacterial; Ertapenem; Humans; Lactams; Microbial Sensitivity Tests; Pneumonia, Pneumococcal; Streptococcus pneumoniae

2005
Selectivity of ertapenem for Pseudomonas aeruginosa mutants cross-resistant to other carbapenems.
    The Journal of antimicrobial chemotherapy, 2005, Volume: 55, Issue:3

    Topics: beta-Lactams; Carbapenems; Culture Media, Serum-Free; Drug Resistance, Bacterial; Ertapenem; Lactams; Microbial Sensitivity Tests; Mutation; Porins; Pseudomonas aeruginosa

2005
[Activity of ertapenem and 19 other antimicrobial agents against beta-lactam-resistant Streptococcus pneumoniae and Haemophilus influenzae respiratory tract isolates].
    Enfermedades infecciosas y microbiologia clinica, 2005, Volume: 23, Issue:2

    Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; beta-Lactam Resistance; beta-Lactams; Child; Drug Resistance, Multiple, Bacterial; Ertapenem; Haemophilus influenzae; Humans; Lactams; Microbial Sensitivity Tests; Penicillin G; Penicillin Resistance; Respiratory Tract Infections; Spain; Streptococcus pneumoniae

2005
Characterization of a new integron containing bla(VIM-1) and aac(6')-IIc in an Enterobacter cloacae clinical isolate from Greece.
    The Journal of antimicrobial chemotherapy, 2005, Volume: 55, Issue:5

    Topics: Acetyltransferases; Aged; Amino Acid Sequence; Bacteremia; beta-Lactamases; beta-Lactams; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Ertapenem; Greece; Humans; Imipenem; Integrons; Lactams; Male; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction

2005
Activity of three {beta}-lactams (ertapenem, meropenem and ampicillin) against intraphagocytic Listeria monocytogenes and Staphylococcus aureus.
    The Journal of antimicrobial chemotherapy, 2005, Volume: 55, Issue:6

    Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactams; Blood Bactericidal Activity; Dose-Response Relationship, Drug; Ertapenem; Lactams; Listeria monocytogenes; Meropenem; Microbial Sensitivity Tests; Staphylococcus aureus; Thienamycins

2005
Exploiting pH mismatch in preparative high-performance liquid chromatographic recovery of ertapenem from mother liquor streams.
    Journal of chromatography. A, 2005, Jun-24, Volume: 1079, Issue:1-2

    Topics: Anti-Bacterial Agents; beta-Lactams; Chromatography, High Pressure Liquid; Drug Stability; Ertapenem; Hydrogen-Ion Concentration; Lactams; Nonlinear Dynamics

2005
Quantification of the carbapenem antibiotic ertapenem in human plasma by a validated liquid chromatography-mass spectrometry method.
    Clinica chimica acta; international journal of clinical chemistry, 2006, Volume: 364, Issue:1-2

    Topics: beta-Lactams; Calibration; Carbapenems; Chromatography, High Pressure Liquid; Drug Stability; Ertapenem; Humans; Kidney Failure, Chronic; Mass Spectrometry; Reference Standards; Reproducibility of Results

2006
Practical synthesis of the new carbapenem antibiotic ertapenem sodium.
    The Journal of organic chemistry, 2005, Sep-16, Volume: 70, Issue:19

    Topics: Anti-Bacterial Agents; beta-Lactams; Ertapenem

2005
Multicentre survey of the in-vitro activity of seven antimicrobial agents, including ertapenem, against recently isolated Gram-negative anaerobic bacteria in Greece.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2005, Volume: 11, Issue:10

    Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; beta-Lactams; Carbapenems; Drug Resistance, Microbial; Ertapenem; Gram-Negative Anaerobic Bacteria; Gram-Negative Bacterial Infections; Greece; Humans; Inhibitory Concentration 50; Metronidazole; Microbial Sensitivity Tests

2005
Disagreements between disc diffusion, and MIC-based susceptibility categorizations of ertapenem versus ESBL producers.
    The Journal of antimicrobial chemotherapy, 2005, Volume: 56, Issue:5

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Enterobacteriaceae; Ertapenem; Humans; Microbial Sensitivity Tests

2005
In vitro activities of doripenem and comparator agents against 364 anaerobic clinical isolates.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:10

    Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; beta-Lactams; Carbapenems; Doripenem; Ertapenem; Humans; Imipenem; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Ofloxacin; Thienamycins

2005
Low-dose aerosol model of pneumococcal pneumonia in the mouse: utility for evaluation of antimicrobial efficacy.
    International journal of antimicrobial agents, 2005, Volume: 26, Issue:6

    Topics: Aerosols; Animals; Anti-Bacterial Agents; beta-Lactams; Disease Models, Animal; Drug Resistance, Bacterial; Ertapenem; Female; Mice; Mice, Inbred CBA; Penicillins; Pneumonia, Pneumococcal; Streptococcus pneumoniae

2005
Determination of free ertapenem in plasma and bronchoalveolar lavage by high-performance liquid chromatography with ultraviolet detection.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2006, Jan-18, Volume: 830, Issue:2

    Topics: beta-Lactams; Bronchoalveolar Lavage Fluid; Calibration; Chromatography, High Pressure Liquid; Ertapenem; Humans; Reproducibility of Results; Spectrophotometry, Ultraviolet

2006
In vitro activities of tigecycline, ertapenem, isepamicin, and other antimicrobial agents against clinically isolated organisms in Taiwan.
    Microbial drug resistance (Larchmont, N.Y.), 2005,Winter, Volume: 11, Issue:4

    Topics: Anti-Bacterial Agents; Bacteria; beta-Lactams; Drug Resistance, Bacterial; Ertapenem; Gentamicins; Hospitals, University; Microbial Sensitivity Tests; Minocycline; Taiwan; Tigecycline

2005
Emergence of cefotaxime resistance in Citrobacter freundii causing necrotizing fasciitis and osteomyelitis.
    The Journal of infection, 2006, Volume: 53, Issue:3

    Topics: Anti-Bacterial Agents; beta-Lactams; Cefepime; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Citrobacter freundii; Enterobacteriaceae Infections; Ertapenem; Fasciitis, Necrotizing; Female; Humans; Middle Aged; Osteomyelitis; Wounds and Injuries

2006
Assay of ertapenem in human serum by high-performance liquid chromatography.
    International journal of antimicrobial agents, 2006, Volume: 27, Issue:2

    Topics: Anti-Bacterial Agents; beta-Lactams; Blood Chemical Analysis; Chromatography, High Pressure Liquid; Ertapenem; Humans; Reproducibility of Results

2006
[Severe pelvic inflammatory disease. Response to ertapenem].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2005, Volume: 18, Issue:4

    Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Ertapenem; Female; Gram-Positive Bacterial Infections; Humans; Pelvic Inflammatory Disease; Peptostreptococcus

2005
A new simple HPLC assay for the quantification of ertapenem in human plasma, lung tissue, and broncho-alveolar lavage fluid.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2006, Mar-07, Volume: 832, Issue:2

    Topics: beta-Lactams; Bronchoalveolar Lavage Fluid; Calibration; Case-Control Studies; Chromatography, High Pressure Liquid; Ertapenem; Humans; Lung; Sensitivity and Specificity; Spectrophotometry, Ultraviolet

2006
Comparative pharmacokinetics and pharmacodynamic target attainment of ertapenem in normal-weight, obese, and extremely obese adults.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:4

    Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Body Mass Index; Ertapenem; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Obesity

2006
Challenges in the analytical method development and validation for an unstable active pharmaceutical ingredient.
    Journal of chromatographic science, 2006, Volume: 44, Issue:3

    Topics: beta-Lactams; Chromatography, High Pressure Liquid; Drug Stability; Ertapenem; Pharmaceutical Preparations; Reproducibility of Results; Sensitivity and Specificity

2006
In vivo development of ertapenem resistance in a patient with pneumonia caused by Klebsiella pneumoniae with an extended-spectrum beta-lactamase.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Jun-01, Volume: 42, Issue:11

    Topics: Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Ertapenem; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Pneumonia, Bacterial

2006
Comparative effects of ertapenem, imipenem, and meropenem on the colonization of the gastrointestinal tract of mice by Candida albicans.
    Medical mycology, 2006, Volume: 44, Issue:3

    Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Candida albicans; Ertapenem; Gastrointestinal Tract; Imipenem; Male; Meropenem; Mice; Mice, Inbred ICR; Thienamycins

2006
Development of a gradient elution preparative high performance liquid chromatography method for the recovery of the antibiotic ertapenem from crystallization process streams.
    Journal of chromatography. A, 2006, Sep-08, Volume: 1126, Issue:1-2

    Topics: beta-Lactams; Chromatography, High Pressure Liquid; Crystallization; Drug Industry; Ertapenem

2006
Evaluation of the in vitro activity of ertapenem and nine other comparator agents against 337 anaerobic bacteria.
    International journal of antimicrobial agents, 2006, Volume: 28, Issue:1

    Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; beta-Lactams; Drug Evaluation, Preclinical; Ertapenem; Gram-Negative Bacteria; Gram-Positive Bacteria; In Vitro Techniques; Microbial Sensitivity Tests

2006
Comparative in vitro activity and the inoculum effect of ertapenem against Enterobacteriaceae resistant to extended-spectrum cephalosporins.
    International journal of antimicrobial agents, 2006, Volume: 28, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Microbial; Enterobacteriaceae; Ertapenem; Microbial Sensitivity Tests; Polymerase Chain Reaction

2006
History of cerebrovascular events: a relative contraindication to ertapenem treatment.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Jul-15, Volume: 43, Issue:2

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Ertapenem; Humans; Male; Seizures; Stroke; Urinary Tract Infections

2006
In vitro and in vivo assessment of linezolid combined with ertapenem: a highly synergistic combination against methicillin-resistant Staphylococcus aureus.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:7

    Topics: Acetamides; Animals; Anti-Infective Agents; beta-Lactams; Drug Synergism; Endocarditis, Bacterial; Ertapenem; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Rabbits; Staphylococcal Infections; Staphylococcus aureus

2006
Outer membrane protein changes and efflux pump expression together may confer resistance to ertapenem in Enterobacter cloacae.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:8

    Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactams; Drug Resistance, Microbial; Enterobacter cloacae; Ertapenem; Gene Expression Regulation, Bacterial; Genes, Bacterial; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Transcription, Genetic

2006
The cathelicidin-derived tritrpticin enhances the efficacy of ertapenem in experimental rat models of septic shock.
    Shock (Augusta, Ga.), 2006, Volume: 26, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; beta-Lactams; Cathelicidins; Cecum; Disease Models, Animal; Drug Synergism; Endotoxins; Enterococcus faecalis; Ertapenem; Escherichia coli; Escherichia coli Infections; Interleukin-6; Ligation; Male; Microbial Sensitivity Tests; Oligopeptides; Rats; Rats, Wistar; Shock, Septic; Tumor Necrosis Factor-alpha

2006
Stability of ertapenem in aqueous solutions.
    Journal of pharmaceutical and biomedical analysis, 2007, Jan-17, Volume: 43, Issue:2

    Topics: Anti-Bacterial Agents; beta-Lactams; Buffers; Catalysis; Chromatography, High Pressure Liquid; Drug Stability; Ertapenem; Hydrogen-Ion Concentration; Hydrolysis; Hydroxides; Kinetics; Models, Chemical; Molecular Structure; Solutions; Spectrophotometry, Ultraviolet; Temperature; Thermodynamics; Water

2007
Pharmacodynamic profiling of imipenem, meropenem and ertapenem against clinical isolates of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. from Brazil.
    International journal of antimicrobial agents, 2006, Volume: 28, Issue:4

    Topics: beta-Lactamases; beta-Lactams; Brazil; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Humans; Imipenem; Klebsiella; Meropenem; Microbial Sensitivity Tests; Models, Biological; Monte Carlo Method; Thienamycins

2006
In vitro activities of ertapenem against drug-resistant Streptococcus pneumoniae and other respiratory pathogens from 12 Asian countries.
    Diagnostic microbiology and infectious disease, 2006, Volume: 56, Issue:4

    Topics: Anti-Bacterial Agents; Asia; Bacterial Infections; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Ertapenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Pneumococcal Infections; Respiratory Tract Infections; Sentinel Surveillance; Streptococcus pneumoniae

2006
Susceptibilities of Propionibacterium acnes ophthalmic isolates to ertapenem, meropenem, and cefepime.
    Journal of clinical microbiology, 2006, Volume: 44, Issue:11

    Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Cefepime; Cephalosporins; Ertapenem; Eye; Meropenem; Microbial Sensitivity Tests; Propionibacterium acnes; Rabbits; Thienamycins

2006
Comparative in vitro activity of ertapenem against extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated in Spain.
    International journal of antimicrobial agents, 2006, Volume: 28, Issue:5

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Ertapenem; Escherichia coli; Humans; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Spain; Thienamycins

2006
In vitro activities of three carbapenems against recent bacterial isolates from severely ill patients at Swedish hospitals.
    Scandinavian journal of infectious diseases, 2006, Volume: 38, Issue:10

    Topics: Acinetobacter; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Carbapenems; Enterobacteriaceae; Ertapenem; Gram-Negative Bacterial Infections; Humans; Imipenem; Klebsiella; Meropenem; Microbial Sensitivity Tests; Proteus; Sweden; Thienamycins

2006
Effect of carbapenem administration on establishment of intestinal colonization by vancomycin-resistant enterococci and Klebsiella pneumoniae in mice.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:1

    Topics: Animals; beta-Lactams; Carbapenems; Ceftriaxone; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Enterococcus; Ertapenem; Female; Imipenem; Intestines; Klebsiella pneumoniae; Mice; Piperacillin; Sodium Chloride; Time Factors; Vancomycin Resistance

2007
Bactericidal activity of ertapenem against major intra-abdominal pathogens.
    International journal of antimicrobial agents, 2006, Volume: 28, Issue:5

    Topics: Abdomen; Anti-Bacterial Agents; Bacterial Infections; Bacteroides fragilis; beta-Lactams; Ceftazidime; Ceftriaxone; Digestive System Diseases; Enterobacter cloacae; Enterococcus faecalis; Ertapenem; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Klebsiella; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Proteus mirabilis; Staphylococcus aureus; Time Factors

2006
Pharmacodynamic activity of ertapenem versus penicillin-susceptible and penicillin-non-susceptible Streptococcus pneumoniae using an in vitro model.
    The Journal of antimicrobial chemotherapy, 2007, Volume: 59, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactams; Ertapenem; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Streptococcus pneumoniae

2007
Carbapenems for surgical prophylaxis?
    The New England journal of medicine, 2006, Dec-21, Volume: 355, Issue:25

    Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Cefotetan; Colorectal Surgery; Drug Resistance, Bacterial; Elective Surgical Procedures; Ertapenem; Humans; Surgical Wound Infection; Treatment Failure

2006
Ertapenem in critically ill patients with early-onset ventilator-associated pneumonia: pharmacokinetics with special consideration of free-drug concentration.
    The Journal of antimicrobial chemotherapy, 2007, Volume: 59, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Chromatography, High Pressure Liquid; Creatinine; Critical Illness; Ertapenem; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged; Pneumonia, Ventilator-Associated; Prospective Studies; Treatment Outcome

2007
Is all free time above the minimum inhibitory concentration the same: implications for beta-lactam in vivo modelling.
    International journal of antimicrobial agents, 2007, Volume: 29, Issue:3

    Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Models, Biological

2007
Bactericidal activities of meropenem and ertapenem against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a neutropenic mouse thigh model.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:4

    Topics: Animals; beta-Lactamases; beta-Lactams; Disease Models, Animal; Ertapenem; Escherichia coli; Escherichia coli Infections; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Mice; Microbial Sensitivity Tests; Thienamycins

2007
Ertapenem resistance among Klebsiella and Enterobacter submitted in the UK to a reference laboratory.
    International journal of antimicrobial agents, 2007, Volume: 29, Issue:4

    Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacter; Ertapenem; Humans; Klebsiella; Laboratories; Microbial Sensitivity Tests; United Kingdom

2007
Susceptibilities of ESBL-producing Enterobacteriaceae to ertapenem, meropenem and piperacillin-tazobactam with and without clavulanic acid.
    Chemotherapy, 2007, Volume: 53, Issue:3

    Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Clavulanic Acid; Drug Interactions; Ertapenem; Escherichia coli; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Thienamycins

2007
Clinical predictors of treatment failure for diabetic foot infections: data from a prospective trial.
    International wound journal, 2007, Volume: 4, Issue:1

    Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Diabetic Foot; Ertapenem; Female; Humans; Leukocyte Count; Male; Middle Aged; Multivariate Analysis; Outcome Assessment, Health Care; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Severity of Illness Index; Treatment Failure

2007
Ertapenem resistance of Escherichia coli.
    Emerging infectious diseases, 2007, Volume: 13, Issue:2

    Topics: Anti-Bacterial Agents; Antifungal Agents; beta-Lactams; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Fluconazole; Gentamicins; Humans; Imipenem; Immunocompromised Host; Middle Aged; Vancomycin

2007
Comparative costs of ertapenem and piperacillin-tazobactam in the treatment of diabetic foot infections.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2007, May-15, Volume: 64, Issue:10

    Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Diabetic Foot; Drug Administration Schedule; Drug Combinations; Ertapenem; Female; Health Care Costs; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination

2007
In vitro activity of piperacillin/tazobactam and ertapenem against Bacteroides fragilis and Escherichia coli in pure and mixed cultures.
    Journal of medical microbiology, 2007, Volume: 56, Issue:Pt 6

    Topics: Anti-Bacterial Agents; Bacteroides fragilis; beta-Lactams; Colony Count, Microbial; Ertapenem; Escherichia coli; Microbial Sensitivity Tests; Microbial Viability; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Time Factors

2007
Ertapenem susceptibility of extended spectrum beta-lactamase-producing organisms.
    Annals of clinical microbiology and antimicrobials, 2007, Jun-06, Volume: 6

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Military Personnel

2007
Collateral damage of flomoxef therapy: in vivo development of porin deficiency and acquisition of blaDHA-1 leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae producing CTX-M-3 and SHV-5 beta-lactamases.
    The Journal of antimicrobial chemotherapy, 2007, Volume: 60, Issue:2

    Topics: Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Cephalosporins; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Bacterial; Electroporation; Ertapenem; Female; Genotype; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Porins; Reverse Transcriptase Polymerase Chain Reaction; Thienamycins

2007
Ertapenem for the treatment of extended-spectrum beta-lactamase-producing Gram-negative bacterial infections.
    International journal of antimicrobial agents, 2007, Volume: 30, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Ertapenem; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Treatment Outcome

2007
Comparative antimicrobial susceptibility of aerobic and facultative bacteria from community-acquired bacteremia to ertapenem in Taiwan.
    BMC infectious diseases, 2007, Jul-17, Volume: 7

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Bacteria, Aerobic; beta-Lactams; Child; Child, Preschool; Community-Acquired Infections; Ertapenem; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Taiwan

2007
Comment on: Best in class: a good principle for antibiotic usage to limit resistance development?
    The Journal of antimicrobial chemotherapy, 2007, Volume: 60, Issue:4

    Topics: Bacterial Infections; beta-Lactams; Ertapenem; Humans

2007
Acute seizures in a patient receiving divalproex sodium after starting ertapenem therapy.
    Pharmacotherapy, 2007, Volume: 27, Issue:8

    Topics: Acute Disease; Adult; Anti-Bacterial Agents; Anticonvulsants; beta-Lactams; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Ertapenem; Humans; Male; Probability; Seizures; Valproic Acid

2007
Diffusion of ertapenem into bone and synovial tissues.
    The Journal of antimicrobial chemotherapy, 2007, Volume: 60, Issue:4

    Topics: Adult; Aged; Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; beta-Lactams; Bone and Bones; Chromatography, High Pressure Liquid; Ertapenem; Female; Humans; Male; Microbial Sensitivity Tests; Serum; Synovial Fluid; Time Factors

2007
Rhodococcus equi lung infection in an allogeneic hematopoietic stem cell transplant recipient.
    Transplant infectious disease : an official journal of the Transplantation Society, 2008, Volume: 10, Issue:1

    Topics: Actinomycetales Infections; Anti-Bacterial Agents; beta-Lactams; Drug Therapy, Combination; Ertapenem; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Lung Diseases; Male; Middle Aged; Radiography; Rhodococcus equi; Rifampin; Transplantation, Homologous

2008
Antipneumococcal activity of ertapenem compared with gatifloxacin in a temperature-sensitive murine model of acute pneumonia.
    Journal of chemotherapy (Florence, Italy), 2007, Volume: 19, Issue:4

    Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Disease Models, Animal; DNA Topoisomerase IV; Ertapenem; Fluoroquinolones; Gatifloxacin; Mice; Mice, Inbred Strains; Mutation; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Temperature; Treatment Outcome

2007
A comparison of the stability of ertapenem and meropenem in pharmaceutical preparations in solid state.
    Journal of pharmaceutical and biomedical analysis, 2008, Jan-07, Volume: 46, Issue:1

    Topics: Algorithms; beta-Lactams; Chromatography, High Pressure Liquid; Drug Packaging; Drug Stability; Drug Storage; Dyphylline; Entropy; Ertapenem; Humidity; Meropenem; Molecular Structure; Pharmaceutical Preparations; Reference Standards; Tandem Mass Spectrometry; Temperature; Thienamycins; Time Factors; Validation Studies as Topic

2008
Comparative activity of ertapenem and piperacillin tazobactam in a murine systemic infection model with Bacteroides fragilis and Escherichia coli.
    Journal of medical microbiology, 2007, Volume: 56, Issue:Pt 11

    Topics: Animals; Anti-Bacterial Agents; Ascitic Fluid; Bacteroides fragilis; Bacteroides Infections; beta-Lactams; Blood; Colony Count, Microbial; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Mice; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis

2007
Seizures associated with ertapenem.
    International journal of antimicrobial agents, 2008, Volume: 31, Issue:3

    Topics: Anti-Bacterial Agents; beta-Lactams; Brain Abscess; Cellulitis; Ertapenem; Humans; Male; Middle Aged; Seizures

2008
Ertapenem-induced acute pancreatitis in a surgical elderly patient.
    Pharmacy world & science : PWS, 2008, Volume: 30, Issue:3

    Topics: Acute Disease; Aged; Amylases; Anti-Bacterial Agents; beta-Lactams; Blood Cell Count; Enteral Nutrition; Eosinophils; Ertapenem; Humans; Leukocyte Count; Lipase; Male; Pancreatic Function Tests; Pancreatitis

2008
A simple and sensitive liquid chromatography-tandem mass spectrometry assay for the quantification of ertapenem in microdialysate.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2008, Feb-01, Volume: 862, Issue:1-2

    Topics: Anti-Bacterial Agents; beta-Lactams; Chromatography, Liquid; Ertapenem; Microdialysis; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry

2008
Activity of ertapenem and other antimicrobials against ESBL-producing enterobacteria isolated from urine in patients from Madrid.
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2007, Volume: 20, Issue:3

    Topics: Adult; Anti-Bacterial Agents; Bacteriuria; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Humans; Male; Membrane Proteins; Microbial Sensitivity Tests; Middle Aged; Outpatient Clinics, Hospital; Spain; Urine

2007
High-level cefepime resistance in Escherichia coli from Singapore producing OXA-1 beta-lactamase.
    International journal of antimicrobial agents, 2008, Volume: 31, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporin Resistance; Cephalosporins; Ertapenem; Escherichia coli; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Reverse Transcriptase Polymerase Chain Reaction; Singapore

2008
[In vitro activity of ertapenem against strains isolated from diabetic foot infections].
    Medecine et maladies infectieuses, 2008, Volume: 38, Issue:3

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Diabetic Foot; Drug Evaluation, Preclinical; Ertapenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Inpatients; Microbial Sensitivity Tests; Species Specificity; Staphylococcal Infections

2008
A simple and fast method for quantification of ertapenem using meropenem as internal standard in human plasma in a clinical setting.
    Therapeutic drug monitoring, 2008, Volume: 30, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactams; Chromatography, High Pressure Liquid; Ertapenem; Humans; Meropenem; Reproducibility of Results; Sensitivity and Specificity; Thienamycins; Ultraviolet Rays

2008
Efficacy of ertapenem for consolidation therapy of extended-spectrum beta-lactamase-producing gram-negative infections: a case series report.
    The Annals of pharmacotherapy, 2008, Volume: 42, Issue:2

    Topics: beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Ertapenem; Female; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Retrospective Studies

2008
Pharmacodynamic activity of ertapenem versus multidrug-resistant genotypically characterized extended-spectrum beta-lactamase-producing Escherichia coli using an in vitro model.
    The Journal of antimicrobial chemotherapy, 2008, Volume: 61, Issue:3

    Topics: beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Genotype; Humans; Models, Biological

2008
[New antibiotics].
    La Revue de medecine interne, 2008, Volume: 29 Suppl 1

    Topics: Anti-Bacterial Agents; beta-Lactams; Daptomycin; Ertapenem; Humans; Ketolides; Minocycline; Ofloxacin; Tigecycline; Virginiamycin

2008
Effects of hyperthermia on pharmacokinetics of ertapenem in rats.
    Fundamental & clinical pharmacology, 2008, Volume: 22, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Area Under Curve; beta-Lactams; Body Temperature; Chromatography, High Pressure Liquid; Ertapenem; Hyperthermia, Induced; Injections, Intravenous; Male; Metabolic Clearance Rate; Rats; Rats, Wistar

2008
Increased postoperative cervical myelopathy and cord compression resulting from the use of Gelfoam.
    The spine journal : official journal of the North American Spine Society, 2009, Volume: 9, Issue:2

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; beta-Lactams; Cervical Vertebrae; Decompression, Surgical; Ertapenem; Female; Gelatin Sponge, Absorbable; Hemostatics; Humans; Laminectomy; Magnetic Resonance Imaging; Postoperative Complications; Spinal Cord Compression

2009
In vitro activity of ertapenem and other carbapenems against extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae clinical isolates in a tertiary care center in Turkey.
    Expert opinion on pharmacotherapy, 2008, Volume: 9, Issue:9

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Child; Child, Preschool; Ertapenem; Escherichia coli; Female; Hospitals, University; Humans; Infant; Infant, Newborn; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Turkey

2008
[In vitro activity of ertapenem against clinical bacterial isolates in 69 Spanish medical centers (E-test study)].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2007, Volume: 20, Issue:4

    Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Community-Acquired Infections; Ertapenem; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Spain

2007
Influence of ertapenem administration on the incidence of carbapenem-resistant Pseudomonas aeruginosa.
    The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, 2008, Volume: 12, Issue:2

    Topics: Anti-Bacterial Agents; beta-Lactams; Brazil; Drug Resistance, Multiple, Bacterial; Ertapenem; Humans; Pseudomonas aeruginosa; Pseudomonas Infections

2008
Ertapenem: no effect on aerobic gram-negative susceptibilities to imipenem.
    The Journal of infection, 2008, Volume: 57, Issue:2

    Topics: beta-Lactamases; beta-Lactams; Drug Interactions; Drug Resistance, Bacterial; Ertapenem; Gram-Negative Aerobic Bacteria; Gram-Negative Bacterial Infections; Hospitals, University; Humans; Imipenem

2008
Do CTX-M beta-lactamases hydrolyse ertapenem?
    The Journal of antimicrobial chemotherapy, 2008, Volume: 62, Issue:5

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Ertapenem; Escherichia coli; Hydrolysis; Microbial Sensitivity Tests

2008
Pharmacokinetics of ertapenem in critically ill patients with acute renal failure undergoing extended daily dialysis.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2009, Volume: 24, Issue:1

    Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; beta-Lactams; Critical Illness; Drug Administration Schedule; Ertapenem; Female; Humans; Injections, Intravenous; Male; Middle Aged; Prospective Studies; Renal Dialysis

2009
Seizures associated with ertapenem use in patients with CNS disorders and renal insufficiency.
    Scandinavian journal of infectious diseases, 2008, Volume: 40, Issue:11-12

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Central Nervous System Diseases; Ertapenem; Female; Humans; Male; Middle Aged; Renal Insufficiency; Risk Factors; Seizures

2008
Effect of protein binding on the pharmacological activity of highly bound antibiotics.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:11

    Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Blood Proteins; Cattle; Ceftriaxone; Drug Discovery; Ertapenem; Escherichia coli; Humans; In Vitro Techniques; Models, Biological; Protein Binding; Serum Albumin; Serum Albumin, Bovine; Streptococcus pneumoniae

2008
Different sample stacking strategies for the determination of ertapenem and its impurities by micellar electrokinetic chromatography in pharmaceutical formulation.
    Journal of chromatography. A, 2009, Apr-03, Volume: 1216, Issue:14

    Topics: Anti-Bacterial Agents; beta-Lactams; Chromatography, Micellar Electrokinetic Capillary; Ertapenem; Pharmaceutical Preparations; Sensitivity and Specificity

2009
Simultaneous determination of three carbapenem antibiotics in plasma by HPLC with ultraviolet detection.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2008, Nov-15, Volume: 875, Issue:2

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Ceftazidime; Chromatography, High Pressure Liquid; Drug Stability; Ertapenem; Humans; Imipenem; Meropenem; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Thienamycins

2008
Carbapenems and SHV-1 beta-lactamase form different acyl-enzyme populations in crystals and solution.
    Biochemistry, 2008, Nov-11, Volume: 47, Issue:45

    Topics: beta-Lactamases; beta-Lactams; Carbapenems; Crystallography, X-Ray; Ertapenem; Imipenem; Meropenem; Molecular Structure; Solutions; Spectrum Analysis, Raman; Thienamycins

2008
Presence of the KPC carbapenemase gene in Enterobacteriaceae causing bacteremia and its correlation with in vitro carbapenem susceptibility.
    Journal of clinical microbiology, 2009, Volume: 47, Issue:1

    Topics: Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Microbial Sensitivity Tests; Middle Aged; Missouri; Predictive Value of Tests

2009
CTX-M expression and selection of ertapenem resistance in Klebsiella pneumoniae and Escherichia coli.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:2

    Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; beta-Lactams; DNA Primers; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mutation

2009
Ertapenem for treatment of extended-spectrum beta-lactamase-producing and multidrug-resistant gram-negative bacteraemia.
    Annals of the Academy of Medicine, Singapore, 2008, Volume: 37, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Urinary Tract Infections

2008
[Ertapenem in combined therapy for generalized peritonitis].
    Khirurgiia, 2008, Issue:10

    Topics: Anti-Bacterial Agents; beta-Lactams; Combined Modality Therapy; Ertapenem; Humans; Peritonitis

2008
Pharmacokinetics of once-daily dosing of ertapenem in critically ill patients with severe sepsis.
    International journal of antimicrobial agents, 2009, Volume: 33, Issue:5

    Topics: Adult; Anti-Bacterial Agents; Area Under Curve; beta-Lactams; Chromatography, High Pressure Liquid; Cohort Studies; Critical Illness; Ertapenem; Female; Humans; Male; Middle Aged; Plasma; Prospective Studies; Sepsis; Time Factors; Urine; Young Adult

2009
Ertapenem peritoneal fluid concentrations in adult surgical patients.
    International journal of antimicrobial agents, 2009, Volume: 33, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Ascitic Fluid; beta-Lactams; Chromatography, High Pressure Liquid; Ertapenem; Female; Humans; Injections, Intravenous; Male; Middle Aged; Plasma; Young Adult

2009
Ertapenem clearance during modeled continuous renal replacement therapy.
    The International journal of artificial organs, 2008, Volume: 31, Issue:12

    Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Dialysis Solutions; Ertapenem; Hemofiltration; Membranes, Artificial; Metabolic Clearance Rate; Models, Biological; Renal Dialysis; Renal Insufficiency; Swine

2008
Oral and parenteral therapeutic options for outpatient urinary infections caused by enterobacteriaceae producing CTX-M extended-spectrum beta-lactamases.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:3

    Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefdinir; Cephalosporins; Cross Infection; Enterobacteriaceae; Ertapenem; Escherichia coli; Fosfomycin; Humans; Infusions, Parenteral; Microbial Sensitivity Tests; Outpatients; Urinary Tract Infections

2009
Specificity of ertapenem susceptibility screening for detection of Klebsiella pneumoniae carbapenemases.
    Journal of clinical microbiology, 2009, Volume: 47, Issue:3

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Ertapenem; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Predictive Value of Tests; Sensitivity and Specificity

2009
Selective determination of ertapenem in the presence of its degradation product.
    Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2009, Volume: 72, Issue:5

    Topics: Algorithms; Anti-Bacterial Agents; beta-Lactams; Ertapenem; Molecular Structure; Reproducibility of Results; Spectrometry, Fluorescence

2009
Levofloxacin-induced delirium.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2009, Volume: 30, Issue:2

    Topics: Age Factors; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Brain; Clarithromycin; Confusion; Delirium; Ertapenem; Hallucinations; Humans; Levofloxacin; Male; Ofloxacin; Pneumonia; Risk Factors; Sex Factors; Time Factors; Withholding Treatment

2009
Ertapenem resistance among extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae isolates.
    Journal of clinical microbiology, 2009, Volume: 47, Issue:4

    Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Electrophoresis, Polyacrylamide Gel; Ertapenem; Genotype; Hospitals; Humans; Israel; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests

2009
Effect of early antibiotic prophylaxis with ertapenem and meropenem in experimental acute pancreatitis in rats.
    Journal of hepato-biliary-pancreatic surgery, 2009, Volume: 16, Issue:3

    Topics: Animals; Antibiotic Prophylaxis; Bacterial Infections; beta-Lactams; Colony Count, Microbial; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Ertapenem; Male; Meropenem; Pancreatitis, Acute Necrotizing; Probability; Random Allocation; Rats; Rats, Sprague-Dawley; Reference Values; Risk Factors; Sensitivity and Specificity; Severity of Illness Index; Thienamycins

2009
[Multiple inflammatory liver pseudotumors and Enterococcus durans bacteremia].
    Gastroenterologia y hepatologia, 2009, Volume: 32, Issue:2

    Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Biopsy, Needle; Diagnosis, Differential; Enterococcus; Ertapenem; Gram-Positive Bacterial Infections; Granuloma, Plasma Cell; Humans; Liver Abscess; Liver Diseases; Male; Middle Aged

2009
Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK.
    The Journal of antimicrobial chemotherapy, 2009, Volume: 63, Issue:4

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Electrophoresis, Polyacrylamide Gel; Enterobacter; Ertapenem; Gene Expression Profiling; Humans; Klebsiella; Microbial Sensitivity Tests; Mutagenesis, Insertional; Polymerase Chain Reaction; Porins; Sequence Analysis, DNA; United Kingdom

2009
Killing of Escherichia coli by beta-lactams at different inocula.
    Diagnostic microbiology and infectious disease, 2009, Volume: 64, Issue:2

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Ceftriaxone; Colony Count, Microbial; Ertapenem; Escherichia coli; Humans; Microbial Viability; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Time Factors

2009
Recurrent bacteremia due to retained embolized glue following variceal obliteration.
    Endoscopy, 2009, Volume: 41 Suppl 2

    Topics: Adult; Bacteremia; beta-Lactams; Embolism; Embolization, Therapeutic; Endoscopy, Gastrointestinal; Ertapenem; Escherichia coli Infections; Esophageal and Gastric Varices; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis, Alcoholic; Male; Recurrence; Risk Assessment; Severity of Illness Index; Tissue Adhesives; Tomography, X-Ray Computed; Treatment Outcome

2009
[In vitro activity of linezolid/ertapenem combination in resistant gram-positive bacteria].
    Mikrobiyoloji bulteni, 2009, Volume: 43, Issue:1

    Topics: Acetamides; Anti-Infective Agents; beta-Lactams; Drug Combinations; Drug Synergism; Enterococcus faecium; Ertapenem; Gram-Positive Cocci; Humans; Linezolid; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus epidermidis; Vancomycin Resistance

2009
The impact of ertapenem use on the susceptibility of Pseudomonas aeruginosa to imipenem: a hospital case study.
    Infection control and hospital epidemiology, 2009, Volume: 30, Issue:5

    Topics: Academic Medical Centers; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Brazil; Cross Infection; Drug Resistance, Bacterial; Drug Utilization; Ertapenem; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections

2009
Ertapenem resistance and the Enterobacteriaceae.
    International journal of antimicrobial agents, 2009, Volume: 34, Issue:2

    Topics: Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem

2009
Detection of plasmid-mediated IMP-1 metallo-beta-lactamase and quinolone resistance determinants in an ertapenem-resistant Enterobacter cloacae isolate.
    Journal of Zhejiang University. Science. B, 2009, Volume: 10, Issue:5

    Topics: beta-Lactamases; beta-Lactams; Enterobacter cloacae; Ertapenem; Plasmids; Quinolones

2009
Emergence of high levels of extended-spectrum-beta-lactamase-producing gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program, 2007.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:8

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; China; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Imipenem; India; Klebsiella; Quinolones; Thailand

2009
Clinical response to ertapenem in severe community-acquired pneumonia: a retrospective series in an elderly population.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2009, Volume: 15, Issue:11

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Case-Control Studies; Community-Acquired Infections; Ertapenem; Female; Hospitals; Humans; Length of Stay; Male; Pneumonia; Retrospective Studies; Severity of Illness Index; Spain; Treatment Outcome

2009
Ertapenem susceptibility of extended spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care centre in India.
    Singapore medical journal, 2009, Volume: 50, Issue:6

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Hospitals; Humans; India; Microbial Sensitivity Tests

2009
Activity of amikacin, ertapenem, ciprofloxacin and levofloxacin alone and in combination against resistant nosocomial pathogens by time-kill.
    The West Indian medical journal, 2008, Volume: 57, Issue:2

    Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Cross Infection; Drug Synergism; Drug Therapy, Combination; Ertapenem; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin

2008
[Comparative activity of ertapenem against extended-spectrum beta-lactamase-producing or plasmid-mediated AmpC beta-lactamase-producing Klebsiella pneumoniae].
    Enfermedades infecciosas y microbiologia clinica, 2010, Volume: 28, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Ertapenem; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Porins; R Factors; Substrate Specificity

2010
[Activity of Ertapenem and Ceftriaxone in the eradication of Salmonella in a model of experimental peritonitis in mice].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2009, Volume: 22, Issue:3

    Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Dose-Response Relationship, Drug; Ertapenem; Male; Mice; Peritonitis; Salmonella enterica; Salmonella Infections

2009
A case of beta lactam-induced visual hallucination.
    The New Zealand medical journal, 2009, Jul-03, Volume: 122, Issue:1298

    Topics: Anti-Bacterial Agents; beta-Lactams; Ertapenem; Hallucinations; Humans; Male; Middle Aged; Surgical Wound Infection

2009
Trends in the frequency of multiple drug-resistant Enterobacteriaceae and their susceptibility to ertapenem, imipenem, and other antimicrobial agents: data from the Study for Monitoring Antimicrobial Resistance Trends 2002 to 2007.
    Diagnostic microbiology and infectious disease, 2010, Volume: 66, Issue:1

    Topics: Anti-Infective Agents; beta-Lactams; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Imipenem; Longitudinal Studies; Microbial Sensitivity Tests; Population Surveillance

2010
Addendum: why not ertapenem for surgical prophylaxis?
    The Medical letter on drugs and therapeutics, 2009, Sep-07, Volume: 51, Issue:1320

    Topics: Antibiotic Prophylaxis; beta-Lactams; Ertapenem; Humans; Postoperative Complications

2009
Emergence of blaKPC-containing Klebsiella pneumoniae in a long-term acute care hospital: a new challenge to our healthcare system.
    The Journal of antimicrobial chemotherapy, 2009, Volume: 64, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Cluster Analysis; Cross Infection; Disease Outbreaks; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Ertapenem; Female; Florida; Hospitals; Humans; Immunoblotting; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Molecular Epidemiology; Polymerase Chain Reaction; Sequence Analysis, DNA

2009
Introduction of ertapenem into a hospital formulary: effect on antimicrobial usage and improved in vitro susceptibility of Pseudomonas aeruginosa.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:12

    Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactams; Ertapenem; Formularies, Hospital as Topic; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Sulbactam

2009
Refractory vertebral osteomyelitis due to CTX-M-14-producing Escherichia coli at ertapenem treatment in a patient with a coexisting urinary tract infection caused by the same pathogen.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2010, Volume: 14 Suppl 3

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Osteomyelitis; Spinal Diseases; Treatment Failure; Urinary Tract Infections

2010
[Treatment of community-acquired pneumonia in adults: ertapenem versus cefditoren?].
    Medicina clinica, 2010, Oct-16, Volume: 135, Issue:12

    Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Ertapenem; Humans; Ofloxacin; Pneumonia, Bacterial

2010
Underdosing of ertapenem in critically ill patients with pneumonia confirmed by Monte Carlo simulations.
    International journal of antimicrobial agents, 2010, Volume: 35, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactams; Critical Illness; Ertapenem; Humans; Monte Carlo Method; Plasma; Pneumonia, Bacterial

2010
Accounting for the development of antibacterial resistance in the cost effectiveness of ertapenem versus piperacillin/tazobactam in the treatment of diabetic foot infections in the UK.
    PharmacoEconomics, 2009, Volume: 27, Issue:12

    Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cost-Benefit Analysis; Decision Trees; Diabetic Foot; Direct Service Costs; Drug Costs; Drug Resistance, Bacterial; Ertapenem; Humans; Models, Biological; Models, Econometric; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Quality-Adjusted Life Years; Treatment Outcome; United Kingdom

2009
Direct ertapenem disk screening method for identification of KPC-producing Klebsiella pneumoniae and Escherichia coli in surveillance swab specimens.
    Journal of clinical microbiology, 2010, Volume: 48, Issue:3

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carrier State; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Mass Screening; Microbial Sensitivity Tests; Rectum; Sensitivity and Specificity

2010
Mechanisms of carbapenem resistance among a collection of Enterobacteriaceae clinical isolates in a Texas city.
    Diagnostic microbiology and infectious disease, 2010, Volume: 66, Issue:4

    Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Microbial Sensitivity Tests; Plasmids; Texas

2010
Changing prevalence of Escherichia coli with CTX-M-type extended-spectrum beta-lactamases in outpatient urinary E. coli between 2003 and 2008.
    Diagnostic microbiology and infectious disease, 2010, Volume: 67, Issue:1

    Topics: Ambulatory Care; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Community-Acquired Infections; Ertapenem; Escherichia coli Infections; Escherichia coli Proteins; Genotype; Humans; Nitrofurantoin; Prevalence; Urinary Tract Infections; Urine; Uropathogenic Escherichia coli

2010
Mutant prevention concentrations of four carbapenems against gram-negative rods.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6

    Topics: Acinetobacter baumannii; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Doripenem; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Genes, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; In Vitro Techniques; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Mutation; Phenotype; Pseudomonas aeruginosa; Thienamycins

2010
Absence of association between use of ertapenem and change in antipseudomonal carbapenem susceptibility rates in 25 hospitals.
    Infection control and hospital epidemiology, 2010, Volume: 31, Issue:5

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Drug Resistance, Bacterial; Ertapenem; Hospitals; Hospitals, Teaching; Humans; Microbial Sensitivity Tests; Practice Patterns, Physicians'; Pseudomonas aeruginosa; Pseudomonas Infections; United States

2010
Biochemical and structural characterization of Mycobacterium tuberculosis beta-lactamase with the carbapenems ertapenem and doripenem.
    Biochemistry, 2010, May-04, Volume: 49, Issue:17

    Topics: beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Crystallization; Crystallography, X-Ray; Cyclotrons; Doripenem; Ertapenem; Fourier Analysis; Hydrogen Bonding; Indicators and Reagents; Kinetics; Mass Spectrometry; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Protein Conformation

2010
Susceptibility of gram-negative pathogens isolated from patients with complicated intra-abdominal infections in the United States, 2007-2008: results of the Study for Monitoring Antimicrobial Resistance Trends (SMART).
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:7

    Topics: Abdomen; Amikacin; beta-Lactams; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Ertapenem; Escherichia coli; Gram-Negative Bacteria; Humans; Imipenem; Microbial Sensitivity Tests

2010
Ertapenem administered as outpatient parenteral antibiotic therapy for urinary tract infections caused by extended-spectrum-beta-lactamase-producing Gram-negative organisms.
    The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:7

    Topics: Adult; Aged; Ambulatory Care; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Ertapenem; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Health Care Costs; Humans; Infusions, Intravenous; Male; Middle Aged; Retrospective Studies; Treatment Outcome; United Kingdom; Urinary Tract Infections

2010
Transfer of carbapenem-resistant plasmid from Klebsiella pneumoniae ST258 to Escherichia coli in patient.
    Emerging infectious diseases, 2010, Volume: 16, Issue:6

    Topics: Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Colistin; Conjugation, Genetic; Drug Resistance, Bacterial; Drug Therapy, Combination; Ertapenem; Escherichia coli; Escherichia coli Infections; Gastrointestinal Tract; Humans; Israel; Klebsiella Infections; Klebsiella pneumoniae; Male; Metronidazole; Plasmids; Vancomycin

2010
Novel genetic context of multiple bla OXA-58 genes in Acinetobacter genospecies 3.
    The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:8

    Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Blotting, Southern; DNA Transposable Elements; DNA, Bacterial; DNA, Ribosomal Spacer; Ertapenem; Gene Duplication; Gene Order; Genes, Bacterial; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Polymerase Chain Reaction; Restriction Mapping; Sequence Analysis, DNA; Thienamycins

2010
Antimicrobial stewardship lessons: do Pseudomonas-sparing agents, such as ertapenem, effectively improve bacterial resistance?
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:7

    Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Ertapenem; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sulbactam

2010
Pharmacokinetics and tolerability of single-dose intravenous ertapenem in infants, children, and adolescents.
    The Pediatric infectious disease journal, 2010, Volume: 29, Issue:12

    Topics: Adolescent; Anti-Bacterial Agents; beta-Lactams; Child; Child, Preschool; Chromatography, High Pressure Liquid; Ertapenem; Female; Humans; Infant; Male; Plasma

2010
Comparison of disk diffusion, Etest and VITEK2 for detection of carbapenemase-producing Klebsiella pneumoniae with the EUCAST and CLSI breakpoint systems.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2011, Volume: 17, Issue:5

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Disk Diffusion Antimicrobial Tests; Ertapenem; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Microbiological Techniques; Thienamycins

2011
Decrease in serum valproic acid levels during treatment with ertapenem.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2010, Volume: 67, Issue:15

    Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Cellulitis; Drug Antagonism; Ertapenem; Female; Humans; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Seizures; Staphylococcal Infections; Staphylococcus epidermidis; Valproic Acid

2010
An ertapenem-resistant extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae clone carries a novel OmpK36 porin variant.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:10

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Electrophoresis, Polyacrylamide Gel; Ertapenem; Imipenem; Klebsiella pneumoniae; Meropenem; Molecular Sequence Data; Porins; Thienamycins

2010
Membrane efflux and influx modulate both multidrug resistance and virulence of Klebsiella pneumoniae in a Caenorhabditis elegans model.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:10

    Topics: Animals; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactams; Biological Transport; Caenorhabditis elegans; Drug Resistance, Bacterial; Ertapenem; Klebsiella pneumoniae; Reverse Transcriptase Polymerase Chain Reaction; Virulence

2010
In vitro selection of ertapenem and piperacillin/tazobactam-resistant strains of Bacteroides fragilis and analysis of their virulence in gnotobiotic mice.
    Journal of chemotherapy (Florence, Italy), 2010, Volume: 22, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; beta-Lactam Resistance; beta-Lactams; Ertapenem; Germ-Free Life; In Vitro Techniques; Mice; Microbial Sensitivity Tests; Penicillanic Acid; Phenotype; Piperacillin; Tazobactam; Virulence

2010
Epidemiologic trends, occurrence of extended-spectrum beta-lactamase production, and performance of ertapenem and comparators in patients with intra-abdominal infections: analysis of global trend data from 2002-2007 from the SMART study.
    Surgical infections, 2010, Volume: 11, Issue:4

    Topics: Africa; Animals; Anti-Bacterial Agents; Asia; Australasia; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Ertapenem; Europe; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Latin America; Middle East; North America; Peritonitis

2010
Prevalence and characteristics of ertapenem-nonsusceptible Escherichia coli in a Taiwanese university hospital, 1999 to 2007.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2010, Volume: 29, Issue:11

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporinase; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Hospitals, University; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Porins; Taiwan

2010
Improved performance of the modified Hodge test with MacConkey agar for screening carbapenemase-producing Gram-negative bacilli.
    Journal of microbiological methods, 2010, Volume: 83, Issue:2

    Topics: Agar; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Culture Media; Ertapenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Mass Screening; Microbial Sensitivity Tests

2010
Selective determination of ertapenem and imipenem in the presence of their degradants.
    Journal of chromatographic science, 2010, Volume: 48, Issue:8

    Topics: beta-Lactams; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Drug Stability; Ertapenem; Imipenem; Kinetics; Linear Models

2010
Salvage therapy with tigecycline for recurrent infection caused by ertapenem-resistant extended-spectrum β-lactamase-producing Klebsiella pneumoniae.
    Diagnostic microbiology and infectious disease, 2010, Volume: 68, Issue:3

    Topics: Anti-Bacterial Agents; beta-Lactams; Diabetes Complications; Ertapenem; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Minocycline; Osteomyelitis; Pyomyositis; Recurrence; Salvage Therapy; Tigecycline; Treatment Outcome

2010
Osteomyelitis after bilateral sagittal split osteotomy: case report and a review of the management.
    Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2011, Volume: 111, Issue:4

    Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Bone Plates; Bone Screws; Clindamycin; Drainage; Enterobacteriaceae Infections; Ertapenem; Female; Gram-Negative Bacterial Infections; Humans; Jaw Fixation Techniques; Mandible; Ofloxacin; Open Bite; Orthognathic Surgical Procedures; Osteomyelitis; Osteotomy; Osteotomy, Le Fort; Retrognathia; Streptococcal Infections

2011
Ertapenem-resistant Enterobacteriaceae: risk factors for acquisition and outcomes.
    Infection control and hospital epidemiology, 2010, Volume: 31, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Boston; Case-Control Studies; Cross Infection; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Equipment Contamination; Ertapenem; Female; Hospitals; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Risk Factors; Treatment Outcome; Urban Population; Young Adult

2010
Genetic context and biochemical characterization of the IMP-18 metallo-beta-lactamase identified in a Pseudomonas aeruginosa isolate from the United States.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:1

    Topics: Amino Acid Sequence; Bacterial Proteins; beta-Lactamases; beta-Lactams; Ertapenem; Meropenem; Microbial Sensitivity Tests; Models, Genetic; Molecular Sequence Data; Open Reading Frames; Pseudomonas aeruginosa; Sequence Homology, Amino Acid; Thienamycins; United States

2011
Molecular analysis of antimicrobial agent translocation through the membrane porin BpsOmp38 from an ultraresistant Burkholderia pseudomallei strain.
    Biochimica et biophysica acta, 2011, Volume: 1808, Issue:6

    Topics: Amino Acid Sequence; Anti-Infective Agents; Bacterial Outer Membrane Proteins; beta-Lactams; Biological Transport; Burkholderia pseudomallei; Cefepime; Ceftazidime; Cephalosporins; Ertapenem; Humans; Imipenem; Kinetics; Lipid Bilayers; Melioidosis; Meropenem; Models, Molecular; Molecular Sequence Data; Norfloxacin; Penicillin G; Phospholipids; Porins; Protein Conformation; Sequence Homology, Amino Acid; Thienamycins

2011
Citrobacter koseri as a cause of early periprosthetic infection after primary total hip arthroplasty.
    The Journal of arthroplasty, 2011, Volume: 26, Issue:6

    Topics: Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; beta-Lactams; Citrobacter koseri; Debridement; Enterobacteriaceae Infections; Ertapenem; Hip Joint; Hip Prosthesis; Humans; Joint Diseases; Male; Middle Aged; Prosthesis-Related Infections; Radiography; Therapeutic Irrigation; Treatment Outcome

2011
Central nervous system toxicity associated with ertapenem use.
    The Annals of pharmacotherapy, 2011, Volume: 45, Issue:1

    Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Central Nervous System Diseases; Delirium; Drug Monitoring; Ertapenem; Humans; Language Disorders; Male; Miosis; Osteomyelitis; Postoperative Complications; Stroke; Treatment Outcome

2011
[Evolution of Escherichia coli resistance in community acquired peritonitis].
    Medecine et maladies infectieuses, 2011, Volume: 41, Issue:4

    Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Appendicitis; beta-Lactams; Cephalosporins; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Intestines; Male; Morocco; Peptic Ulcer Perforation; Peritonitis; Practice Guidelines as Topic; Prospective Studies

2011
Risk factors for the acquisition of nosocomial infection with carbapenem-resistant Klebsiella pneumoniae.
    Southern medical journal, 2011, Volume: 104, Issue:2

    Topics: Age Factors; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Case-Control Studies; Chi-Square Distribution; Confidence Intervals; Cross Infection; Drug Resistance, Bacterial; Ertapenem; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Logistic Models; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Odds Ratio; Risk Factors; Thienamycins

2011
In vitro susceptibilities of clinical isolates of ertapenem-non-susceptible Enterobacteriaceae to nemonoxacin, tigecycline, fosfomycin and other antimicrobial agents.
    International journal of antimicrobial agents, 2011, Volume: 37, Issue:3

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Fosfomycin; Humans; Microbial Sensitivity Tests; Minocycline; Quinolones; Tigecycline

2011
Ertapenem for the treatment of urinary tract infections caused by extended-spectrum β-lactamase-producing bacteria in children.
    Scandinavian journal of infectious diseases, 2011, Volume: 43, Issue:5

    Topics: Adolescent; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Child; Child, Preschool; Community-Acquired Infections; Disk Diffusion Antimicrobial Tests; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Follow-Up Studies; Hospitals; Humans; Infant; Male; Pyelonephritis; Recurrence; Retrospective Studies; Turkey; Urinary Tract Infections

2011
New Delhi metallo-beta-lactamase from traveler returning to Canada.
    Emerging infectious diseases, 2011, Volume: 17, Issue:2

    Topics: Adult; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Canada; Carbapenems; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Fosfomycin; Humans; India; Male; Microbial Sensitivity Tests; Prostatitis; Pyelonephritis; Travel; Urine

2011
Changes in antibiotic usage and susceptibility in nosocomial Enterobacteriaceae and Pseudomonas isolates following the introduction of ertapenem to hospital formulary.
    Epidemiology and infection, 2012, Volume: 140, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactams; Cross Infection; Drug Prescriptions; Drug Resistance, Bacterial; Enterobacteriaceae; Ertapenem; Humans; Pseudomonas; Regression Analysis

2012
Comparison of in vitro activity of ertapenem with other carbapenems against extended-spectrum beta-lactamase-producing Escherichia coli and Kleibsella species isolated in a tertiary children's hospital.
    Expert opinion on pharmacotherapy, 2011, Volume: 12, Issue:6

    Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Child; Enterobacteriaceae Infections; Ertapenem; Escherichia coli; Hospitals, University; Humans; Klebsiella; Microbial Sensitivity Tests

2011
Phenotypic and genotypic screening and clonal analysis of carbapenem-resistant Klebsiella pneumoniae at a single hospital.
    Microbial drug resistance (Larchmont, N.Y.), 2011, Volume: 17, Issue:2

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; DNA, Bacterial; Doripenem; Electrophoresis, Gel, Pulsed-Field; Ertapenem; Genotype; Hospitals, Urban; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Phylogeny; Polymerase Chain Reaction; Sensitivity and Specificity; Thienamycins; United States

2011
[Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
    Mikrobiyoloji bulteni, 2011, Volume: 45, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Klebsiella Infections; Klebsiella oxytoca; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Thienamycins

2011
Carbapenem therapy for bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
    Diagnostic microbiology and infectious disease, 2011, Volume: 70, Issue:1

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Carbapenems; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Middle Aged; Thienamycins; Treatment Outcome

2011
Evaluation of a real-time PCR assay for the detection of the Klebsiella pneumoniae carbapenemase genes in microbiological samples in comparison with the modified Hodge test.
    American journal of clinical pathology, 2011, Volume: 135, Issue:4

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; DNA, Bacterial; Ertapenem; Genes, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymerase Chain Reaction; Predictive Value of Tests

2011
Risk factors and clinical significance of ertapenem-resistant Klebsiella pneumoniae in hospitalised patients.
    The Journal of hospital infection, 2011, Volume: 78, Issue:1

    Topics: Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactams; Cluster Analysis; Ertapenem; Female; Genotype; Hospitalization; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Multilocus Sequence Typing; Porins; Risk Factors; Treatment Outcome

2011
Activity of ertapenem and comparators against recent clinical isolates from intra-abdominal abscesses (SMART 2009).
    The Journal of infection, 2011, Volume: 62, Issue:6

    Topics: Abdominal Abscess; Anti-Bacterial Agents; Bacteria; beta-Lactams; Ertapenem; Humans; Microbial Sensitivity Tests

2011
Change in antipseudomonal carbapenem susceptibility in 25 hospitals across 9 years is not associated with the use of ertapenem.
    The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:6

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Carbapenems; Drug Utilization; Ertapenem; Hospitals; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections

2011
Comparative in vitro susceptibility of Burkholderia pseudomallei to doripenem, ertapenem, tigecycline and moxifloxacin.
    International journal of antimicrobial agents, 2011, Volume: 37, Issue:6

    Topics: Anti-Bacterial Agents; Aza Compounds; beta-Lactams; Burkholderia pseudomallei; Carbapenems; Doripenem; Ertapenem; Fluoroquinolones; Humans; Melioidosis; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Quinolines; Tigecycline

2011
Clinical epidemiology of carbapenem-intermediate or -resistant Enterobacteriaceae.
    The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:7

    Topics: Academic Medical Centers; Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Carbapenems; Case-Control Studies; Drug Utilization; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Humans; Male; Meropenem; Middle Aged; Risk Factors; Thienamycins

2011
Drug fever induced by ertapenem.
    QJM : monthly journal of the Association of Physicians, 2011, Volume: 104, Issue:8

    Topics: Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Drug-Related Side Effects and Adverse Reactions; Ertapenem; Female; Fever; Humans

2011
Hand hygiene, and not ertapenem use, contributed to reduction of carbapenem-resistant Pseudomonas aeruginosa rates.
    Infection control and hospital epidemiology, 2011, Volume: 32, Issue:6

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Carbapenems; Cross Infection; Ertapenem; Hand Disinfection; Hospitals, University; Humans; Incidence; Pseudomonas aeruginosa; Pseudomonas Infections; Regression Analysis

2011
Pharmacokinetics of free ertapenem in critically ill septic patients: intermittent versus continuous infusion.
    Minerva anestesiologica, 2011, Volume: 77, Issue:11

    Topics: Aged; Anti-Bacterial Agents; Bacteria; beta-Lactams; Critical Illness; Ertapenem; Female; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Sepsis

2011
An epistemological dilemma: is ertapenem adequate to treat severe infections in critically ill patients?
    Minerva anestesiologica, 2011, Volume: 77, Issue:11

    Topics: Anti-Bacterial Agents; beta-Lactams; Ertapenem; Female; Humans; Male; Sepsis

2011
Superior in vitro activity of ertapenem and piperacillin/tazobactam against recent clinical isolates of Proteus mirabilis from intra-abdominal infections (SMART 2009-2010).
    International journal of antimicrobial agents, 2011, Volume: 38, Issue:2

    Topics: Abdominal Abscess; Anti-Bacterial Agents; beta-Lactams; Ertapenem; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Proteus Infections; Proteus mirabilis

2011
Ertapenem in plasma and peritoneal fluid from patients with severe intra-abdominal infections.
    The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ascitic Fluid; beta-Lactams; Ertapenem; Female; Humans; Intensive Care Units; Male; Middle Aged; Peritonitis; Plasma

2011
Susceptibility of European Escherichia coli clinical isolates from intra-abdominal infections, extended-spectrum β-lactamase occurrence, resistance distribution, and molecular characterization of ertapenem-resistant isolates (SMART 2008-2009).
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2012, Volume: 18, Issue:3

    Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Europe; Female; Humans; Imipenem; Intraabdominal Infections; Male; Microbial Sensitivity Tests

2012
Susceptibility of Klebsiella pneumoniae isolates from intra-abdominal infections and molecular characterization of ertapenem-resistant isolates.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:8

    Topics: Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Ertapenem; Humans; Imipenem; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests

2011
Impact of derepressed AmpC beta-lactamase ACT-9 on the clinical efficacy of ertapenem.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:9

    Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Enterobacteriaceae Infections; Ertapenem; Humans; Male; Molecular Sequence Data; Mutation; N-Acetylmuramoyl-L-alanine Amidase; Pantoea

2011
Phenotypic changes in a laboratory-derived ertapenem-resistant Escherichia coli strain.
    Journal of chemotherapy (Florence, Italy), 2011, Volume: 23, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactams; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Mice; Microbial Sensitivity Tests; Phenotype; Two-Dimensional Difference Gel Electrophoresis; Virulence

2011
Rapid acquisition of decreased carbapenem susceptibility in a strain of Klebsiella pneumoniae arising during meropenem therapy.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2012, Volume: 18, Issue:2

    Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactam Resistance; beta-Lactams; Catheter-Related Infections; Conjugation, Genetic; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Ertapenem; Gene Expression Profiling; Gene Transfer, Horizontal; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Molecular Typing; Molecular Weight; Mutation; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Selection, Genetic; Thienamycins; Urinary Tract Infections; Urine

2012
Emergence of ertapenem resistance in an Escherichia coli clinical isolate producing extended-spectrum beta-lactamase AmpC.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:9

    Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Ertapenem; Escherichia coli; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Homology, Amino Acid

2011
Mandibular Actinomyces osteomyelitis complicating florid cemento-osseous dysplasia: case report.
    BMC oral health, 2011, Jul-21, Volume: 11

    Topics: Actinomycosis, Cervicofacial; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactams; Denture, Complete, Lower; Drug Combinations; Ertapenem; Female; Fibrous Dysplasia of Bone; Humans; Mandibular Diseases; Middle Aged; Oral Ulcer; Osteomyelitis; Radiography

2011
[Clinical and economic expedience of ertapenem therapy of complicated urinary tract infection].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2011, Volume: 56, Issue:1-2

    Topics: Anti-Bacterial Agents; beta-Lactams; Costs and Cost Analysis; Drug Resistance, Bacterial; Ertapenem; Female; Gram-Negative Bacteria; Humans; Male; Russia; Urinary Tract Infections

2011
Does ertepenem alter the susceptibility of Pseudomonas aeruginosa to carbapenems?
    Journal of chemotherapy (Florence, Italy), 2011, Volume: 23, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Drug Interactions; Ertapenem; Humans; Intensive Care Units; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections

2011
Ertapenem compared to combination drug therapy for the treatment of postpartum endometritis after cesarean delivery.
    The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2012, Volume: 25, Issue:6

    Topics: Adult; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Cesarean Section; Clindamycin; Cohort Studies; Cost-Benefit Analysis; Drug Costs; Drug Therapy, Combination; Endometritis; Ertapenem; Female; Gentamicins; Humans; Infant, Newborn; Postnatal Care; Pregnancy; Puerperal Infection; Retrospective Studies; Young Adult

2012
[Characteristics of ertapenem use in critical state patients].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2011, Volume: 56, Issue:3-4

    Topics: Abdominal Cavity; Adult; Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Ertapenem; Humans; Lung; Microbial Sensitivity Tests; Skin; Time Factors; Tissue Distribution

2011
Reduction in fluoroquinolone use following introduction of ertapenem into a hospital formulary is associated with improvement in susceptibility of Pseudomonas aeruginosa to group 2 carbapenems: a 10-year study.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:12

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Ertapenem; Fluoroquinolones; Formularies, Hospital as Topic; Hospitals, Teaching; Humans; Microbial Sensitivity Tests; North Carolina; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies

2011
Fusobacterium nucleatum prosthetic hip infection in an adult with sickle cell-beta thalassemia.
    Infection, 2012, Volume: 40, Issue:3

    Topics: Anti-Bacterial Agents; beta-Lactams; beta-Thalassemia; Ertapenem; Fusobacterium Infections; Fusobacterium nucleatum; Hip Prosthesis; Humans; Infusions, Parenteral; Male; Middle Aged; Prosthesis-Related Infections

2012
Trending eight years of in vitro activity of ertapenem and comparators against Escherichia coli from intra-abdominal infections in North America--SMART 2002-2009.
    Journal of chemotherapy (Florence, Italy), 2011, Volume: 23, Issue:5

    Topics: Abdominal Cavity; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Intraabdominal Infections; Microbial Sensitivity Tests; North America; Population Surveillance

2011
[Clinical-economic analysis of antibacterial therapy of acute peritonitis].
    Klinichna khirurhiia, 2011, Issue:8

    Topics: Acute Disease; Anti-Bacterial Agents; beta-Lactams; Clinical Trials as Topic; Cost-Benefit Analysis; Decision Trees; Drug Therapy, Combination; Ertapenem; Health Care Costs; Humans; Models, Theoretical; Peritonitis; Treatment Outcome

2011
Ertapenem in the treatment of bacteremia caused by extended-spectrum beta-lactamase-producing Escherichia coli: a propensity score analysis.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2012, Volume: 16, Issue:1

    Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Carbapenems; Ertapenem; Escherichia coli; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Propensity Score; Thienamycins

2012
Ertapenem pharmacokinetics and pharmacodynamics during continuous ambulatory peritoneal dialysis.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:2

    Topics: Adult; Aged; Anti-Bacterial Agents; Area Under Curve; beta-Lactams; Chromatography, High Pressure Liquid; Ertapenem; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Models, Biological; Monte Carlo Method; Peritoneal Cavity; Peritoneal Dialysis, Continuous Ambulatory; Urine

2012
Characterization of ertapenem-resistant Enterobacter cloacae in a Taiwanese university hospital.
    Journal of clinical microbiology, 2012, Volume: 50, Issue:2

    Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactamases; beta-Lactams; Cluster Analysis; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Electrophoresis, Polyacrylamide Gel; Enterobacter cloacae; Enterobacteriaceae Infections; Ertapenem; Gene Expression Profiling; Genotype; Hospitals, University; Humans; Microbial Sensitivity Tests; Molecular Typing; Reverse Transcriptase Polymerase Chain Reaction; Taiwan

2012
Outcomes and characteristics of ertapenem-nonsusceptible Klebsiella pneumoniae bacteremia at a university hospital in Northern Taiwan: a matched case-control study.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2012, Volume: 45, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactams; Case-Control Studies; Ertapenem; Female; Hospitals, University; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Risk Factors; Survival Analysis; Taiwan; Treatment Outcome

2012
Pharmacokinetics of ertapenem in colorectal tissue.
    Chemotherapy, 2011, Volume: 57, Issue:5

    Topics: Adult; Aged; beta-Lactams; Colon; Ertapenem; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Protein Binding; Rectum; Tissue Distribution

2011
Cefoxitin as an alternative to carbapenems in a murine model of urinary tract infection due to Escherichia coli harboring CTX-M-15-type extended-spectrum β-lactamase.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Bacterial Load; beta-Lactamases; beta-Lactams; Carbapenems; Cefoxitin; Ceftriaxone; Conjugation, Genetic; Disease Models, Animal; Drug Administration Schedule; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Kidney; Mice; Microbial Sensitivity Tests; Mutation Rate; Plasmids; Urinary Bladder; Urinary Tract Infections

2012
Effect of body mass index on treatment of complicated intra-abdominal infections in hospitalized adults: comparison of ertapenem with piperacillin-tazobactam.
    Surgical infections, 2012, Volume: 13, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Body Mass Index; Ertapenem; Female; Humans; Intraabdominal Infections; Male; Middle Aged; Multicenter Studies as Topic; Obesity, Morbid; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Randomized Controlled Trials as Topic; Young Adult

2012
Development of an UPLC-MS/MS method for the determination of antibiotic ertapenem on dried blood spots.
    Journal of pharmaceutical and biomedical analysis, 2012, Mar-05, Volume: 61

    Topics: Anti-Bacterial Agents; beta-Lactams; Blood Specimen Collection; Dried Blood Spot Testing; Ertapenem; Humans; Mass Spectrometry; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry

2012
Efficacy of ertapenem for treatment of bloodstream infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:4

    Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cohort Studies; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Treatment Outcome

2012
Development of carbapenem resistance during therapy for non-typhoid Salmonella infection.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2012, Volume: 18, Issue:4

    Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Ertapenem; Feces; Female; Humans; Microbial Sensitivity Tests; Plasmids; Point Mutation; Porins; RNA, Bacterial; Salmonella Infections; Salmonella typhimurium; Urinary Tract Infections; Wound Infection

2012
Broad-spectrum β-lactam antibiotics for treating experimental peritonitis in mice due to Klebsiella pneumoniae producing the carbapenemase OXA-48.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cefotaxime; Ceftazidime; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Ertapenem; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Lethal Dose 50; Mice; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Plasmids; Survival Rate

2012
Clinical outcomes with ertapenem as a first-line treatment option of infections caused by extended-spectrum β-lactamase producing gram-negative bacteria.
    The Annals of pharmacotherapy, 2012, Volume: 46, Issue:3

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Ertapenem; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Male; Middle Aged

2012
Carbapenem therapy for bacteremia due to extended-spectrum-β-lactamase-producing Escherichia coli or Klebsiella pneumoniae: implications of ertapenem susceptibility.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:6

    Topics: Adult; Bacteremia; beta-Lactams; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Retrospective Studies; Thienamycins; Young Adult

2012
Chronic pelvic osteomyelitis.
    Surgical infections, 2012, Volume: 13, Issue:2

    Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Chronic Disease; Debridement; Ertapenem; Humans; Ilium; Magnetic Resonance Imaging; Male; Negative-Pressure Wound Therapy; Osteomyelitis; Pressure Ulcer; Spina Bifida Occulta; Treatment Failure; Wound Healing

2012
Class A carbapenemase FPH-1 from Francisella philomiragia.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:6

    Topics: Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Clavulanic Acid; Doripenem; Ertapenem; Escherichia coli; Francisella; Imipenem; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam; Tazobactam; Thienamycins

2012
Risk factors, molecular epidemiology and outcomes of ertapenem-resistant, carbapenem-susceptible Enterobacteriaceae: a case-case-control study.
    PloS one, 2012, Volume: 7, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Case-Control Studies; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Humans; Logistic Models; Male; Middle Aged; Molecular Epidemiology; Multivariate Analysis; Risk Factors; Singapore; Treatment Outcome; Young Adult

2012
Use of Carbapenems against clinical, nontyphoid Salmonella isolates: results from in vitro and in vivo animal studies.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:6

    Topics: Animals; beta-Lactams; Carbapenems; Cell Line; Doripenem; Ertapenem; Female; Imipenem; Meropenem; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Peritonitis; Salmonella; Thienamycins

2012
Low frequency of ertapenem-resistant intra-abdominal isolates of Escherichia coli from Latin America: susceptibility, ESBL-occurrence, and molecular characterisation (SMART 2008-2009).
    Journal of chemotherapy (Florence, Italy), 2012, Volume: 24, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Intraabdominal Infections; Latin America; Microbial Sensitivity Tests

2012
In vitro activity of ertapenem versus ceftriaxone against Neisseria gonorrhoeae isolates with highly diverse ceftriaxone MIC values and effects of ceftriaxone resistance determinants: ertapenem for treatment of gonorrhea?
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:7

    Topics: Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Drug Resistance, Bacterial; Ertapenem; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae

2012
Acute prolonged neurotoxicity associated with recommended doses of ertapenem in 2 patients with advanced renal failure.
    Clinical nephrology, 2013, Volume: 80, Issue:6

    Topics: Acute Disease; Aged; Anti-Bacterial Agents; beta-Lactams; Ertapenem; Female; Humans; Neurotoxicity Syndromes; Renal Insufficiency, Chronic

2013
Inter-hospital outbreak of Klebsiella pneumoniae producing KPC-2 carbapenemase in Ireland.
    The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:10

    Topics: beta-Lactamases; beta-Lactams; Disease Outbreaks; Ertapenem; Genes, Bacterial; Hospitals; Humans; Imipenem; Ireland; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Typing; Polymerase Chain Reaction; Thienamycins

2012
Study for Monitoring Antimicrobial Resistance Trends (SMART) in the Asia-Pacific region, 2002-2010.
    International journal of antimicrobial agents, 2012, Volume: 40 Suppl

    Topics: Anti-Bacterial Agents; Asia; Australasia; beta-Lactams; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Global Health; Humans; Microbial Sensitivity Tests

2012
Correlation between carbapenem consumption and resistance to carbapenems among Enterobacteriaceae isolates collected from patients with intra-abdominal infections at five medical centers in Taiwan, 2006-2010.
    International journal of antimicrobial agents, 2012, Volume: 40 Suppl

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Intraabdominal Infections; Linear Models; Meropenem; Microbial Sensitivity Tests; Prevalence; Prospective Studies; Taiwan; Thienamycins

2012
Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009-2010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART).
    International journal of antimicrobial agents, 2012, Volume: 40 Suppl

    Topics: Amikacin; Anti-Bacterial Agents; Asia; Australasia; beta-Lactamases; beta-Lactams; Carbapenems; Ceftazidime; Drug Resistance, Bacterial; Ertapenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prevalence; Prospective Studies; Urinary Tract Infections

2012
Impact of revised CLSI breakpoints for susceptibility to third-generation cephalosporins and carbapenems among Enterobacteriaceae isolates in the Asia-Pacific region: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2002-2010
    International journal of antimicrobial agents, 2012, Volume: 40 Suppl

    Topics: Anti-Bacterial Agents; Asia; Australasia; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Intraabdominal Infections; Microbial Sensitivity Tests; Prevalence; Prospective Studies

2012
Emergence of NDM-1- and IMP-14a-producing Enterobacteriaceae in Thailand.
    The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:11

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Hospitals, University; Humans; Imipenem; Microbial Sensitivity Tests; Molecular Typing; Polymerase Chain Reaction; Thailand

2012
A swordless knight: epidemiology and molecular characteristics of the blaKPC-negative sequence type 258 Klebsiella pneumoniae clone.
    Journal of clinical microbiology, 2012, Volume: 50, Issue:10

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Electrophoresis, Gel, Pulsed-Field; Ertapenem; Genotype; Humans; Israel; Klebsiella Infections; Klebsiella pneumoniae; Molecular Epidemiology; Molecular Typing; Multilocus Sequence Typing; Plasmids; Polymerase Chain Reaction; Prospective Studies

2012
In vitro activity of tigecycline and molecular characterization of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates from a university hospital in south-western Germany.
    Chemotherapy, 2012, Volume: 58, Issue:3

    Topics: beta-Lactamases; beta-Lactams; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Ertapenem; Escherichia coli; Germany; Hospitals, University; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Prevalence; Retrospective Studies; Tigecycline

2012
Spontaneous abscess of the anterior abdominal wall caused by Clostridium perfringens resistant to clindamycin.
    Surgical infections, 2012, Volume: 13, Issue:4

    Topics: Abdominal Abscess; Abdominal Pain; Abdominal Wall; Aged; Anti-Bacterial Agents; beta-Lactams; Clindamycin; Clostridium Infections; Clostridium perfringens; Drug Resistance, Bacterial; Ertapenem; Female; Humans; Soft Tissue Infections; Tomography, X-Ray Computed

2012
[Ertapenem administered intravenously or subcutaneously for urinary tract infections caused by ESBL producing enterobacteriacea].
    Medecine et maladies infectieuses, 2012, Volume: 42, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Ambulatory Care; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cystitis; Drug Evaluation; Ertapenem; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Humans; Injections, Intravenous; Injections, Subcutaneous; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Prostatitis; Pyelonephritis; Recurrence; Retrospective Studies; Risk Factors

2012
Association of ertapenem and antipseudomonal carbapenem usage and carbapenem resistance in Pseudomonas aeruginosa among 12 hospitals in Queensland, Australia.
    The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:2

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Carbapenems; Drug Utilization; Ertapenem; Hospitals; Humans; Pseudomonas aeruginosa; Queensland

2013
Impact of pH on activity of trimethoprim, fosfomycin, amikacin, colistin and ertapenem in human urine.
    Pharmacology, 2012, Volume: 90, Issue:5-6

    Topics: Amikacin; Anti-Bacterial Agents; Bacteria; beta-Lactams; Colistin; Ertapenem; Fosfomycin; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Trimethoprim; Urine

2012
Quantification and validation of HPLC-UV and LC-MS assays for therapeutic drug monitoring of ertapenem in human plasma.
    Biomedical chromatography : BMC, 2013, Volume: 27, Issue:5

    Topics: beta-Lactams; Chromatography, High Pressure Liquid; Drug Monitoring; Drug Stability; Ertapenem; Humans; Least-Squares Analysis; Limit of Detection; Mass Spectrometry; Reproducibility of Results

2013
Activity of moxifloxacin, imipenem, and ertapenem against Escherichia coli, Enterobacter cloacae, Enterococcus faecalis, and Bacteroides fragilis in monocultures and mixed cultures in an in vitro pharmacokinetic/pharmacodynamic model simulating concentrat
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:12

    Topics: Anti-Bacterial Agents; Aza Compounds; Bacterial Load; Bacteroides fragilis; beta-Lactams; Colony Count, Microbial; Enterobacter cloacae; Enterococcus faecalis; Ertapenem; Escherichia coli; Fluoroquinolones; Humans; Imipenem; Microbial Sensitivity Tests; Models, Statistical; Moxifloxacin; Pancreas; Pancreatitis, Acute Necrotizing; Quinolines; Regression Analysis

2012
Impact of susceptibility profiles of Gram-negative bacteria before and after the introduction of ertapenem at a medical center in northern Taiwan from 2004 to 2010.
    Diagnostic microbiology and infectious disease, 2013, Volume: 75, Issue:1

    Topics: Academic Medical Centers; Anti-Bacterial Agents; beta-Lactams; Drug Utilization; Ertapenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Retrospective Studies; Taiwan

2013
Clinical experience with ertapenem in the treatment of infections of the biliary tract in daily practice in five Spanish hospitals.
    Journal of chemotherapy (Florence, Italy), 2012, Volume: 24, Issue:6

    Topics: Abdominal Abscess; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Cholangitis; Cholecystectomy; Cholecystitis; Combined Modality Therapy; Drug Resistance, Bacterial; Ertapenem; Female; Follow-Up Studies; Humans; Length of Stay; Male; Medical Records; Middle Aged; Retrospective Studies; Spain

2012
[Comparison of ertapenem-EMB Agar with traditional methods for screening carbapenem-resistant Klebsiella pneumoniae from rectal swabs].
    Mikrobiyoloji bulteni, 2012, Volume: 46, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Culture Media; Doripenem; Drug Resistance, Bacterial; Ertapenem; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Multiplex Polymerase Chain Reaction; Rectum; Sensitivity and Specificity; Thienamycins; Time Factors

2012
Drug interaction between tacrolimus and ertapenem in renal transplantation recipients.
    Transplantation proceedings, 2012, Volume: 44, Issue:10

    Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Cytochrome P-450 CYP3A; Drug Dosage Calculations; Drug Interactions; Drug Monitoring; Ertapenem; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Retrospective Studies; Tacrolimus; Young Adult

2012
Risk factors and treatment outcome of ertapenem non-susceptible enterobacteriaceae bacteraemia.
    The Journal of infection, 2013, Volume: 66, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Case-Control Studies; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Risk Factors; Thienamycins; Treatment Outcome

2013
The binding of antibiotics in OmpF porin.
    Structure (London, England : 1993), 2013, Jan-08, Volume: 21, Issue:1

    Topics: Amino Acid Sequence; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Binding Sites; Carbenicillin; Crystallography, X-Ray; Diffusion; Disk Diffusion Antimicrobial Tests; Ertapenem; Escherichia coli; Molecular Dynamics Simulation; Molecular Sequence Data; Porins; Protein Binding; Protein Structure, Secondary; Protein Structure, Tertiary

2013
Tissue pharmacokinetics of ertapenem at steady-state in diabetic patients with leg infections.
    The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:4

    Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Diabetic Foot; Ertapenem; Female; Humans; Male; Middle Aged; Plasma; Skin; Young Adult

2013
KPC presence in Pseudomonas aeruginosa has minimal impact on the in vivo efficacy of carbapenem therapy.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Doripenem; Ertapenem; Mice; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections

2013
The modified Hodge test is a useful tool for ruling out Klebsiella pneumoniae carbapenemase.
    Clinics (Sao Paulo, Brazil), 2012, Volume: 67, Issue:12

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; DNA, Bacterial; Ertapenem; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Predictive Value of Tests

2012
Monitoring the global in vitro activity of ertapenem against Escherichia coli from intra-abdominal infections: SMART 2002-2010.
    International journal of antimicrobial agents, 2013, Volume: 41, Issue:3

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Ertapenem; Escherichia coli; Escherichia coli Infections; Global Health; Humans; Intraabdominal Infections; Microbial Sensitivity Tests

2013
Rapid detection of carbapenemase activity through monitoring ertapenem hydrolysis in Enterobacteriaceae with LC-MS/MS.
    Bioanalysis, 2013, Volume: 5, Issue:2

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacteriological Techniques; beta-Lactamases; beta-Lactams; Chromatography, Liquid; Enterobacteriaceae; Ertapenem; Microbial Sensitivity Tests; Tandem Mass Spectrometry

2013
Effectiveness of a double-carbapenem regimen for infections in humans due to carbapenemase-producing pandrug-resistant Klebsiella pneumoniae.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:5

    Topics: Adult; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Doripenem; Drug Combinations; Drug Resistance, Bacterial; Ertapenem; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Middle Aged; Thienamycins; Treatment Outcome; Urinary Tract Infections

2013
Rapid selection of carbapenem-resistant Pseudomonas aeruginosa by clinical concentrations of ertapenem.
    International journal of antimicrobial agents, 2013, Volume: 41, Issue:5

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Carbapenems; Ertapenem; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Selection, Genetic

2013
Efficacy of doripenem and ertapenem against KPC-2-producing and non-KPC-producing Klebsiella pneumoniae with similar MICs.
    The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:7

    Topics: Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Disease Models, Animal; Doripenem; Ertapenem; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Treatment Outcome

2013
Frequent emergence of porin-deficient subpopulations with reduced carbapenem susceptibility in ESBL-producing Escherichia coli during exposure to ertapenem in an in vitro pharmacokinetic model.
    The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:6

    Topics: Anti-Bacterial Agents; Bacterial Load; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Kinetics; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction; Porins; Trans-Activators

2013
Unusual drug reaction between valproate sodium and meropenem.
    International journal of clinical pharmacy, 2013, Volume: 35, Issue:3

    Topics: Aged; Anti-Bacterial Agents; Anticonvulsants; Bacterial Infections; beta-Lactams; Drug Interactions; Drug Monitoring; Epilepsy; Ertapenem; Humans; Male; Meropenem; Thienamycins; Valproic Acid

2013
Serum in vivo and in vitro activity of single dose of ertapenem in surgical obese patients for prevention of SSIs.
    Obesity surgery, 2013, Volume: 23, Issue:7

    Topics: Abdomen; Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bariatric Surgery; beta-Lactams; Enterobacter cloacae; Ertapenem; Escherichia coli; Female; Follow-Up Studies; Humans; Incidence; Italy; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Obesity, Morbid; Practice Guidelines as Topic; Proteus mirabilis; Surgical Wound Infection; Treatment Outcome

2013
Impact of ertapenem use on Pseudomonas aeruginosa and Acinetobacter baumannii imipenem susceptibility rates: collateral damage or positive effect on hospital ecology?
    The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:8

    Topics: Acinetobacter baumannii; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Ciprofloxacin; Cross Infection; Drug Utilization; Ecosystem; Ertapenem; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Retrospective Studies; Selection, Genetic; Tertiary Care Centers

2013
Successful ertapenem-doripenem combination treatment of bacteremic ventilator-associated pneumonia due to colistin-resistant KPC-producing Klebsiella pneumoniae.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:6

    Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Carbapenems; Colistin; Doripenem; Drug Resistance, Bacterial; Drug Therapy, Combination; Ertapenem; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Pneumonia, Ventilator-Associated; Treatment Outcome

2013
Structure of Enterococcus faeciuml,d-transpeptidase acylated by ertapenem provides insight into the inactivation mechanism.
    ACS chemical biology, 2013, Volume: 8, Issue:6

    Topics: Acetylation; Anti-Bacterial Agents; beta-Lactams; Enterococcus faecium; Ertapenem; Gram-Positive Bacterial Infections; Humans; Models, Molecular; Peptidyl Transferases; Protein Conformation

2013
Pharmacokinetics of ertapenem in burns patients.
    International journal of antimicrobial agents, 2013, Volume: 42, Issue:1

    Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Burns; Ertapenem; Humans; Male; Middle Aged; Models, Statistical; Plasma; Prospective Studies; Young Adult

2013
Antimicrobial susceptibility of inpatient urinary tract isolates of gram-negative bacilli in the United States: results from the study for monitoring antimicrobial resistance trends (SMART) program: 2009-2011.
    Clinical therapeutics, 2013, Volume: 35, Issue:6

    Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Epidemiological Monitoring; Ertapenem; Female; Gram-Negative Bacteria; Humans; Imipenem; Inpatients; Male; United States; Urinary Tract Infections

2013
Population pharmacokinetics of ertapenem in juvenile and old rats.
    Fundamental & clinical pharmacology, 2014, Volume: 28, Issue:2

    Topics: Aging; Animals; Anti-Bacterial Agents; beta-Lactams; Ertapenem; Humans; Injections, Intravenous; Male; Models, Biological; Predictive Value of Tests; Rats; Rats, Wistar; Software

2014
Assessment of extended-spectrum β-lactamase, KPC carbapenemase and porin resistance mechanisms in clinical samples of Klebsiella pneumoniae and Enterobacter spp.
    International journal of antimicrobial agents, 2013, Volume: 42, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Porins

2013
Oral ertapenem for refractory pouchitis.
    Journal of Crohn's & colitis, 2013, Volume: 7, Issue:10

    Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Colonic Pouches; Ertapenem; Humans; Male; Middle Aged; Pouchitis; Remission Induction

2013
OXA-48-like carbapenemase-producing Enterobacteriaceae in Ottawa, Canada.
    Diagnostic microbiology and infectious disease, 2013, Volume: 76, Issue:3

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Ontario; Plasmids; Young Adult

2013
Efficacy of humanized carbapenem exposures against New Delhi metallo-β-lactamase (NDM-1)-producing enterobacteriaceae in a murine infection model.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:8

    Topics: Animals; Anti-Bacterial Agents; Bacterial Load; beta-Lactamases; beta-Lactams; Carbapenems; Disease Models, Animal; Doripenem; Drug Evaluation, Preclinical; Drug Resistance, Bacterial; Ertapenem; Humans; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Time Factors

2013
A 10 year surveillance for antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae in community- and hospital-associated intra-abdominal infections in China.
    Journal of medical microbiology, 2013, Volume: 62, Issue:Pt 9

    Topics: Anti-Bacterial Agents; beta-Lactams; China; Community-Acquired Infections; Cross Infection; Ertapenem; Escherichia coli; Humans; Imipenem; Intraabdominal Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Prevalence

2013
Synergistic activity of colistin plus rifampin against colistin-resistant KPC-producing Klebsiella pneumoniae.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:8

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Ertapenem; Genes, Bacterial; Gentamicins; Klebsiella pneumoniae; Microbial Sensitivity Tests; Microbial Viability; Rifampin

2013
Rectocutaneous fistula and nonunion after TranS1 axial lumbar interbody fusion L5-S1 fixation: case report.
    Journal of neurosurgery. Spine, 2013, Volume: 19, Issue:2

    Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactams; Ertapenem; Humans; Intervertebral Disc Degeneration; Intraoperative Complications; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Pseudarthrosis; Rectal Fistula; Rectum; Reoperation; Sacrum; Sigmoidoscopy; Spinal Fusion; Tomography, X-Ray Computed; Treatment Outcome

2013
Delayed recovery from ertapenem induced encephalopathy: case-report and a possible mechanism.
    International journal of clinical pharmacy, 2013, Volume: 35, Issue:4

    Topics: Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Dose-Response Relationship, Drug; Ertapenem; Female; Humans; Neurotoxicity Syndromes; Renal Insufficiency; Severity of Illness Index; Time Factors

2013
Outbreak caused by an ertapenem-resistant, CTX-M-15-producing Klebsiella pneumoniae sequence type 101 clone carrying an OmpK36 porin variant.
    Journal of clinical microbiology, 2013, Volume: 51, Issue:10

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cluster Analysis; Disease Outbreaks; DNA, Bacterial; Ertapenem; Female; Genotype; Greece; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Plasmids; Porins; Young Adult

2013
Ertapenem-induced acute generalized exanthematous pustulosis with cross-reactivity to other beta-lactam antibiotics on patch testing.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2013, Volume: 111, Issue:2

    Topics: Acute Generalized Exanthematous Pustulosis; beta-Lactams; Cross Reactions; Drug-Related Side Effects and Adverse Reactions; Ertapenem; Erysipelas; Humans; Male; Middle Aged; Patch Tests

2013
Susceptibility to antibiotics of aerobic bacteria isolated from community acquired secondary peritonitis in children: therapeutic guidelines might not always fit with and everyday experience.
    Journal of chemotherapy (Florence, Italy), 2013, Volume: 25, Issue:4

    Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Child; Community-Acquired Infections; Drug Resistance, Bacterial; Drug Therapy, Combination; Ertapenem; Gentamicins; Hospitals, Pediatric; Humans; Italy; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Practice Guidelines as Topic; Sulbactam; Thienamycins

2013
Chemical shift perturbations induced by the acylation of Enterococcus faecium L,D-transpeptidase catalytic cysteine with ertapenem.
    Biomolecular NMR assignments, 2014, Volume: 8, Issue:2

    Topics: Acylation; Amino Acid Sequence; beta-Lactams; Catalytic Domain; Cysteine; Enterococcus faecium; Ertapenem; Molecular Sequence Data; Nuclear Magnetic Resonance, Biomolecular; Peptidyl Transferases

2014
Outbreak of ertapenem-resistant Enterobacter cloacae urinary tract infections due to a contaminated ureteroscope.
    The Journal of hospital infection, 2013, Volume: 85, Issue:2

    Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Cluster Analysis; Cross Infection; Disease Outbreaks; Disinfection; Electrophoresis, Gel, Pulsed-Field; Enterobacter cloacae; Enterobacteriaceae Infections; Ertapenem; Female; Genes, Bacterial; Genotype; Hospitals, Teaching; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Polymerase Chain Reaction; Sequence Analysis, DNA; Taiwan; Ureteroscopes; Urinary Tract Infections

2013
Effect of experimentally induced hypovolemia on ertapenem tissue distribution using microdialysis in rats.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2014, Jan-23, Volume: 51

    Topics: Animals; Area Under Curve; beta-Lactams; Ertapenem; Hypovolemia; Male; Microdialysis; Muscle, Skeletal; Rats; Rats, Sprague-Dawley; Renal Circulation; Tissue Distribution

2014
Susceptibility of gram-negative aerobic bacilli from intra-abdominal pathogens to antimicrobial agents collected in the United States during 2011.
    The Journal of infection, 2014, Volume: 68, Issue:1

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Ertapenem; Gram-Negative Bacteria; Humans; Intraabdominal Infections; Microbial Sensitivity Tests; Population Surveillance; United States

2014
In vitro cross-linking of Mycobacterium tuberculosis peptidoglycan by L,D-transpeptidases and inactivation of these enzymes by carbapenems.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:12

    Topics: Antitubercular Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Cell Wall; Clavulanic Acid; Doripenem; Enzyme Assays; Ertapenem; Escherichia coli; Gene Expression; Imipenem; Kinetics; Meropenem; Mycobacterium tuberculosis; Peptidoglycan; Peptidyl Transferases; Recombinant Proteins; Thienamycins

2013
Exposure to ertapenem is possibly associated with Pseudomonas aeruginosa antibiotic resistance.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2014, Volume: 20, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Case-Control Studies; Drug Resistance, Bacterial; Ertapenem; Humans; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections

2014
Perioperative antimicrobial prophylaxis for intra-abdominal surgery in patients with cancer: a retrospective study comparing ertapenem and nonertapenem antibiotics.
    Annals of surgical oncology, 2014, Volume: 21, Issue:2

    Topics: Abdominal Neoplasms; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Ertapenem; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Perioperative Care; Postoperative Complications; Prognosis; Retrospective Studies; Risk Factors; Surgical Wound Infection

2014
Ertapenem: lack of allergic reactions in hospitalised adults reporting a history of penicillin allergy.
    International journal of antimicrobial agents, 2013, Volume: 42, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Ertapenem; Female; Humans; Hypersensitivity; Male; Middle Aged; Penicillins

2013
Discordance in the minimal inhibitory concentrations of ertapenem for Enterobacter cloacae: Vitek 2 system versus Etest and agar dilution methods.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2014, Volume: 18

    Topics: Agar; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Culture Media; Drug Resistance, Bacterial; Enterobacter cloacae; Ertapenem; Escherichia coli; Microbial Sensitivity Tests

2014
Evaluation of Ertapenem use with impact assessment on extended-spectrum beta-lactamases (ESBL) production and gram-negative resistance in Singapore General Hospital (SGH).
    BMC infectious diseases, 2013, Nov-06, Volume: 13

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Ertapenem; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, General; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Singapore; Thienamycins; Young Adult

2013
[Analysis of the carbapenemase-producing mechanism of Enterobacteriaceae with decreased susceptibility to carbapenems].
    Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2013, Volume: 33, Issue:11

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Enterobacteriaceae; Ertapenem; Gene Amplification; Imipenem; Meropenem; Microbial Sensitivity Tests; Polymerase Chain Reaction; Thienamycins

2013
MALDI-TOF MS, a useful instrument for differentiating metallo-β-lactamases in Enterobacteriaceae and Pseudomonas spp.
    Letters in applied microbiology, 2014, Volume: 58, Issue:4

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Enterobacteriaceae; Ertapenem; Humans; Pseudomonas aeruginosa; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

2014
In vivo efficacy of human simulated regimens of carbapenems and comparator agents against NDM-1-producing Enterobacteriaceae.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:3

    Topics: Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Disease Models, Animal; Doripenem; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Klebsiella pneumoniae; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests

2014
Efficacy of humanized carbapenem and ceftazidime regimens against Enterobacteriaceae producing OXA-48 carbapenemase in a murine infection model.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:3

    Topics: Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Ceftazidime; Disease Models, Animal; Doripenem; Ertapenem; Humans; Klebsiella pneumoniae; Levofloxacin; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests

2014
Rapid ertapenem susceptibility testing and Klebsiella pneumoniae carbapenemase phenotype detection in Klebsiella pneumoniae isolates by use of automated microscopy of immobilized live bacterial cells.
    Journal of clinical microbiology, 2014, Volume: 52, Issue:3

    Topics: Anti-Bacterial Agents; Automation, Laboratory; Bacterial Proteins; beta-Lactamases; beta-Lactams; Ertapenem; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Microscopy; Phenotype

2014
Ertapenem-associated seizures in a patient without prior CNS disorder or severe renal dysfunction.
    International journal of clinical pharmacology and therapeutics, 2014, Volume: 52, Issue:3

    Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Ertapenem; Female; Humans; Seizures

2014
Use of the parenteral antibiotic Ertapenem as short term prophylaxis in bariatric surgery: a pharmaco-kinetic-pharmacodynamic study in class III obese female patients.
    Minerva anestesiologica, 2014, Volume: 80, Issue:9

    Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Area Under Curve; Bariatric Surgery; beta-Lactams; Ertapenem; Female; Humans; Infusions, Intravenous; Liver; Middle Aged; Monte Carlo Method; Obesity, Morbid

2014
Pyogenic liver abscess as a complication of internal hemorrhoid banding.
    The American surgeon, 2014, Volume: 80, Issue:2

    Topics: Ambulatory Surgical Procedures; beta-Lactams; Drainage; Ertapenem; Female; Follow-Up Studies; Hemorrhoidectomy; Hemorrhoids; Humans; Infusions, Intravenous; Ligation; Liver Abscess, Pyogenic; Middle Aged; Proctoscopy; Risk Assessment; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Outcome

2014
Detection of carbapenemase activities of Bacteroides fragilis strains with matrix-assisted laser desorption ionization--time of flight mass spectrometry (MALDI-TOF MS).
    Anaerobe, 2014, Volume: 26

    Topics: Bacterial Proteins; Bacteriological Techniques; Bacteroides fragilis; beta-Lactamases; beta-Lactams; Ertapenem; Humans; Hydrolysis; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

2014
Evaluation of the activity of ertapenem against gonococcal isolates exhibiting a range of susceptibilities to cefixime.
    The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:6

    Topics: Anti-Bacterial Agents; beta-Lactams; Cefixime; Ertapenem; Gonorrhea; Humans; Inhibitory Concentration 50; Microbial Sensitivity Tests; Multilocus Sequence Typing; Neisseria gonorrhoeae

2014
Antimicrobial resistance to cefotaxime and ertapenem in Enterobacteriaceae: the effects of altering clinical breakpoints.
    Journal of infection in developing countries, 2014, Mar-13, Volume: 8, Issue:3

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Cefotaxime; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Microbial Sensitivity Tests

2014
High prevalence of Klebsiella pneumoniae carbapenemase-mediated resistance in K. pneumoniae isolates from Egypt.
    Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit, 2013, Volume: 19, Issue:11

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Egypt; Ertapenem; Humans; Klebsiella Infections; Klebsiella pneumoniae; Prospective Studies

2013
[In vitro emergence of ertapenem resistance in Escherichia coli producing extended-spectrum β-lactamase].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2014, Volume: 27, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Imipenem; Meropenem; Microbial Sensitivity Tests; Mutation; Thienamycins

2014
Use of outpatient parenteral antimicrobial therapy for transrectal ultrasound-guided prostate biopsy prophylaxis in the setting of community-associated multidrug-resistant Escherichia coli rectal colonization.
    Urology, 2014, Volume: 83, Issue:4

    Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; beta-Lactams; Carbapenems; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Hospitalization; Humans; Image-Guided Biopsy; Infusions, Parenteral; Male; Middle Aged; Outpatients; Prevalence; Prospective Studies; Prostate; Prostatitis; Rectum; Ultrasonography, Interventional

2014
Visual hallucinations related to use of ertapenem.
    Neurologia (Barcelona, Spain), 2015, Volume: 30, Issue:8

    Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Ertapenem; Female; Hallucinations; Humans; Male; Urinary Tract Infections

2015
Safety and efficacy of long-term outpatient ertapenem therapy.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:6

    Topics: Adult; Aged; Arthritis, Infectious; beta-Lactams; Bone and Bones; Cohort Studies; Ertapenem; Follow-Up Studies; Humans; Intraabdominal Infections; Middle Aged; Outpatients; Pneumonia, Bacterial; Retrospective Studies; Skin; Soft Tissue Infections; Surgical Wound Infection; Treatment Outcome; Young Adult

2014
The detection and verification of carbapenemases using ertapenem and Matrix Assisted Laser Desorption Ionization-Time of Flight.
    BMC microbiology, 2014, Apr-10, Volume: 14

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Ertapenem; Hydrolysis; Klebsiella pneumoniae; Pseudomonas aeruginosa; Sensitivity and Specificity; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Time Factors

2014
Quantification and validation of ertapenem using a liquid chromatography-tandem mass spectrometry method.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:6

    Topics: Anti-Bacterial Agents; beta-Lactams; Calibration; Chromatography, High Pressure Liquid; Drug Monitoring; Drug Stability; Ertapenem; Humans; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry

2014
Pharmacokinetics of ertapenem in outpatients with complicated urinary tract infections.
    The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Chromatography, Liquid; Ertapenem; Humans; Infusions, Intravenous; Male; Middle Aged; Models, Statistical; Outpatients; Prospective Studies; Serum; Tandem Mass Spectrometry; Urinary Tract Infections; Urine; Young Adult

2014
Impact of a change in antibacterial prophylaxis on bacteremia and hospitalization rates following outpatient autologous peripheral blood stem cell transplantation for multiple myeloma.
    Transplant infectious disease : an official journal of the Transplantation Society, 2014, Volume: 16, Issue:3

    Topics: Aged; Anti-Bacterial Agents; Antineoplastic Agents; Bacteremia; beta-Lactams; Ertapenem; Female; Hospitalization; Humans; Levofloxacin; Male; Middle Aged; Multiple Myeloma; Outpatients; Peripheral Blood Stem Cell Transplantation; Retrospective Studies

2014
Heteroresistance to carbapenems in New Delhi metallo-β-lactamase-1-producing isolates: a challenge for detection?
    Infection control and hospital epidemiology, 2014, Volume: 35, Issue:6

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Disease Susceptibility; Drug Resistance, Multiple; Enterobacteriaceae Infections; Ertapenem; Humans; Meropenem; Providencia; Thienamycins

2014
Pharmacodynamic activity of ertapenem versus genotypically characterized extended-spectrum β-lactamase (ESBL)-, KPC- or NDM-producing Escherichia coli with reduced susceptibility or resistance to ertapenem using an in vitro model.
    The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:9

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Ertapenem; Escherichia coli; Humans; Microbial Sensitivity Tests; Microbial Viability

2014
Instant screening and verification of carbapenemase activity in Bacteroides fragilis in positive blood culture, using matrix-assisted laser desorption ionization--time of flight mass spectrometry.
    Journal of medical microbiology, 2014, Volume: 63, Issue:Pt 8

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacteriological Techniques; Bacteroides fragilis; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Ertapenem; Gene Expression Regulation, Bacterial; Humans; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

2014
Determination of free vancomycin, ceftriaxone, cefazolin and ertapenem in plasma by ultrafiltration: impact of experimental conditions.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2014, Jun-15, Volume: 961

    Topics: beta-Lactams; Cefazolin; Ceftriaxone; Drug Stability; Ertapenem; Humans; Protein Binding; Ultrafiltration; Vancomycin

2014
Ertapenem prophylaxis reduces sepsis after transrectal biopsy of the prostate.
    BJU international, 2014, Volume: 113 Suppl 2

    Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Biopsy; Ciprofloxacin; Drug Therapy, Combination; Ertapenem; Escherichia coli Infections; Humans; Male; Middle Aged; Patient Selection; Prospective Studies; Prostatic Neoplasms; Rectum; Risk Assessment; Risk Factors; Sepsis; Surveys and Questionnaires; Treatment Outcome; Ultrasonography, Interventional

2014
Effects of Group 1 versus Group 2 carbapenems on the susceptibility of Acinetobacter baumannii to carbapenems: a before and after intervention study of carbapenem-use stewardship.
    PloS one, 2014, Volume: 9, Issue:6

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Drug Resistance, Bacterial; Ertapenem; Humans; Microbial Sensitivity Tests

2014
Antimicrobial susceptibility and extended-spectrum beta-lactamase rates in aerobic gram-negative bacteria causing intra-abdominal infections in Vietnam: report from the Study for Monitoring Antimicrobial Resistance Trends (SMART 2009-2011).
    Diagnostic microbiology and infectious disease, 2014, Volume: 79, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Ertapenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intraabdominal Infections; Microbial Sensitivity Tests; Vietnam

2014
Cluster of Escherichia coli isolates producing a plasmid-mediated OXA-48 β-lactamase in a Spanish hospital in 2012.
    Journal of clinical microbiology, 2014, Volume: 52, Issue:9

    Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Conjugation, Genetic; Ertapenem; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Gene Transfer, Horizontal; Genotype; Hospitals; Humans; Imipenem; Male; Middle Aged; Plasmids; Spain

2014
Unbound fraction of ertapenem in intensive care unit patients.
    The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:11

    Topics: Anti-Bacterial Agents; beta-Lactams; Chromatography, High Pressure Liquid; Ertapenem; Humans; Intensive Care Units; Protein Binding

2014
Microbiological features of KPC-producing Enterobacter isolates identified in a U.S. hospital system.
    Diagnostic microbiology and infectious disease, 2014, Volume: 80, Issue:2

    Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Enterobacter cloacae; Enterobacteriaceae Infections; Ertapenem; Female; Genotype; Hospitals; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Multilocus Sequence Typing; Pennsylvania; Plasmids; Young Adult

2014
Ertapenem induced hyperbilirubinemia.
    Clinics and research in hepatology and gastroenterology, 2015, Volume: 39, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactams; Ertapenem; Humans; Hyperbilirubinemia; Male; Middle Aged

2015
Stability of ertapenem 100 mg/mL in polypropylene syringes stored at 25, 4, and -20 °C.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2014, Sep-01, Volume: 71, Issue:17

    Topics: beta-Lactams; Chromatography, High Pressure Liquid; Drug Stability; Drug Storage; Ertapenem; Pharmaceutical Solutions; Polypropylenes; Syringes; Temperature; Time Factors

2014
Nosocomial extended-spectrum beta-lactamase-producing Klebsiella pneumoniae bacteremia in hemodialysis patients and the implications for antibiotic therapy.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2014, Volume: 28

    Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Cephalosporins; Cross Infection; Ertapenem; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Renal Dialysis; Retrospective Studies; Treatment Outcome

2014
Clinical comparison of ertapenem and cefepime for treatment of infections caused by AmpC beta-lactamase-producing Enterobacteriaceae.
    Scandinavian journal of infectious diseases, 2014, Volume: 46, Issue:11

    Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Case-Control Studies; Cefepime; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Hospitalization; Humans; Male; Middle Aged; Retrospective Studies; Treatment Outcome

2014
Evaluation of inhibitory action of novel non β-lactam inhibitor against Klebsiella pneumoniae carbapenemase (KPC-2).
    PloS one, 2014, Volume: 9, Issue:9

    Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Cell Line; Ertapenem; HeLa Cells; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Protein Binding; Thienamycins

2014
Design, synthesis, structure-function relationship, bioconversion, and pharmacokinetic evaluation of ertapenem prodrugs.
    Journal of medicinal chemistry, 2014, Oct-23, Volume: 57, Issue:20

    Topics: Animals; beta-Lactams; Chemistry Techniques, Synthetic; Dogs; Drug Design; Drug Stability; Ertapenem; Esters; Humans; Hydrolysis; Male; Prodrugs; Rats, Sprague-Dawley; Structure-Activity Relationship

2014
Multidrug-resistant Escherichia coli soft tissue infection investigated with bacterial whole genome sequencing.
    BMJ case reports, 2014, Oct-19, Volume: 2014

    Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Diagnosis, Differential; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Floxacillin; Follow-Up Studies; Genome, Bacterial; Gentamicins; Humans; Liver Diseases; Male; Meropenem; Middle Aged; Sequence Analysis, DNA; Soft Tissue Infections; Thienamycins; Treatment Outcome; Vancomycin

2014
Efficacy of cefepime, ertapenem and norfloxacin against leptospirosis and for the clearance of pathogens in a hamster model.
    Microbial pathogenesis, 2014, Volume: 77

    Topics: Animal Structures; Animals; Anti-Bacterial Agents; beta-Lactams; Cefepime; Cephalosporins; Cricetinae; Disease Models, Animal; Ertapenem; Histocytochemistry; Leptospira interrogans serovar autumnalis; Leptospirosis; Norfloxacin; Survival Analysis; Treatment Outcome

2014
Transport across the outer membrane porin of mycolic acid containing actinomycetales: Nocardia farcinica.
    Biochimica et biophysica acta, 2015, Volume: 1848, Issue:2

    Topics: Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Biological Transport; Cell Membrane; Cell Wall; Ertapenem; Escherichia coli; Gene Expression; Hydrophobic and Hydrophilic Interactions; Kanamycin; Liposomes; Models, Molecular; Mutagenesis, Site-Directed; Mutation; Mycolic Acids; Nocardia; Porins; Recombinant Proteins; Static Electricity; Structural Homology, Protein

2015
Impact of ertapenem on antimicrobial resistance in a sentinel group of Gram-negative bacilli: a 6 year antimicrobial resistance surveillance study.
    The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:3

    Topics: Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Bacterial; Ertapenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Retrospective Studies; Sentinel Surveillance; Tertiary Care Centers

2015
Kinetic and structural requirements for carbapenemase activity in GES-type β-lactamases.
    Biochemistry, 2015, Jan-20, Volume: 54, Issue:2

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Catalytic Domain; Crystallography, X-Ray; Doripenem; Ertapenem; Escherichia coli; Kinetics; Meropenem; Models, Molecular; Thienamycins

2015
The recommended dose of ertapenem poses a potential risk for central nervous system toxicity in haemodialysis patients - case reports and literature reviews.
    Journal of clinical pharmacy and therapeutics, 2015, Volume: 40, Issue:2

    Topics: Aged; Anti-Bacterial Agents; Asian People; beta-Lactams; Central Nervous System Diseases; Dose-Response Relationship, Drug; Ertapenem; Female; Humans; Male; Renal Dialysis; Renal Insufficiency

2015
Chronic osteomyelitis of the mandible: diagnosis and management--an institution's experience over 7 years.
    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2015, Volume: 73, Issue:4

    Topics: Administration, Intravenous; Adult; Age Factors; Aged; Aged, 80 and over; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Chronic Disease; Clindamycin; Doxycycline; Ertapenem; Female; Follow-Up Studies; Fractures, Spontaneous; Humans; Male; Mandibular Diseases; Mandibular Fractures; Middle Aged; Osteomyelitis; Osteosclerosis; Retrospective Studies; Sulbactam; Treatment Outcome; Vancomycin; Young Adult

2015
Carbapenem susceptibility among Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae isolates obtained from patients in intensive care units in Taiwan in 2005, 2007, and 2009.
    Diagnostic microbiology and infectious disease, 2015, Volume: 81, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Enterobacter cloacae; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Escherichia coli; Hospitals, Teaching; Humans; Imipenem; Intensive Care Units; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Taiwan; Thienamycins

2015
Osteomyelitis, discitis, epidural and psoas abscess secondary to Salmonella enterica in a man with diabetes mellitus and newly diagnosed α-thalassaemia trait.
    BMJ case reports, 2015, Jan-21, Volume: 2015

    Topics: Aged; alpha-Thalassemia; Anti-Bacterial Agents; beta-Lactams; Diabetes Mellitus, Type 2; Discitis; Ertapenem; Humans; Laminectomy; Male; Meropenem; Osteomyelitis; Psoas Abscess; Salmonella enterica; Thienamycins; Treatment Outcome

2015
Candida albicans in peritoneal fluid in a patient with hepatic encephalopathy.
    The Israel Medical Association journal : IMAJ, 2014, Volume: 16, Issue:12

    Topics: Administration, Intravenous; Anti-Bacterial Agents; Antifungal Agents; Ascites; Ascitic Fluid; beta-Lactams; Candida albicans; Ertapenem; Escherichia coli; Escherichia coli Infections; Fatal Outcome; Female; Fluconazole; Hepatic Encephalopathy; Hepatitis C; Humans; Liver Cirrhosis; Middle Aged; Paracentesis; Shock, Septic

2014
Association between hypoalbuminemia and mortality among subjects treated with ertapenem versus other carbapenems: prospective cohort study.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2015, Volume: 21, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Hypoalbuminemia; Israel; Middle Aged; Prospective Studies; Risk Factors

2015
Comparison of the effectiveness and antibiotic cost among ceftriaxone, ertapenem, and levofloxacin in treatment of community-acquired complicated urinary tract infections.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2016, Volume: 49, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Community-Acquired Infections; Costs and Cost Analysis; Ertapenem; Escherichia coli; Female; Humans; Length of Stay; Levofloxacin; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Urinary Tract Infections; Young Adult

2016
β-Lactams enhance daptomycin activity against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium in in vitro pharmacokinetic/pharmacodynamic models.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:5

    Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactams; Ceftaroline; Cephalosporins; Daptomycin; Enterococcus faecalis; Enterococcus faecium; Ertapenem; Microbial Sensitivity Tests; Vancomycin; Vancomycin-Resistant Enterococci

2015
Impact of a Dynamic Microbiological Environment on the Clinical Efficacy of Ertapenem and Piperacillin/Tazobactam in the Treatment of Complicated Community-Acquired Intra-Abdominal Infection in Spain: A Cost-Consequence Analysis.
    Applied health economics and health policy, 2015, Volume: 13, Issue:4

    Topics: Anti-Bacterial Agents; APACHE; beta-Lactams; Clinical Trials, Phase III as Topic; Community-Acquired Infections; Cost-Benefit Analysis; Decision Trees; Double-Blind Method; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Ertapenem; Humans; Intraabdominal Infections; Length of Stay; Models, Economic; Monte Carlo Method; Multicenter Studies as Topic; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Spain

2015
Different antimicrobial susceptibility testing methods to detect ertapenem resistance in Enterobacteriaceae: VITEK2, MicroScan, Etest, disk diffusion, and broth microdilution.
    Journal of microbiological methods, 2015, Volume: 112

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Hospitals, University; Humans; Microbial Sensitivity Tests; Predictive Value of Tests; Sensitivity and Specificity; Tertiary Care Centers

2015
Trends in susceptibility of Escherichia coli from intra-abdominal infections to ertapenem and comparators in the United States according to data from the SMART program, 2009 to 2013.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:6

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Ertapenem; Escherichia coli; Genotype; Humans; Intraabdominal Infections; Microbial Sensitivity Tests; United States

2015
A critical interaction between ertapenem and valproic acid.
    Journal of clinical psychopharmacology, 2015, Volume: 35, Issue:3

    Topics: Aged, 80 and over; Anti-Bacterial Agents; Antimanic Agents; beta-Lactams; Bipolar Disorder; Drug Interactions; Ertapenem; Escherichia coli Infections; Humans; Male; Valproic Acid

2015
Ertapenem usage in cancer patients with and without neutropenia: a report on 97 cases from a comprehensive cancer center.
    Infection, 2015, Volume: 43, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Child; Drug Utilization; Ertapenem; Female; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Retrospective Studies; Treatment Outcome; Young Adult

2015
In vitro activity of daptomycin in combination with β-lactams, gentamicin, rifampin, and tigecycline against daptomycin-nonsusceptible enterococci.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:7

    Topics: Ampicillin; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; beta-Lactams; Cathelicidins; Daptomycin; DNA Mutational Analysis; DNA, Bacterial; Drug Combinations; Drug Interactions; Drug Resistance, Bacterial; Drug Synergism; Enterococcus; Enterococcus faecium; Ertapenem; Gentamicins; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Mutation; Rifampin; Vancomycin Resistance

2015
Identification of New Natural CphA Metallo-β-Lactamases CphA4 and CphA5 in Aeromonas veronii and Aeromonas hydrophila Isolates from Municipal Sewage in Central Italy.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:8

    Topics: Aeromonas hydrophila; Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Ertapenem; Imipenem; Italy; Molecular Sequence Data; Point Mutation; Sewage; Thienamycins

2015
Risk Factors for Resistance to β-Lactam/β-Lactamase Inhibitors and Ertapenem in Bacteroides Bacteremia.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:8

    Topics: Adult; Anti-Bacterial Agents; Bacteremia; Bacteroides; Bacteroides Infections; beta-Lactamase Inhibitors; beta-Lactams; Case-Control Studies; Drug Resistance, Bacterial; Drug Therapy, Combination; Ertapenem; Humans; Microbial Sensitivity Tests; Retrospective Studies; Risk Factors; Tertiary Care Centers

2015
Acyl acceptor recognition by Enterococcus faecium L,D-transpeptidase Ldtfm.
    Molecular microbiology, 2015, Volume: 98, Issue:1

    Topics: Acylation; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Binding Sites; Catalytic Domain; Enterococcus faecium; Ertapenem; Models, Molecular; Molecular Docking Simulation; Mutagenesis, Site-Directed; Peptidoglycan; Peptidyl Transferases; Substrate Specificity

2015
The Use of Therapeutic Drug Monitoring to Optimize Treatment of Carbapenem-Resistant Enterobacter Osteomyelitis.
    Microbial drug resistance (Larchmont, N.Y.), 2015, Volume: 21, Issue:6

    Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; C-Reactive Protein; Drug Monitoring; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Ertapenem; Female; Fosfomycin; Humans; Meropenem; Middle Aged; Osteomyelitis; Staphylococcal Infections; Staphylococcus epidermidis; Thienamycins

2015
Trends in Susceptibility Rates and Extended-Spectrum β-Lactamase Production of Klebsiella pneumoniae in Bloodstream Infections Across the United States Veterans Affairs Healthcare System.
    Microbial drug resistance (Larchmont, N.Y.), 2015, Volume: 21, Issue:6

    Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Cefepime; Cefoxitin; Ceftazidime; Cephalosporins; Drug Resistance, Multiple, Bacterial; Ertapenem; Fluoroquinolones; Gene Expression Regulation, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sulbactam; United States; United States Department of Veterans Affairs

2015
Ertapenem Prophylaxis Associated With an Increased Risk of Clostridium difficile Infection Among Surgical Patients.
    Infection control and hospital epidemiology, 2015, Volume: 36, Issue:11

    Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Case-Control Studies; Clostridioides difficile; Clostridium Infections; Cross Infection; Ertapenem; Female; Hospitalization; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Postoperative Complications; Retrospective Studies; Risk Factors

2015
Role of efflux pumps inhibitor in decreasing antibiotic resistance of Klebsiella pneumoniae in a tertiary hospital in North India.
    Journal of infection in developing countries, 2015, Aug-29, Volume: 9, Issue:8

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Doripenem; Drug Resistance, Bacterial; Ertapenem; Genotype; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Polymerase Chain Reaction; Tigecycline

2015
Rapid detection of carbapenemase activity: benefits and weaknesses of MALDI-TOF MS.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2015, Volume: 34, Issue:11

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Ertapenem; Fungi; Humans; Hydrolysis; Kinetics; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Time Factors

2015
In Vitro Activities of Novel Antimicrobial Combinations against Extensively Drug-Resistant Acinetobacter baumannii.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:12

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Area Under Curve; beta-Lactams; Colistin; Colony Count, Microbial; Daptomycin; Drug Administration Schedule; Drug Combinations; Drug Resistance, Multiple, Bacterial; Ertapenem; Humans; Imipenem; Limit of Detection; Microbial Sensitivity Tests; Models, Biological; Models, Statistical

2015
Bactericidal and synergistic activity of double-carbapenem regimen for infections caused by carbapenemase-producing Klebsiella pneumoniae.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2016, Volume: 22, Issue:2

    Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Cross Infection; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Drug Synergism; Ertapenem; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Sepsis; Thienamycins

2016
Post-traumatic chronic bone and joint infection caused by Butyricimonas spp, and treated with high doses of ertapenem administered subcutaneously in a 30-year-old obese man.
    BMJ case reports, 2015, Oct-13, Volume: 2015

    Topics: Accidents, Traffic; Administration, Cutaneous; Adult; Anti-Bacterial Agents; Arm Injuries; Bacteria; beta-Lactams; Bone Diseases; Ertapenem; Fractures, Open; Humans; Infections; Joint Diseases; Male

2015
Molecular Characterization of Carbapenem-Nonsusceptible Enterobacterial Isolates Collected during a Prospective Interregional Survey in France and Susceptibility to the Novel Ceftazidime-Avibactam and Aztreonam-Avibactam Combinations.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1

    Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Bacterial Outer Membrane Proteins; beta-Lactamases; beta-Lactams; Ceftazidime; Dipeptides; Drug Combinations; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Epidemiological Monitoring; Ertapenem; France; Gene Expression; Humans; Microbial Sensitivity Tests; Plasmids; Prevalence; Prospective Studies

2016
Antimicrobial Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China in 2012 and 2013.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1

    Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefoxitin; China; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Gene Expression; Humans; Imipenem; Intraabdominal Infections; Levofloxacin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam

2016
EMERGENCY ROOM: AN UNRECOGNIZED SOURCE OF EXTENDED-SPECTRUM β-LACTAMASE PRODUCING ESCHERICHIA COLI AND KLEBSIELLA PNEUMONIAE.
    The Southeast Asian journal of tropical medicine and public health, 2015, Volume: 46, Issue:1

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cross Infection; Emergency Service, Hospital; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Middle Aged; Plasmids; Thailand; Thienamycins; Young Adult

2015
Ertapenem-Containing Double-Carbapenem Therapy for Treatment of Infections Caused by Carbapenem-Resistant Klebsiella pneumoniae.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1

    Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Carbapenems; Ertapenem; Female; Humans; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Male; Middle Aged; Pneumonia, Bacterial; Survival Analysis; Treatment Outcome; Urinary Tract Infections

2016
Ertapenem-induced acute reversible peripheral neuropathy in chronic kidney disease: 3 case reports.
    Clinical nephrology, 2015, Volume: 84, Issue:6

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Diabetes Mellitus, Type 2; Electroencephalography; Electromyography; Enterococcus faecalis; Ertapenem; Escherichia coli Infections; Gram-Positive Bacterial Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Neurotoxicity Syndromes; Peripheral Nervous System Diseases; Renal Insufficiency, Chronic; Risk Factors; Urinary Tract Infections

2015
Efficacy of ertapenem in severe hidradenitis suppurativa: a pilot study in a cohort of 30 consecutive patients.
    The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:2

    Topics: Adolescent; Adult; Anti-Bacterial Agents; beta-Lactams; Combined Modality Therapy; Ertapenem; Female; Hidradenitis Suppurativa; Humans; Male; Middle Aged; Pilot Projects; Retrospective Studies; Severity of Illness Index; Surgical Procedures, Operative; Treatment Outcome; Young Adult

2016
Ertapenem in the treatment of multidrug-resistant tuberculosis: first clinical experience.
    The European respiratory journal, 2016, Volume: 47, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Antitubercular Agents; beta-Lactams; Drug Therapy, Combination; Ertapenem; Extensively Drug-Resistant Tuberculosis; Female; Humans; Male; Middle Aged; Retrospective Studies; Tuberculosis, Multidrug-Resistant; Young Adult

2016
Camellia sinensis Ameliorates the Efficacy of Last Line Antibiotics Against Carbapenem Resistant Escherichia coli.
    Phytotherapy research : PTR, 2016, Volume: 30, Issue:2

    Topics: Amoxicillin-Potassium Clavulanate Combination; beta-Lactams; Camellia sinensis; Carbapenems; Colistin; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Flavonoids; Free Radical Scavengers; Meropenem; Microbial Sensitivity Tests; Minocycline; Phytochemicals; Plant Extracts; Plant Leaves; Thienamycins; Tigecycline

2016
Short article: Successful faecal coliform sensitivity-based oral ertapenem therapy for chronic antibiotic-refractory pouchitis: a case series.
    European journal of gastroenterology & hepatology, 2016, Volume: 28, Issue:3

    Topics: Administration, Oral; Adult; Anti-Bacterial Agents; beta-Lactams; Chronic Disease; Colitis, Ulcerative; Drug Resistance, Multiple, Bacterial; Endoscopy, Gastrointestinal; Enterobacteriaceae; Ertapenem; Feces; Female; Humans; Microbial Sensitivity Tests; Middle Aged; Pouchitis; Proctocolectomy, Restorative; Treatment Outcome

2016
Rapid Detection of OXA-48-Producing Enterobacteriaceae by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry.
    Journal of clinical microbiology, 2016, Volume: 54, Issue:3

    Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Enterobacteriaceae; Ertapenem; Humans; Sensitivity and Specificity; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

2016
Antimicrobial susceptibility of clinical Enterobacteriaceae isolates at the emergency department in a regional hospital: A threat of extended spectrum beta-lactamase-producers among nursing home residents.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2016, Volume: 49, Issue:4

    Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Blood; Drug Resistance, Multiple, Bacterial; Emergency Service, Hospital; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Nursing Homes; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Proteus Infections; Proteus mirabilis; Retrospective Studies; Sputum; Taiwan; Thienamycins; Urine

2016
Ertapenem failure as therapy for nosocomial spontaneous bacterial peritonitis.
    Gastroenterologia y hepatologia, 2016, Volume: 39, Issue:10

    Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Substitution; Ertapenem; Escherichia coli; Escherichia coli Infections; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hepatorenal Syndrome; Humans; Klebsiella Infections; Klebsiella pneumoniae; Liver Transplantation; Male; Middle Aged; Peritonitis; Postoperative Complications; Treatment Failure

2016
Once-Daily Ceftriaxone Plus Metronidazole Versus Ertapenem and/or Cefoxitin for Pediatric Appendicitis.
    Journal of the Pediatric Infectious Diseases Society, 2017, Mar-01, Volume: 6, Issue:1

    Topics: Abdominal Abscess; Adolescent; Appendectomy; Appendicitis; beta-Lactams; Cefoxitin; Ceftriaxone; Child; Child, Preschool; Cost Savings; Cost-Benefit Analysis; Drug Administration Schedule; Drug Substitution; Drug Therapy, Combination; Ertapenem; Female; Humans; Infant; Laparoscopy; Male; Metronidazole; Retrospective Studies; Treatment Outcome; Young Adult

2017
Ertapenem Associated With Seizures in Treatment of Pyelonephritis in a Chronic Peritoneal Dialysis Patient.
    Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2016, Volume: 20, Issue:1

    Topics: Administration, Intravenous; Anti-Bacterial Agents; beta-Lactams; Drug Dosage Calculations; Ertapenem; Escherichia coli; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Pyelonephritis; Seizures

2016
What Is the Appropriate Meropenem MIC for Screening of Carbapenemase-Producing Enterobacteriaceae in Low-Prevalence Settings?
    Antimicrobial agents and chemotherapy, 2015, Dec-28, Volume: 60, Issue:3

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Enterobacter; Enterobacteriaceae Infections; Ertapenem; Escherichia coli; Escherichia coli Proteins; Humans; Klebsiella; Meropenem; Microbial Sensitivity Tests; Multiplex Polymerase Chain Reaction; Thienamycins

2015
Triton Hodge Test: Improved Protocol for Modified Hodge Test for Enhanced Detection of NDM and Other Carbapenemase Producers.
    Journal of clinical microbiology, 2016, Volume: 54, Issue:3

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Detergents; Ertapenem; Gram-Negative Bacteria; Humans; Meropenem; Microbial Sensitivity Tests; Octoxynol; Sensitivity and Specificity; Thienamycins

2016
Pharmacokinetics of ertapenem in patients with multidrug-resistant tuberculosis.
    The European respiratory journal, 2016, Volume: 47, Issue:4

    Topics: Adolescent; Adult; Aged; Antitubercular Agents; Area Under Curve; beta-Lactams; Ertapenem; Extensively Drug-Resistant Tuberculosis; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Netherlands; Retrospective Studies; Tuberculosis, Multidrug-Resistant; Young Adult

2016
[Analysis of carbapenems by hydrophilic interaction chromatography and its application].
    Se pu = Chinese journal of chromatography, 2015, Volume: 33, Issue:9

    Topics: beta-Lactams; Carbapenems; Chromatography; Doripenem; Drinking Water; Ertapenem; Humans; Hydrophobic and Hydrophilic Interactions; Meropenem; Thienamycins

2015
A physiologically-based pharmacokinetic model for the antibiotic ertapenem.
    Mathematical biosciences and engineering : MBE, 2016, Volume: 13, Issue:1

    Topics: Adipose Tissue; Anti-Bacterial Agents; beta-Lactams; Computer Simulation; Ertapenem; Humans; Infusions, Intravenous; Intestinal Mucosa; Kidney; Metabolic Clearance Rate; Models, Biological; Organ Specificity; Tissue Distribution

2016
Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactams; Cefazolin; Ceftaroline; Cephalosporins; Daptomycin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Ertapenem; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nafcillin; Staphylococcal Infections; Vancomycin; Vancomycin-Resistant Enterococci

2016
Ertapenem therapy for pneumonia requiring hospital admission in elderly people.
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2016, Volume: 29, Issue:1

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Case-Control Studies; Drug Resistance, Bacterial; Ertapenem; Female; Hospital Mortality; Hospitalization; Humans; Male; Patient Discharge; Pneumonia, Bacterial; Retrospective Studies; Treatment Outcome

2016
A Case of Sepsis in a 92-Year-Old Korean Woman Caused by Aerococcus urinae and Identified by Sequencing the 16S Ribosomal RNA Gene.
    Laboratory medicine, 2016, Volume: 47, Issue:2

    Topics: Aerococcus; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Ertapenem; Female; Gram-Positive Bacterial Infections; Humans; Meropenem; Remission Induction; RNA, Ribosomal, 16S; Sepsis; Sequence Analysis, RNA; Thienamycins; Urinary Tract Infections

2016
Predictors of ertapenem therapeutic efficacy in the treatment of urinary tract infections (UTIs) in hospitalized adults: the importance of renal insufficiency and urinary pH.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2016, Volume: 35, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Ertapenem; Female; Hospitalization; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Renal Insufficiency; Retrospective Studies; Treatment Outcome; Urinary Tract Infections; Urine; Young Adult

2016
Severe Bloodstream Infection due to KPC-Producer E coli in a Renal Transplant Recipient Treated With the Double-Carbapenem Regimen and Analysis of In Vitro Synergy Testing: A Case Report.
    Medicine, 2016, Volume: 95, Issue:7

    Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Drug Synergism; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Kidney Transplantation; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Middle Aged; Surgical Wound Infection; Thienamycins

2016
Colistin Increases the Cidal Activity of Antibiotic Combinations Against Multidrug-Resistant Klebsiella pneumoniae: An In Vitro Model Comparing Multiple Combination Bactericidal Testing at One Peak Serum Concentration and Time-Kill Method.
    Microbial drug resistance (Larchmont, N.Y.), 2016, Volume: 22, Issue:5

    Topics: Anti-Bacterial Agents; beta-Lactams; Colistin; Culture Media; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Ertapenem; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Minocycline; Predictive Value of Tests; Rifampin; Thienamycins; Tigecycline

2016
Modulation of Membrane Influx and Efflux in Escherichia coli Sequence Type 131 Has an Impact on Bacterial Motility, Biofilm Formation, and Virulence in a Caenorhabditis elegans Model.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:5

    Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Biofilms; Biological Transport; Caenorhabditis elegans; Cefoxitin; Chloramphenicol; Ertapenem; Escherichia coli; Mutation; Virulence

2016
Susceptibility Testing of Antibiotics That Degrade Faster than the Doubling Time of Slow-Growing Mycobacteria: Ertapenem Sterilizing Effect versus Mycobacterium tuberculosis.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:5

    Topics: Anti-Bacterial Agents; beta-Lactams; Ertapenem; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium tuberculosis

2016
A case of hypermucoviscous Klebsiella pneumoniae liver abscess syndrome in an Iraqi male.
    QJM : monthly journal of the Association of Physicians, 2016, Volume: 109, Issue:7

    Topics: Administration, Intravenous; Anti-Bacterial Agents; beta-Lactams; Communicable Diseases, Emerging; Decompression, Surgical; Drainage; Ertapenem; Humans; Iraq; Klebsiella Infections; Klebsiella pneumoniae; Liver Abscess; Male; Microbial Sensitivity Tests; Middle Aged; Syndrome; Treatment Outcome

2016
In Vitro Comparison of Ertapenem, Meropenem, and Imipenem against Isolates of Rapidly Growing Mycobacteria and Nocardia by Use of Broth Microdilution and Etest.
    Journal of clinical microbiology, 2016, Volume: 54, Issue:6

    Topics: Anti-Bacterial Agents; beta-Lactams; Ertapenem; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Nocardia; Nontuberculous Mycobacteria; Thienamycins

2016
[Investigation of carbapenemases in carbapenem-resistant Escherichia coli and Klebsiella pneumoniae strains isolated in 2014 in Turkey].
    Mikrobiyoloji bulteni, 2016, Volume: 50, Issue:1

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Proteins; Humans; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Multiplex Polymerase Chain Reaction; Phenotype; Thienamycins; Turkey

2016
Daptomycin-β-Lactam Combinations in a Rabbit Model of Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Endocarditis.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:7

    Topics: Animals; beta-Lactams; Ceftriaxone; Cephalosporins; Daptomycin; Endocarditis, Bacterial; Ertapenem; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Rabbits

2016
Mechanisms of ertapenem resistance in Enterobacteriaceae isolates in a tertiary university hospital.
    Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 2016, Volume: 64, Issue:5

    Topics: Aged; Aged, 80 and over; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Electrophoresis, Polyacrylamide Gel; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Hospitals, University; Humans; Infant; Male; Microbial Sensitivity Tests; Molecular Epidemiology; Tertiary Care Centers

2016
Carbapenemase-producing Escherichia coli is becoming more prevalent in Spain mainly because of the polyclonal dissemination of OXA-48.
    The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:8

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Disk Diffusion Antimicrobial Tests; Ertapenem; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Genetic Variation; Humans; Male; Middle Aged; Molecular Epidemiology; Multilocus Sequence Typing; Phylogeny; Polymerase Chain Reaction; Prevalence; Spain

2016
Emergence of Serratia marcescens isolates possessing carbapenem-hydrolysing β-lactamase KPC-2 from China.
    The Journal of hospital infection, 2016, Volume: 94, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; China; DNA, Bacterial; Ertapenem; Female; Genotype; Hospitals; Humans; Hydrolysis; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Polymerase Chain Reaction; Serratia Infections; Serratia marcescens; Thienamycins; Young Adult

2016
An Immunocompromised Child with Bloodstream Infection Caused by Two Escherichia coli Strains, One Harboring NDM-5 and the Other Harboring OXA-48-Like Carbapenemase.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:6

    Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactamases; beta-Lactams; Ciprofloxacin; Ertapenem; Escherichia coli; Female; Gentamicins; Humans; Immunocompromised Host; Meropenem; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam; Thienamycins; Tobramycin

2016
Comparison of fosfomycin to ertapenem for outpatient or step-down therapy of extended-spectrum β-lactamase urinary tract infections.
    International journal of antimicrobial agents, 2016, Volume: 48, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Fosfomycin; Humans; Male; Middle Aged; Outpatients; Patient Readmission; Retrospective Studies; Treatment Outcome; Urinary Tract Infections; Young Adult

2016
Ertapenem in outpatient parenteral antimicrobial therapy for complicated urinary tract infections.
    Journal of chemotherapy (Florence, Italy), 2017, Volume: 29, Issue:1

    Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Ambulatory Care; Anti-Bacterial Agents; beta-Lactams; Ertapenem; Female; Humans; Male; Middle Aged; Prospective Studies; Urinary Tract Infections; Young Adult

2017
Evaluation of different pretreatment protocols to detect accurately clinical carbapenemase-producing Enterobacteriaceae by MALDI-TOF.
    The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:10

    Topics: Acinetobacter; Anti-Bacterial Agents; Bacteria; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Clinical Laboratory Techniques; Enterobacter aerogenes; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Hydrolysis; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

2016
[Adequacy of treatment with ertapenem according to the criterion approved for the infection´s commission of a specialty hospital].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2016, Volume: 29, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Cross Infection; Ertapenem; Female; Guideline Adherence; Hospitals; Humans; Inappropriate Prescribing; Internal Medicine; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Urinary Tract Infections; Young Adult

2016
The Effect of Different Carbapenem Antibiotics (Ertapenem, Imipenem/Cilastatin, and Meropenem) on Serum Valproic Acid Concentrations.
    Therapeutic drug monitoring, 2016, Volume: 38, Issue:5

    Topics: Anti-Bacterial Agents; Anticonvulsants; beta-Lactams; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Interactions; Ertapenem; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Retrospective Studies; Thienamycins; Valproic Acid

2016
Plasma and intraprostatic concentrations of ertapenem following preoperative single dose administration: a single-centre prospective experience and clinical implications-the ERTAPRO study.
    International journal of antimicrobial agents, 2016, Volume: 48, Issue:2

    Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Chromatography, Liquid; Ertapenem; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Plasma; Preoperative Care; Prostate; Tandem Mass Spectrometry; Young Adult

2016
Comparison of the Modified-Hodge test, Carba NP test, and carbapenem inactivation method as screening methods for carbapenemase-producing Enterobacteriaceae.
    Journal of microbiological methods, 2016, Volume: 128

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Enterobacteriaceae; Ertapenem; Imipenem; Meropenem; Microbial Sensitivity Tests; Sensitivity and Specificity; Thienamycins

2016
A pharmacokinetic-pharmacodynamic model characterizing the emergence of resistant Escherichia coli subpopulations during ertapenem exposure.
    The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:9

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Microbial Sensitivity Tests; Microbial Viability; Porins; Selection, Genetic; Time Factors

2016
Integrated pharmacokinetic-pharmacodynamic modelling to evaluate antimicrobial prophylaxis in abdominal surgery.
    The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:10

    Topics: Abdomen; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Bacteria, Anaerobic; Bacteroides fragilis; beta-Lactams; Cefoxitin; Clindamycin; Computer Simulation; Drug Dosage Calculations; Ertapenem; Female; Gentamicins; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Monte Carlo Method; Surgical Wound Infection

2016
IMP-27, a Unique Metallo-β-Lactamase Identified in Geographically Distinct Isolates of Proteus mirabilis.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:10

    Topics: Aztreonam; beta-Lactamases; beta-Lactams; Ceftazidime; Drug Resistance, Bacterial; Ertapenem; Hydrolysis; Integrons; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Proteus Infections; Proteus mirabilis; United States

2016
Massive paediatric cervicofacial actinomycoses masquerading as an ulcerative malignancy.
    BMC infectious diseases, 2016, Aug-15, Volume: 16, Issue:1

    Topics: Actinomycosis, Cervicofacial; Administration, Intravenous; Anti-Bacterial Agents; beta-Lactams; Child; Diagnosis, Differential; Ertapenem; Female; Humans; Penicillins; Prognosis

2016
Cefazolin and Ertapenem, a Synergistic Combination Used To Clear Persistent Staphylococcus aureus Bacteremia.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:11

    Topics: Aged, 80 and over; Animals; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cefazolin; Disease Models, Animal; Disk Diffusion Antimicrobial Tests; Drug Synergism; Drug Therapy, Combination; Ertapenem; Female; Humans; Methicillin-Resistant Staphylococcus aureus; Mice; Staphylococcal Infections; Staphylococcal Skin Infections

2016
RP-HPLC×HILIC chromatography for quantifying ertapenem sodium with a look at green chemistry.
    Talanta, 2016, Nov-01, Volume: 160

    Topics: Anti-Bacterial Agents; beta-Lactams; Chromatography, Liquid; Ertapenem; Green Chemistry Technology

2016
The use of ertapenem for the treatment of community-acquired pneumonia in routine hospital practice: a matched cohort study.
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2016, Volume: 29, Issue:5

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Cohort Studies; Community-Acquired Infections; Comorbidity; Ertapenem; Female; Frail Elderly; Hospitalization; Humans; Male; Middle Aged; Nursing Homes; Pneumonia; Retrospective Studies; Risk Factors

2016
Risk factors for hospital-acquired bacteremia due to carbapenem-resistant Pseudomonas aeruginosa in a Colombian hospital.
    Biomedica : revista del Instituto Nacional de Salud, 2016, Feb-23, Volume: 36, Issue:0

    Topics: Bacteremia; beta-Lactams; Carbapenems; Case-Control Studies; Ciprofloxacin; Drug Resistance, Bacterial; Ertapenem; Hospitals; Humans; Meropenem; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Thienamycins

2016
Outbreak of OXA-48-Producing Klebsiella pneumoniae Involving a Sequence Type 101 Clone in Batna University Hospital, Algeria.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:12

    Topics: Algeria; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Clone Cells; Conjugation, Genetic; Disease Outbreaks; Ertapenem; Gene Expression; Hospitals, University; Humans; Klebsiella Infections; Klebsiella pneumoniae; Nephritis; Phylogeny; Plasmids

2016
River otter bite in a 52-year-old woman: managing animal bites.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2016, Dec-06, Volume: 188, Issue:17-18

    Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Bites and Stings; Cellulitis; Disease Management; Ertapenem; Female; Humans; Leg Injuries; Middle Aged; Otters; Post-Exposure Prophylaxis; Rabies; Rabies Vaccines; Suture Techniques; Tetanus; Tetanus Toxoid; Wound Infection

2016
The Plasma Protein Binding Proteome of Ertapenem: A Novel Compound-Centric Proteomic Approach for Elucidating Drug-Plasma Protein Binding Interactions.
    ACS chemical biology, 2016, 12-16, Volume: 11, Issue:12

    Topics: Anti-Bacterial Agents; beta-Lactams; Blood Proteins; Ertapenem; Humans; Models, Molecular; Protein Binding; Proteome; Proteomics; Staphylococcal Infections; Staphylococcus aureus

2016
Bypass graft infection and bacteremia caused by Anaerostipes caccae: First report of human infection caused by a recently described gut anaerobe.
    Anaerobe, 2016, Volume: 42

    Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anastomosis, Surgical; Anti-Bacterial Agents; beta-Lactams; Blood Culture; Clostridiales; Ertapenem; Female; Gram-Positive Bacterial Infections; Humans; Metronidazole; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Surgical Wound Infection; Vancomycin

2016
Distribution of ESBLs, AmpC β-lactamases and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal and urinary tract infections in the Asia-Pacific region during 2008-14: results from the Study for Monitoring Antimicrobial Resistance Tr
    The Journal of antimicrobial chemotherapy, 2017, Volume: 72, Issue:1

    Topics: Anti-Bacterial Agents; Asia; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Epidemiological Monitoring; Ertapenem; Humans; Microbial Sensitivity Tests; Multiplex Polymerase Chain Reaction; Pacific Islands; Urinary Tract Infections

2017
Antimicrobial susceptibility testing in predicting the presence of carbapenemase genes in Enterobacteriaceae in South Africa.
    BMC infectious diseases, 2016, Oct-04, Volume: 16, Issue:1

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Enterobacteriaceae; Ertapenem; Humans; Microbial Sensitivity Tests; Real-Time Polymerase Chain Reaction; South Africa

2016
Morphological changes induced by β-lactam antibiotics observed on Gram staining.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2017, Volume: 23, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Ertapenem; Gentian Violet; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Osteomyelitis; Phenazines

2017
Ertapenem-Induced Acute Interstitial Nephritis (AIN) in a Case of Protein S Deficiency and Factor V Leiden Mutation with Deep Vein Thrombosis.
    The Journal of the Association of Physicians of India, 2016, Volume: 64, Issue:3

    Topics: Administration, Intravenous; beta-Lactams; Biopsy; Ertapenem; Factor V; Femoral Vein; Humans; Male; Middle Aged; Mutation; Nephritis, Interstitial; Prednisolone; Protein S Deficiency; Thrombophilia; Venous Thrombosis

2016
Effect of High N-Acetylcysteine Concentrations on Antibiotic Activity against a Large Collection of Respiratory Pathogens.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:12

    Topics: Acetylcysteine; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Drug Combinations; Drug Interactions; Enterobacter cloacae; Ertapenem; Escherichia coli; Humans; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Penicillins; Pseudomonas aeruginosa; Respiratory Tract Infections; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes; Thienamycins

2016
Population Pharmacokinetics and Target Attainment of Ertapenem in Plasma and Tissue Assessed via Microdialysis in Morbidly Obese Patients after Laparoscopic Visceral Surgery.
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:1

    Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Ertapenem; Female; Humans; Laparoscopy; Microbial Sensitivity Tests; Microdialysis; Middle Aged; Monte Carlo Method; Obesity, Morbid

2017
Clonal Spread of Colistin-Resistant Klebsiella pneumoniae Coproducing KPC and VIM Carbapenemases in Neonates at a Tunisian University Hospital.
    Microbial drug resistance (Larchmont, N.Y.), 2017, Volume: 23, Issue:4

    Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Chloramphenicol; Clone Cells; Colistin; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Ertapenem; Female; Gene Expression; Hospitals, University; Humans; Imipenem; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Minocycline; Retrospective Studies; Survival Analysis; Tigecycline; Tunisia

2017
Antimicrobial susceptibility of Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Asia-Pacific countries: SMART 2013-2015.
    Journal of medical microbiology, 2017, Volume: 66, Issue:1

    Topics: Acinetobacter baumannii; Amikacin; Anti-Infective Agents; Asia; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacter; Ertapenem; Gram-Negative Bacteria; Hospitalization; Humans; Imipenem; Intraabdominal Infections; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Urinary Tract Infections

2017
Treatment efficacy and superinfection rates in complicated urinarytract infections treated with ertapenem or piperacillin tazobactam.
    Turkish journal of medical sciences, 2016, Dec-20, Volume: 46, Issue:6

    Topics: Anti-Bacterial Agents; beta-Lactams; Ertapenem; Humans; Penicillanic Acid; Piperacillin; Retrospective Studies; Superinfection; Tazobactam; Treatment Outcome

2016
Development of an algorithm for phenotypic screening of carbapenemase-producing Enterobacteriaceae in the routine laboratory.
    BMC infectious diseases, 2017, 01-17, Volume: 17, Issue:1

    Topics: Algorithms; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Cefepime; Cephalosporins; Clavulanic Acids; Drug Resistance, Bacterial; Enterobacteriaceae; Ertapenem; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Tazobactam; Thienamycins; Ticarcillin

2017
Epidemiology and susceptibility of pathogens from SMART 2011-12 Turkey: evaluation of hospital-acquired versus community-acquired urinary tract infections and ICU- versus non-ICU-associated intra-abdominal infections.
    The Journal of antimicrobial chemotherapy, 2017, 05-01, Volume: 72, Issue:5

    Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefoxitin; Community-Acquired Infections; Cross Infection; Enterobacteriaceae; Ertapenem; Escherichia coli; Humans; Imipenem; Intensive Care Units; Intraabdominal Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Turkey; Urinary Tract Infections

2017
Occurrence of bla
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2017, Volume: 23, Issue:4

    Topics: Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Conjugation, Genetic; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; India; Plasmids

2017
Carbapenem MICs in Escherichia coli and Klebsiella Species Producing Extended-Spectrum β-Lactamases in Critical Care Patients from 2001 to 2009.
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:4

    Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Critical Care; Doripenem; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Gene Expression; Genotype; Humans; Imipenem; Klebsiella; Klebsiella Infections; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Thienamycins; United States

2017
Role of piperacillin/tazobactam as a carbapenem-sparing antibiotic for treatment of acute pyelonephritis due to extended-spectrum β-lactamase-producing Escherichia coli.
    International journal of antimicrobial agents, 2017, Volume: 49, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Hospitals, University; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pyelonephritis; Republic of Korea; Retrospective Studies; Survival Analysis; Treatment Failure; Young Adult

2017
Rapid detection of carbapenemase-producing Klebsiella pneumoniae strains derived from blood cultures by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS).
    BMC microbiology, 2017, 03-08, Volume: 17, Issue:1

    Topics: Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Blood Culture; Cell Culture Techniques; Cross Infection; Enterobacteriaceae; Ertapenem; Humans; Italy; Klebsiella Infections; Klebsiella pneumoniae; Laboratories; Proteomics; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Time Factors

2017
Combinations of avibactam and carbapenems exhibit enhanced potencies against drug-resistant Mycobacterium abscessus.
    Future microbiology, 2017, Volume: 12

    Topics: Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactams; Carbapenems; Drug Resistance, Multiple, Bacterial; Ertapenem; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Thienamycins

2017
IMI-2 carbapenemase in a clinical Klebsiella variicola isolated in the UK.
    The Journal of antimicrobial chemotherapy, 2017, 07-01, Volume: 72, Issue:7

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Ertapenem; Gene Transfer, Horizontal; Humans; Imipenem; Klebsiella; Meropenem; Plasmids; Thienamycins; United Kingdom

2017
Difficult Cases of Odontogenic Deep Neck Infections: A Report of Three Patients.
    Balkan medical journal, 2017, Apr-05, Volume: 34, Issue:2

    Topics: Adult; Ampicillin; beta-Lactams; Clindamycin; Drainage; Ertapenem; Focal Infection, Dental; Gentamicins; Humans; Infections; Klebsiella Infections; Male; Middle Aged; Neck; Periodontal Abscess; Streptococcal Infections; Sulbactam

2017
First Case of NDM-1-Producing Klebsiella pneumoniae in Annaba University Hospital, Algeria.
    Microbial drug resistance (Larchmont, N.Y.), 2017, Volume: 23, Issue:7

    Topics: Adult; Algeria; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Clone Cells; Drug Resistance, Multiple, Bacterial; Ertapenem; Gene Expression; Hospitals, University; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phylogeny; Plasmids

2017
Transrectal ultrasound guided prostate biopsy in the era of increasing fluoroquinolone resistance: prophylaxis with single-dose ertapenem.
    World journal of urology, 2017, Volume: 35, Issue:11

    Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Biopsy, Large-Core Needle; Ciprofloxacin; Endosonography; Ertapenem; Humans; Image-Guided Biopsy; Male; Middle Aged; Prostate; Retrospective Studies; Surgical Wound Infection; Urinary Tract Infections

2017
Differential flap dynamics in l,d-transpeptidase2 from mycobacterium tuberculosis revealed by molecular dynamics.
    Molecular bioSystems, 2017, Jun-01, Volume: 13, Issue:6

    Topics: beta-Lactams; Carbapenems; Ertapenem; Imipenem; Meropenem; Molecular Dynamics Simulation; Mycobacterium tuberculosis; Principal Component Analysis; Thienamycins

2017
Every cloud has a silver lining.
    Internal and emergency medicine, 2017, Volume: 12, Issue:6

    Topics: Anti-Bacterial Agents; beta-Lactams; Diagnosis, Differential; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Ertapenem; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Multiple Organ Failure; Thienamycins

2017
Oligopeptides as full-length New Delhi metallo-β-lactamase-1 (NDM-1) inhibitors.
    PloS one, 2017, Volume: 12, Issue:5

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Catalytic Domain; Drug Synergism; Enzyme Inhibitors; Ertapenem; Escherichia coli; Hydrogen Bonding; Ions; Molecular Docking Simulation; Molecular Structure; Oligopeptides; Protein Binding; Pseudomonas aeruginosa; Static Electricity; Water; Zinc

2017
Synergistic activities of meropenem double and triple combinations against carbapenemase-producing Enterobacteriaceae.
    Diagnostic microbiology and infectious disease, 2017, Volume: 88, Issue:4

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenem-Resistant Enterobacteriaceae; Drug Synergism; Ertapenem; Humans; Meropenem; Polymyxins; Rifampin; Thienamycins

2017
Carbapenemase-Producing Enterobacteriaceae Isolates from Edo State, Nigeria.
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:8

    Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenem-Resistant Enterobacteriaceae; Cefotaxime; Ceftazidime; Disk Diffusion Antimicrobial Tests; Enterobacteriaceae Infections; Ertapenem; Fluoroquinolones; Humans; Nigeria; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination

2017
Patterns of antimicrobial resistance in intensive care unit patients: a study in Vietnam.
    BMC infectious diseases, 2017, 06-15, Volume: 17, Issue:1

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; beta-Lactams; Ceftazidime; Ciprofloxacin; Drug Resistance, Bacterial; Ertapenem; Female; Humans; Imipenem; Intensive Care Units; Klebsiella; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections; Vietnam

2017
Impact of broad-spectrum antimicrobial treatment on the ecology of intestinal flora.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2018, Volume: 51, Issue:5

    Topics: Acinetobacter baumannii; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; beta-Lactams; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Ertapenem; Feces; Female; Fluoroquinolones; Gastrointestinal Microbiome; Humans; Male; Microbial Viability; Middle Aged; Moxifloxacin; Pseudomonas aeruginosa; Taiwan

2018
Sterilizing Effect of Ertapenem-Clavulanate in a Hollow-Fiber Model of Tuberculosis and Implications on Clinical Dosing.
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:9

    Topics: Antitubercular Agents; beta-Lactams; Clavulanic Acid; Computer Simulation; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ertapenem; Humans; Microbial Sensitivity Tests; Monte Carlo Method; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant

2017
Zero and second-derivative synchronous fluorescence spectroscopy for the quantification of two non-classical β-lactams in pharmaceutical vials: Application to stability studies.
    Luminescence : the journal of biological and chemical luminescence, 2017, Volume: 32, Issue:8

    Topics: beta-Lactams; Chelating Agents; Ertapenem; Meropenem; Molecular Structure; Spectrometry, Fluorescence; Terbium; Thermodynamics; Thienamycins; Zirconium

2017
Effectiveness of a Double-Carbapenem Regimen in a KPC-Producing Klebsiella pneumoniae Infection in an Immunocompromised Patient.
    Microbial drug resistance (Larchmont, N.Y.), 2018, Volume: 24, Issue:2

    Topics: Adult; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; beta-Lactams; Drug Combinations; Ertapenem; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Sarcoma, Myeloid; Sepsis; Thienamycins; Transplantation, Homologous; Treatment Outcome

2018
Probing the binding affinities of imipenem and ertapenem for outer membrane carboxylate channel D1 (OccD1) from P. aeruginosa: simulation studies.
    Journal of molecular modeling, 2017, Volume: 23, Issue:8

    Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactams; Computational Biology; Ertapenem; Imipenem; Molecular Dynamics Simulation; Porins; Protein Binding; Pseudomonas aeruginosa

2017
Risk factors associated with the development of seizures among adult patients treated with ertapenem: A matched case-control study.
    PloS one, 2017, Volume: 12, Issue:7

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Case-Control Studies; Ertapenem; Female; Humans; Male; Seizures

2017
Translational Efficacy of Humanized Exposures of Cefepime, Ertapenem, and Levofloxacin against Extended-Spectrum-β-Lactamase-Producing Escherichia coli in a Murine Model of Complicated Urinary Tract Infection.
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:11

    Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Disease Models, Animal; Ertapenem; Escherichia coli Infections; Female; Humans; Levofloxacin; Mice, Inbred ICR; Microbial Sensitivity Tests; Urinary Tract Infections; Uropathogenic Escherichia coli

2017
A Triple-Disk Enrichment Method for Carbapenem-Resistant Enterobacteriaceae (CRE) Screening.
    Journal of clinical microbiology, 2017, Volume: 55, Issue:12

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactams; Carbapenem-Resistant Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Fluconazole; Humans; Linezolid; Microbial Sensitivity Tests; Polymerase Chain Reaction; Sensitivity and Specificity

2017
In vitro interaction of ceftazidime-avibactam in combination with different antimicrobials against KPC-producing Klebsiella pneumoniae clinical isolates.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2017, Volume: 65

    Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactams; Ceftazidime; Cephalosporins; Drug Combinations; Ertapenem; Gentamicins; Humans; Imipenem; Italy; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Minocycline; Thienamycins; Tigecycline

2017
Seizure Induced by Ertapenem in an Elderly Patient with Dementia.
    The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists, 2017, Oct-01, Volume: 32, Issue:10

    Topics: Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Dementia; Ertapenem; Female; Humans; Seizures

2017
The use of cefepime as a carbapenem-sparing antibiotic for treating uncomplicated acute pyelonephritis caused by extended-spectrum β-lactamase producing Escherichia coli.
    Infectious diseases (London, England), 2018, Volume: 50, Issue:3

    Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Cefepime; Cephalosporins; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Hospitals, University; Humans; Male; Middle Aged; Pyelonephritis; Republic of Korea; Retrospective Studies; Risk Factors; Treatment Outcome

2018
Copper Ions and Coordination Complexes as Novel Carbapenem Adjuvants.
    Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:2

    Topics: Adjuvants, Pharmaceutic; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Coordination Complexes; Copper; Ertapenem; Escherichia coli; Humans; Ions; Meropenem; Microbial Sensitivity Tests; Urinary Tract Infections

2018
Update of incidence and antimicrobial susceptibility trends of Escherichia coli and Klebsiella pneumoniae isolates from Chinese intra-abdominal infection patients.
    BMC infectious diseases, 2017, 12-18, Volume: 17, Issue:1

    Topics: Abdomen; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; China; Community-Acquired Infections; Cross Infection; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Incidence; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests

2017
Increased exposure to extended-spectrum β-lactamase-producing multidrug-resistant Enterobacteriaceae through the consumption of chicken and sushi products.
    International journal of food microbiology, 2018, Mar-23, Volume: 269

    Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefpodoxime; Ceftizoxime; Chickens; Chloramphenicol; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Ertapenem; Fishes; Food Contamination; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phylogeny; Poultry; Prevalence; Quinolones; Raw Foods; Salmon; Spain; Tetracyclines; Trout

2018
A nitrocefin disc supplemented with ertapenem for rapid screening of carbapenemase-producing Enterobacteriaceae.
    Diagnostic microbiology and infectious disease, 2018, Volume: 91, Issue:1

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Disk Diffusion Antimicrobial Tests; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Microbial Sensitivity Tests; Sensitivity and Specificity

2018
Global survey of Klebsiella pneumoniae major porins from ertapenem non-susceptible isolates lacking carbapenemases.
    Journal of medical microbiology, 2018, Volume: 67, Issue:3

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; DNA, Bacterial; Electrophoresis, Polyacrylamide Gel; Ertapenem; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mutation; Porins

2018
Antimicrobial susceptibility trends and evolution of isolates with extended spectrum β-lactamases among Gram-negative organisms recovered during the SMART study in Spain (2011-2015).
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2018, Volume: 31, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cross Infection; Drug Combinations; Ertapenem; Escherichia coli; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Spain

2018
Activity of Ertapenem against Enterobacteriaceae in seven global regions-SMART 2012-2016.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2018, Volume: 37, Issue:8

    Topics: Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Global Health; Humans

2018
Rapid detection of carbapenemase activity of Enterobacteriaceae isolated from positive blood cultures by MALDI-TOF MS.
    Annals of clinical microbiology and antimicrobials, 2018, May-18, Volume: 17, Issue:1

    Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; beta-Lactams; Blood Culture; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Ertapenem; Humans; Hydrolysis; Microbial Sensitivity Tests; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

2018
Environmental superbugs: The case study of Pedobacter spp.
    Environmental pollution (Barking, Essex : 1987), 2018, Volume: 241

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Ciprofloxacin; Drug Resistance, Microbial; Ertapenem; Escherichia coli; Humans; Meropenem; Microbial Sensitivity Tests; Pedobacter; Thienamycins

2018
Carbapenem susceptibilities of Gram-negative pathogens in intra-abdominal and urinary tract infections: updated report of SMART 2015 in China.
    BMC infectious diseases, 2018, Sep-29, Volume: 18, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactams; China; Enterobacteriaceae; Ertapenem; Escherichia coli; Gram-Negative Bacteria; Humans; Imipenem; Intraabdominal Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Urinary Tract Infections

2018
Modeling Ertapenem: the impact of body mass index on distribution of the antibiotic in the body.
    Mathematical biosciences and engineering : MBE, 2019, 01-15, Volume: 16, Issue:2

    Topics: Algorithms; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Body Mass Index; Body Weight; Carbapenems; Computer Simulation; Drug Administration Schedule; Ertapenem; Female; Humans; Male; Models, Theoretical; Obesity; Thinness

2019
Higher rates of carbapenem-related seizures in older hospitalised adults.
    Internal medicine journal, 2020, Volume: 50, Issue:1

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Ertapenem; Female; Hospitalization; Humans; Imipenem; Logistic Models; Male; Meropenem; Seizures; Singapore

2020
Faropenem resistance causes in vitro cross-resistance to carbapenems in ESBL-producing Escherichia coli.
    International journal of antimicrobial agents, 2020, Volume: 55, Issue:3

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Porins

2020
Mechanistic Insights Into the Differential Efficacy of Daptomycin Plus β-Lactam Combinations Against Daptomycin-Resistant Enterococcus faecium.
    The Journal of infectious diseases, 2020, 10-01, Volume: 222, Issue:9

    Topics: Ampicillin; Animals; Anti-Bacterial Agents; beta-Lactams; Ceftaroline; Cephalosporins; Daptomycin; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecium; Ertapenem; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Rats; Sequence Alignment; Transcriptome

2020
Ertapenem and Faropenem against Mycobacterium tuberculosis: in vitro testing and comparison by macro and microdilution.
    BMC microbiology, 2020, 08-31, Volume: 20, Issue:1

    Topics: Amoxicillin-Potassium Clavulanate Combination; Antitubercular Agents; beta-Lactams; Drug Resistance, Bacterial; Ertapenem; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis; Tuberculosis, Multidrug-Resistant

2020
Ertapenem neurotoxicity in liver transplantation.
    Revista espanola de enfermedades digestivas, 2022, Volume: 114, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactams; Ertapenem; Humans; Liver Transplantation; Microbial Sensitivity Tests; Neurotoxicity Syndromes

2022
Evaluating the Effects of Ertapenem and Meropenem on Tacrolimus.
    Journal of pharmacy practice, 2023, Volume: 36, Issue:6

    Topics: Anti-Bacterial Agents; beta-Lactams; Ertapenem; Humans; Meropenem; Retrospective Studies; Tacrolimus

2023
Proteomics profiling of ertapenem challenged major porin deficient carbapenem-resistant Klebsiella pneumoniae.
    Journal of proteomics, 2022, 09-30, Volume: 268

    Topics: Anti-Bacterial Agents; Antioxidants; ATP-Binding Cassette Transporters; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Ertapenem; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Porins; Proteomics

2022
Ertapenem-induced neurotoxicity in an end-stage renal disease patient on intermittent haemodialysis: a case report.
    BMC nephrology, 2022, 11-08, Volume: 23, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Ertapenem; Humans; Kidney Failure, Chronic; Male; Middle Aged; Neurotoxicity Syndromes; Renal Dialysis; Renal Insufficiency, Chronic

2022
Evaluation of Oral Tebipenem as a Step-Down Therapy following Intravenous Ertapenem against Extended-Spectrum β-Lactamase-Producing Escherichia coli in a Hollow-Fiber
    Antimicrobial agents and chemotherapy, 2023, 03-16, Volume: 67, Issue:3

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Ertapenem; Escherichia coli; Humans

2023